var title_f42_17_43280="Eyelid lesion in blastomycosis";
var content_f42_17_43280=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F78481&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F78481&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Disseminated blastomycosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 242px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Nodular lesion of the left upper eyelid with a granular surface due to disseminated blastomycosis. Courtesy of Charles V Sanders, MD.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from The Skin and Infection: A Color Atlas and Text. Sanders CV, Nesbitt LT Jr (Eds) Williams and Wilkins, Baltimore 1995.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_17_43280=[""].join("\n");
var outline_f42_17_43280=null;
var title_f42_17_43281="Botulinum toxin injection sites for mouth frown";
var content_f42_17_43281=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F69123&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F69123&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 521px\">",
"   <div class=\"ttl\">",
"    Example of botulinum toxin injection sites for mouth frown",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 501px; height: 347px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The two lateral injections represent injection into the posterior margin of the DAO muscle. The medial injections are placed at the insertion points of the mentalis muscles.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_17_43281=[""].join("\n");
var outline_f42_17_43281=null;
var title_f42_17_43282="Ileoanal hand-sewn pouch anastomosis";
var content_f42_17_43282=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F83919&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F83919&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 522px\">",
"   <div class=\"ttl\">",
"    Ileoanal hand-sewn pouch anastomosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 502px; height: 382px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF+AfYDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDlQp7hce/NJsGflwQeuO1PUHbzzUe45xjBrO9zpGyZGBnI9QKjBbbnoKlYOSecCkUMpyQTmlzMLERB289KbI2SAxwKkkJ/hqAgkgsMj3o5gsRs3OByKjIIxuHJ6VO+MDioZBuQ59KL3J5e40gAkMOoprguDxwKecCMH1ANRbyHO3n1p81tAsMUBTnPNQzvhsgY9anYls5FVps7Tzhun/16TkOwkeHkdZJPIIG5WYE5YdvbNKZgpAYfUCoZmaQsXJdj3qGMgsobO4VPO0LluWXmGRkZGOgqPfuVigx75pl1u2r5ZpE3FTuwa1hO2pnKF9CSG6IlOGGVxxW1p9yGBBbtgZrnZJFVmCjOD2HQ0Wt2wbDEZr28Bik/dkeRjMO4+8jodQXKfLzWDJkTYOcHqM1uW0qzx4PBrP1OzMYZkIJ9q3x1CUlzxMcJWUXysoGZhgDO4cHmknl2qAPlYnqelVS7oxJIyOn/ANeklk3ruY4I7Y4NfOubi9T29GtCaR/3RIYhi2CvP51Gs0jllIzjnn0oE01y26YqzBdofoMAcVFvIwqsBnqSOtbwqJrUwqU2QySTMhlxhN238adHI5y2dvPJPSmXLLHGyFgVJzxUiW7tZhkJznGOxq+e5lyNakf2jDfL0z61ci1DZgNkZPXNZDhgH3KBk5AAojby5VZ0LRrywx2qVINUdPb3kY+bndV2ymWWXdcuFXBwa4uKRjnBAOenpVtL6ZVKvt/KrTRrGdjduZg5BCkKDzS6bIHlJjbA9qwRfuEZFx8w7DmtDw87Mdz889CK7MGuaqrHNjZ/uzqmkIgb6Vy2qS7bn0PTFdY0ebctjjFcZrvyXBBI56Zr0cwp3hc83CT9+wRXT8jPOP6VItw7Diq9spkTIxT44yVG1hmvBbZ63KWYz848zkEVYHlkjaMHNU0RoziVxntVqBPN+/8AmOKHNGsady9auXYjgqo61M5GGI61VjRkYLGwKVNMDuA7Cs2zaCsIvmqwKknHY1ZguAX5WoYmJOG7UyRDuDR5Dd6zbNYrU03kxkqKc8yNbIyOfNJIdMcAdjms9SSwGT71dg2GLB60rjt2FjOXJbgHke9SkhTSKqh87uO1OaPcxYdKSkO19xkbnd+NXlYeUDuUNnG3v9aqFMDPGc1JuCruPSm3cdixkg571BNKQOailuV2sQenpVeOTzWJxxXfgMM6s7taHn47FKjG3UuWoDMCRzWtC6Qxb+KxlbYODzUct02MZwK+kcVGNnsfPQqOUtNzRudSklfAJxTcscDPXvWfGwYj2rQToBnPvXymOqJ1Wo7H1GDi/Zrm3J5GLCMMo3KuCR0NMZjjgYpEOV5py9eRXFc6xuWPrTASatKuR2qIrg9KHIpIAcDpT4z2zTlXK5xTEHzmlzFWDaR2xzUgBPUVLsyo5pVIpXCwsfQ/WinbsDAwaKfMLlRQ2Eghjx7VG0YHK5LHrmrSjcSG6+vrTTHz1JHpS5rE8pXbkDjHHTvSMPlHP51aKL2WonjJOV/KhjSK5UE8g0jIPLGB09anZSPvEbqZnMZ9aRVig4IPtSY3YC091YseP1prqwUFetNaENMrXKbeF4J5NRhMgtk/Sp3QsCD1pkmQD3NS2JIrAMTyaSaMHsc460iswY5H0pZmcjKkcdqXONIqMgXcQSfUGopOAGAyc1c2MQc4ye4qK5gJU9d2KhzDUrCfcrZAB/u9afuAi4BYjsO1VJ1ZAShycDNOEm75T+NXGVxOA/aNzMQCfSqU0bRSBlOF4rQK7eQahfcWw656EGrhVlB3QpU4yVmWtPumjIO7r/D610DyLcQ5BySMAYrkX3xNx1rW065JHPAzX1uAxMa8LS3PmMXQlQnzLYo69AU+dIwDn6A1nwI722cYwcEgdTXS3MZkUEgEA1zdzG0c5GCB1xXlZphXTfPHY78vxHOuVk0ClY97hWUP0PQnHSm3BhBXy1KtjLFsEZ9qjXJUDPyjOKJIWfJ3AjsMc4rx1Kx6clcjEQlGA6+azfLuxjjqTUtneGGIrhXXJ/Cqt3gwBBgmNdpCr29frTkt9oLgNzgZ/CtoStuZODKl/OJGjZGUhs8DgqfT/wCvTzqLQ24ht0KF8q0g5Zh/d+lJ9mLHJyuT+RpJ7UgqQuBir5iHCRT3+WVBYKOvHcVZSZSvT8ahMQGDtHU/jXQaDpEF1as8rLuxxz0oUm9ETydzDDbH3ZPB6itrw7NuYg/QH1FZ+p2wtbkpGQ8fOCvaptBJS7O5sj3rvwEnGsrnLioXps71p1NoVbG0CuF8SMpuVAGD2r0Kx0W7vNJN1FEDEQcZ9q4HWomkuGUZ3dMYr1sxrJU7I87A0p+0u0Z9vcmNc85xjHrTrefLq5bb0yPX2p62LgDzAckZ4+lPh06Rmyq55GF9a+dTvoe3ytFqCYtKGbYVzwDWpKpkRtowvUEVnz6ZcWNzFHceX5rLuKqcmP2b0PtWlFG6jYxx71lKVmdMY6DLRZGf7xyMVdYMPvf/AK6W2HlvtI64Gauw2ysrszjpxmmnctRs9SlEVAJb3qeNQyqUOR3FSG1Dg47HvTxbhMKOAetSUlYZNBn50IGOoojfD/NjnirhiCgfNxVaZQsmetSxkjBMZyfaprdSy/LiooBuUmrVupG75aSAbIowAeTVaZio9u9T3LMAQOD1FUJHaUkDrnrXVh6Eq01FHPXrqkrsvQWMN1pElxA7/a45gpjxkOhHUehpgQRQbjnA4pLYNaxttkddww204zVG9ugDhTjnoDX09OEcHS1Pmqk5YyorIWa4+bC96WJRJ1zmq9qhk5brmtS3hBIB714WLzKVW6joj2cJl8aWstxscJz/AHT0q5Gu3aGPep/K28AHApwQKoPcV5Tlc9VRsI8eMU9VOMmlVctn1/SpV4YDt61Fy0hI1746daTYS+Mde1WVXJJpu3EgpNjGhNo55FMKjqOBVhgWGMVFtKtwOKLjEVvxFP8ALwAe2aZgg9KuRxgoCaFFtgyNIfx96KtBMAYorXQgzmGxcnnI9Ki25IPXPPFWGQsPWnCLAGRisyitllPAFBUBNxI5qyyL/E5qFwFx1poCnLyfm/SotoK4Uda0ViEgzgYqOWLZwqgUNagUmjAGDx7moRCN+OvvV3yhjnpQYwvOKlgZskeF+XnIzVKUEBiw4HWtKYZPUjtVeVVQnv8AhSYyiYiqgvggc4BqEjJPYdRWmVUpg8EVQuiqlgD+dZtWAaw9Oae4Hl8jt1qJWJbAyOKuxrmIAjNIDFuIyXOzHTGaouo53HHHbvW/PbCQcBg3THrVG7twFwq8YxVRVhFOKYbsEd8HParaBSCev0qCOAxnrkVKFByoHygcfWqJsV5zkH5huHTmi2dxIc56/hSTIQfkyMdcUgIjfDZxnAruwWJdKouxyYvDxq02jpISWiAABzWRq1sfmPO6r1lIFIAP41dvIhJGSuc19hKEcRS97qfJxnKhUumcUu4ziIKcDqatMkjPhAW2jsOcVoCzMkgIHQ0jW7o5YErxjINfG4ug6NRxsfV4Woq1NSKcNmDHuP1yO9WLiHy4sooDdcelTRtPIvlxRfP+lPksZvKIbO7OcmsVBt3RtdGFGsjsd4yc/lUpAPBxwOmeanmt9hXdk+oFWdNtI5JCWQ8HjNVa+gtzBmgZm+WPHpxT9PtrgEeWSAfeuyezhCDgZqtCESXoPTpWlmmS0nqc1e2Fxnd69ar2ySwOeOOfwrs7gx+2Kw50Bfcozg9K0TcHdMzlBSVj6B+E80V38M4/MRTKm8ZNeKarC6ahORFwHbB/GvWvgxcL/wAIbcRnHyuR+Yrl9QitpbqdTgMHIrsknNamdOKTsef3DkKCFOT1zW7occKWFxqI2lrVlVIyOrt0P0FaN1oiz/dU57YrOuNOe2QgkgegrllTcToSTKnk75S5XLMck+9SGL5wGwD60kdwYxscHPrScycjPpWU7bF2ZeFqfLBXGOtQRIykhuB9adbySIoUtwOxqHz2Z2AA/CkMtrJGSADggcU53yhLqAB0IqlgA/PuBPSrVi7FHjcBlxkZoGmOEm9BtFRyuAenPepgBFG3yYHUGmwmOViWBGehFZy3KTJbTD/UVbZ9iktwMVVgkSNjlqbLMZW2qMA11YbCzxDtFaHPXxMKKuyK9cyMqx9amgtvJTdJwetXbK3igi3S8t1ye1ZOrX4LlYyCB6V9HTjSwULs+eqSqYyfkQahdHJVenTrVCGPzXy/TPenpAZpN2eetXYYtoOa+exuPliJNJ6HuYLBRoQ03JLWEqeAcVoQrjBbjFOgUBBinj73Jwa8253qJbUkqKaykjgUR/dHGOasoq7h81DKSsQhSBtIqTY2ASO9TsFDDFP27RQMiQe+DTkUl+lAT5+ARVyGI5z3oUWxXsRLEfSpUtyTkqOKstGFXHeoPMYNx09a0UUgeo2WJfTmm7SMDFSFgT1JqURkrkZ/Cpk2wSI9nAxzRVyGA/SiizFcyNp7kDHNCKxb73Jq2sfc0xkG8EMM/SkMg8oZ3OTg0yVFfHXrVp92Qc856CnyEFTkY/CgaKAUJlcZ+pqKRVYE8fSroAVuEpkisDuOOe2KaEyiYTsyGIPpVd0fPXOK2Ng2DcQD2qu0a54xk0TVnoJO5kFACd3eopE4yccmtC4Qq38OapSFslSoIrMuxCVIJxjFVJoCckCtI42Zxg1XLckHmpkFjNMZByR06UGQr8q5yeOtWJc5OcmoSjGQHqPSpQhxBOMv24qCRQw5H0qx91sHj3pjDLZXJPpWhLdilOoIYqKiXaGzkdBWhJGCp4x6+1VNu1+eR9KLMSZB8uDkiq0kbvKdhB2nHrVq44BKqCfSrdjCrBSw5zk4qqa97UJ7FVMxhD6Yq/DcFkIzwT60+7tA6HaME1XWI2sRLgEkZ4Oa+ly/HcvuT2PAzDAqpecNzUtLWTYZSh8v+9iopYUkY4HBr0LwSbHVtCYDbvUbXQ9enWuH1+0m0u/ePaShJKn2pZhKFZ8yRrgISpU1B7lKIi0Jbgk9eKkabzyRgAD170sA85CpwOe9altpdq25icnvzXnJfynoKL6nKXltukJVsEelOS3lhRTFkk8nIrvdP0vTwT5mzI9ah1JbGA4Rlx6UOl1GlrY4dmutgVVIGefeq7RTxv8AOT7V1rXEC4AXPccVnSQT6hOTBF8o9qiUGWoJGMkUj7dzE8/lSyWoXLMT07d63F02ROHUjHpUyaaCh3c/Wlyt7jslsdZ8H7hBo+oRswXDg4PfIrl9VufI1W7VQD+8NZv9oy6C0qQMdjjoPWq9g8l/LJM+STnoK6ef3V3OblfMzorK+bcm4NjGODVq+dbgAE/mKo6edsgUpn3FXnZGk+XOB7U91ZlWsZTaWCxOePrTXsnj+70rVmKofl5HqKqpPIwIKkjNYypRZpzmf5QZsMmD71VaMWzbwNwxzXRGSIAM64bpzWZMY3yMg5OKxnTcS4yTKUrpPg4KNjpR5TKgdT8wH51Ld24Ee6MYbtVeO4KEJIcGpST3E9CdLsFRDKAPUmkhCo5QEY7Y9aWdYioLg5I5xVa0BEvzGuzCYR1567HHisUqMbvcu2lnJcS8Z2561oSwraDnH1qcX1vYWg5AbHSudvb572fKt8g9e9fRRnRwsGkeDOFTEz1Jb66eTAU/Ln1qoLXzADgAnrzVtLaMsDIWAPPuKvQKgAwBxXyuNxTrz8j6TB4VUY6lG3j2OAMVdYAADaM1JNDnDAdDTowrA7iN3pXntHcuw+NcJ0qdVUkAimwKdwz0qaWEggg9KaQx+0E4xjHIqUJg5xSwjdnParagEfdNO1xX7lUJlgO9XIYCe3WnpF+8zxg1dgZFA3GtYw7kuRWNtghicClVcYx1qedwQdvPNRp6kUOyHuRuzdKNp2gtTyhZ8461ZiUYC889xULXUNiqkYJ9B0zV2MDZjbjHH1pyw4UuoG0EA5PQ0m0jnNVohbjwcACioSx3cAmijmCxSYuE5IqvufzAMVcIDKTlifeoGASQEYrMtiNH8hKYD9ieRT4lcxjzDnntRvBOCwyf4cdKnBwuKbBEWw5zj8aZIu773IqdSSSKZISEIIAFIGVMAHHBGe9OaNSpyBikZQOcH2phOOT0qmIp3FuRjcoGRVWWMDtj0rRlYMdzHtiq8hBBOAQKTQzP25HNVpYwHJY4PbFX5DtBIA6VTcOSTwSRxWXUojKjBweoppjAUEMMjpxTn3bcd6aquwJOQPfoKBFWVctkkGmA4J6/jVjaWbA5FPurZVQ7Tz2qhECKu3G7rww64qJ7cBhu6UtsSJSM5Jqa5GDk5x2q0rmbZTkgU/KB171bjhCFTkDFKiqwyoOKo37SNmOM4Pc+laxpshz0HXWoqkwXIye1Z89y1zJhV2oDUiWjFCXxnv64qVITwF6njGK22RCjzFzw9qU2iXizQkiPPzjPBFdL4jvodVtBJHghhng9DXMW8AclTyffpVe8S6jLpbLI6/3EGf0raFey5WKdH7SJrFZJ2Kq2OcYzWj9luF4VjXL6VrP2WXLYxnHPXGa6P/hJbdVBDgnpxWcZRNFqtCxHa3WOXYfjV6300PtMhJ/GsCTxSpf5QW555qG68RSI6KnBPODVc0Nrit3O3gsLVT8+Dj1q4lxZ2isVUHt0rza48Szn5UIH41nza7cOwLSEqferVeMVZEtNnd6lq9uJTsYDntWFfa4EXKtgk/nXH3F3PKV+fGM9+abEXkI3lj1J75rKVVMtJvoO1zUmu5htYnH4Vu+CtUiQeTK/PvXPy242rtUnPJ4zioVVoZkeNiGHNYe1sx+zd2z1acZfehXB6YFQw322Rlk6jjA4/GuZsNZnWIDBbgA1dNx9olKnCuBzXaptoycNTYaVWYlWxu9DTh5kcZb7x9Ko2+FC88+hq4t22NsijbVN9jP1M6/u3dCCoAFc9LqMkMyjI2k557V17xQ3EZIxkCudvdISRiQenQdjWU0xofb6j5xAZufal1GFXjyDgjkVnNC1sTkcDkYFS2t085WMDcx4AHesWm3ZFc6a1K39oSebHHICTjAxU5vTAd0hCL09Sa7O08PW9jbfabvAldec/wANcBrkQe7cxnK5OOOa9GlVlQhZs83EUVUncdPffaJMKWx7nJrX0xCi7jn64qlp2mhtrSHHFbMLLGwjCk1yYiu5nVhsOoamhbxI0Zye9TeUF55OaWDiPI4Bq2iblHrXnu7Z6S2G7fkxg+tNihLuWUVZZCvOO3rUtnhWJ/UUKN9yhIowOMVOsILetWEjy4yeDzUzxBSGUAiqUCXIrJb7GJA4qwkeB1qwjLsIwOlGB6CqVok3uMYAAVXZmyME4q06joelMEBaUcdOwobuV0G7WKZFSRLk4NX1t0Cr6HrTvs6jkdM8UlALqxCYGEecmlhQjPJq6FynFR7PmyQadrIEyMrzmkydnzYp7KQSKglkC45qHcpEbjnIFFDMcDk0UWYyu4EYYZJz71EI8EbRk9uatyoSS2046dKr8pIDjpVWJGtDmQZJU+lWDHhcUqO5Ibb2qRixXcR196LDuR7MoDxUbIcDkYzU7chSPyqFlYL82Bk9KTC414BjqDmopogignBPUCrK44PUVFMpPQmpYjPYIzfMvNRzx7k+QKKsyxHJwM96i3YAyAD6UXux2MySBw2SRimzRgLzzWqoTGdx56iqN4mHPzZHak4dh3KLKAvNIEyucfgacw5PpTgcDmoegFFhhsDjmmzM2zBGTUzrlye9VLptoI3fjTQmV4XCykkY5ovbwKAG7cVmzXflylT3PrUeHuHBXA6dq2prmZjJ2Zaa+YjbFnNXbSHeAZOp6mora1VMkqAavxHywcHtXVaxn1I5QirgA1EkRY5U4qTBlkyScCrC7ACBgGoZvTQyHbGTkjNUtRupYJBLA5jcAgMhwQDwalmT5i279KxtRlJlKqAePwrKbNGkc3dqXuGIJVBTkDK3oQcgVbePC/c4B6mk2YJBAyR2rNSZmqVtRLKGSR8YDdT9BUiKWnLEhQMjJ5NLGxjjJHfoB2qXIRW2437S1CbBq25WZSqqznnPQf1pBECN3yk5OKkR8uN23gc/4013w23PbjjrSuy0oh5QK7ujdzj3q5BGVUFecD0qqHAK5Xd/SrNvcZ+XA70m2bR5R7QEINnB71RlXaQp27e4q8ZgNvGRjmqkjjcOe/ApJMppWLlncLEoIU528Z7GrFpIY58l8gjniqaKSQvAOOc+lWgWVgDggDsK6qdS6sck6fVHT2hgu4VKOpPfnoatKIWtzGWAf1rkftYtJN8TDOPTimJq5ZyWbBrr9pHoc0ovc2LgSwOwjPFVkvCB85I9qhj1ZSoyyn1zSz3Fq8Ry6gnvWc5X2JsMvLiNhtblvQGu98GeDhaWP9raiVMhUMqn+EGvK0lDXqEEcHIIHWvQo/FN5eaetqQBEAFJA61VKShqzOVpuyKviXWHvbqSOLKwR8Y/vVz3kB5A2RjryKv3ke2TeF61AD5Zxjhj1rGdVydzohRSWwok8nPVv6VYtQPM3Z5FSLBvT8OlPtoyjkY96ybbZSVjWtlLx/KM81bhUhxjt61BZMVUZAzU7MwPHAPJqWupotTRMW9ByBUMaBXIp0RJjGTk0+FSZO3WgrmLMJ4GeoqY5wBjANRxp8xx1zzmpVVywBH501oyWKI9vHWnhD/jU7INgwOaEwB33Gk1cE7EeOcYNP5DAjgmp0QbcnJNSqgbaCBj1qlEfMRxq2QScCptvygYOaklGxML+lRwXAm5UMCDjDDHSnewmOhOJCtT7SyZOKVnQoORzwKWMkghgOKlsEVLhSqnNZrgOxAFbcyh0PTiqsVuCeg+uKEWmUhETRWjsSM4YdfeimHMUflOcuQT2zUbxAnJPT1qVAnUjp1pfMUnlgMeoqES2UWVlcFR8v1q3EQV5Qc9R6VGQjy8k7fyp0i7QAoIFUUPlQAZC4/Gq7Jv2k5xSmRQ2Gye30qxFs25YZpNAQJGgU8ZNIsXPKgHpzUxC5yqDFSKABuI5IqWiUynNESDgDPoKzLuJlUkjGPWtbq+cd+Kq6iMjGQB3BqZLQpPoZUZOOlMkIZ8EHNWBGR/FxUci4OR1pRlYbIngUr61G8IVSBg8d6dJPsBBxn3qFpwy9/rVaSFqihM5QH5QDWDf3K/MCSPetbVZlUdfmrBeFrpu5XvUqDbsTKZDbW32mbcyttPQ1uWtmkfIBHFNsYxCAFGCKsyS7BXbCCijmvzMjkYjIQZNIhIxkH2oVwx+XqatRWxYgk55/Kq1ZrFa6lNmbOMEenvQ6Fec8mr00SxnOQcVRu34OO/Ws5Jx3OlKxXuJsjYxJC9KyzCG3Mxb2wasyOXfCnjOKbIVUBMjPfFZPUGZ72/7tsEn1PoKY0I85xlxj1FXGG47c8ZqKaMlpGLHk44rLRDb0MqbPmDAYYPOD1qxcINqNg5AqrISJCM9DU9ww2sS+Ao6YoSZjOSIrdtspbPLDGPQGkUKJT94j1zTrCxmuoZZ4kaSKH7zjoPY1HdNtlypOMdPSr8mZ81hsjLtUYYd855NWLaVVPQ8ZzU82jXFulmZyMXEfmxbTkkGoprK4gtY7iWJ1jkyqse+KUqclrY2UrK45JQ4+TOaYXXAYZ656VDaSc4ZeOKsHcQGYcLU2LhNMngnx95WDc9aJ53IAPJxnIqDz1X5mznkfXik85DtAGD6mhNoptDJnLHLLxQVJQNjNLIfnwGDYp/JjKjcfUgdKFKxDir2KYiO5hySQDyeKi2lf4mJ9M8VpINyrnGSKhjjDO28NtHQryauM+pzzpJbD9JtvNuV3k+oxXd6ZboEAUdua5TS1EVwpPJIrrbF8kHoD6VvFc0QjDlHapEixMMdRWRGqtEygHjtnpXQ38YeM45yKyIbRkmJYYTtispQ1NtyOKcwhUbOfWtiyCzLuXPPWqb2y7S2RntxTbS48qVlB29j6VcGlozJqzNzCRLz1p6HenJOcetZhYzAsGyPSr9g7FdmCcdcilMcHqW4nJULjHFXLdcDODUNsA4I4JrVtYwIiHx68+lSimrEKsu7nOc8Vo2oSTGevWqflKpzxirlouwgg8U4q7JHTptOVoXBALD2qe4+ZMBgc81FGhII/Gm9xpXJIBnPFKeGI/KkQGNgM8GnlhnsT7UrjshnmfNtIzSGAMeGZVPYUrpghh1qVmAQE9+3cVl3HZCIqoPlUA9alRjnmox84ADCp4Vx1oUugcvUauVzxTuAwI49aeFAB9qgkOGzVKXcaHzBGABGec80U+Nt3Tge9FHMTYwFbJGCdtOLjnK81BHNGEHPNQvcruIDD6VKTexTaLAciQenf2q/t3IoyaxPP2tkNz2yKsR3hIAyc1006U3pYwnUj3LU1vhiw6/WmofLUBunaonuHIILDFRPMpGG6V3Qy2pU1OaeOhHQu+dlSTjaOCBQJTsOR9KzXu1QEADb1571VbUSMjPHsK7I5O3uzknm0Is195BIz+VUb5uD3Oaof2lzl84NJJfbkINN5I2JZxAkQuRwKjlkZTg4zjimC9UDGe3Wq/nrJNjd1rnqZJOKumaQzeEnZjbl/lJbFUJbkAckVb1QYiUrXNXzOEyoAFeJWoSpS5Op6kaylHmINVvBLMoUg49KuWskYhzXNXJxJkt0Ip0V35LHLZOeMnpWkXyKzM1JT2OshlRSd5wPSq13KJHG1toNYSXzvkhhgHjB6003Mu/CkhuM+1DqmkIWOrt41RRuYE471bFz8vYZrltPuJZ2xuZvrW/DFkLuOTnr3rphO8dB2s9RLiXdLtHK1DckbTkdquTKscbBRz2rHumJD7nCsO2aymUpXZEy5JOefbvVaZQjkksB9c06FiW5LYJ9aS7UhdwHU4xWT1Rd0Vopssx3Akdu9IXadXyNoB44qtNI8cOGAwDgeuO9aT3FubVfIYZAGfXNRysjnS3MZI3W5LNgENuplw/mIecljk1eELyl+rHHJxVFbgW13FIMGSNgQpHBIpx3szGqm3cs6bqU9jBLbGRlgfBaMDqc96qO6Slt33g2SR1HtWrL/pUk99J8sj42xquQx74+lYm5xI+c5J5OMVpLfQhOz1PRfAlrpWoxySXupeS1pDmMS/yGa47WL+6uG+zGcyWyMxjXHvWaruSMOeDzQhdwoYgZ4GO1VUq3goIcXq2aWg3VtbO5uoEmTbgf7JqA3CFCecAnP41TW3lBcxqzIpyx9BXa/DybwrZ291c+JrOe6nTHkBfun2NFKDk+VuwOpyq9jk54J0t0umgkW3ZsByMKeKqrLyi7v1rsPF3iWTXUhsbS2FtYo58mJB3PTmqel+GVtgJfEUc9jaTZEc7D5QRyQat0ouTUNl1J9rKKuzB80BgAR6ZqXzSVIViAPvVnzuBPtiIMeTsJ6kA8VZhyIySSRyBjvXNKNtDRVr7F2BkKDKHb/E2eW9KTCgDDNxzxUdspk5Y7Rxj3q/EA38IJPUVMdzcLfcF3EnHbFdboxWW36ZNYloiMwjY7M+la+mN5E+ATg/rXXRg0YzeprMNyEenFVJImZSozg1pWib5wvTdU9zZ7ScZ9qc4NmiasVbO23w7MbjjpWRqVk0EjkYUEZrobONoGDNkYNQ+IishzEAUP86nk93mBvoZ2mW7FVkJwCK3LRFWIs3XpVbw5tlTy5ccHrW3faY4jZoSQAelaexvG6MFKzsQWkHylx0J61aRX8xT/DUNoP8ARcFiCPetG0hBjU5yen0rPkL5xtxCxj3Kc/SrmnW58v8Aed+hqUskTIDz61uR2yfZxIAPaqVNMTmYk0RXjFIi4PSr9wmQMZFVmHAwST71jNcrNIu6BwDjGKiPyYyOD0pec80248tgP7w7A1A2x55XjrSBMAZ6j1pR93p0qRXyBxSkCG26KM8cmrDYA9cU3kDIpEO4kVFikxoYuDgHApQm4YNTbAg/nSRjrgc1UQb7BHGFGBnFFWBjA4orQzueWLeEuQetSQTEy87s9qpeX8/Lc5rVhQLtyCcd6+qwuXU1G7R8zXzGpzuMR2CQDJnAqQyFAORiqtxdpGxBA/PNULzVMD5SpJ4rvjQhHocc8TUluzWkuNoyWGPaqst+iLksevAxXPyXryMcnp6VBJNIfvHmtU0jnlKUlc2Zr9mY7ScVW+2McZbkVnB2AJzxTldiDxVe1ijL2bZca4PXPPvQbrHU5qkZD04psju2NoyPSp+sxXUpYZvoXftKgEZxTIJ/3nynmooYZHxuAI9KtQ2TqScDb6ntXHXzOnT3Ouhls6jT2I9VvW8kBiOBWA99GwC7gT3zW3qlqVjJbnNcqLN2u8KpKjk18xWr+3q8yR9HGj7OCi2R6lEWBZDwSMVUgtpnZsIeeK6SVUDANHjoBUkDLzgYPeol7z1RpCKiihZaW5UFyFYdSa0otMQYOQcVPE3HepGcKDzzVwpxsXzu4ttaRQklMCrYdRjaRWSZ3XOOg5qRbklgMdTildI1TbL90wEYNY9wElYhSNx7VLcXu/KoMAGssysJMA5zWEncqLtqyzsEXHQ1Nb3FuEkjlwX7cVlXd8fLY88DGBUNvM5XOCWyD1qbpdAc0ybV7CdYvOMJ8k45weDWXuKQk5wN2fpXUXHifztDNjJbkzYK5PTHrXOFdqsWICilLlWzEtVqaCagsen4Vcc8571g3Bdp+MFn6DHGatMcQlkAMeRnmmWUirdrMwIMYJTP97sfwppdTCdRvQ1XibT49v2hH6blPQHqaxJ5Y3kDxZAbnHpUk06tbpDz5gZmZvXNVM5YYY+3GafLd6E+0SVh0kowoXIJ5wec0tpIGPzH95z8xpt3CqrG0U6S56gKVI+tRRbgMcAEE03C25PPrc3LaZxDIqvlGG0j+9VW+mcxgLhYxjKj27mqMVzIi4U59B2olkeQcI3H3qNjR1LrUuWV3LbzRyqw3JyvtXo9t4usdX8KyaT4gkaaYAyQyf3W9K8xiJTGQeevtVqNlwvGeOc1dOq6ewXUo2J5Lm1g0q5sRZ+ZdTyBknPOxB2HvVGISxybZQUHXDDkZqzbTst7E7IXEZ+UDuavajdS3+pvNdxBXwFxt24464qZy5kxRVpXK9rkkfNk4AAqxkRKdzZIBGQePwqKNiCYwRlR2pJM7D8wzjI9q5nod8di2Lgxsu7JwOcVs6dchwCCQT69q50M4QtkDI7nJrc0ArIhLYBA4rrw8ruxjVXY6CC8aK5iYkAj1re+2pLgjHPvXNmMMwHeplZomx2rSUnFijqdVboJ939zoakXRGmifYu4dqpaLc7o2VsDnI966fQtWhjV45QCw6VtCMZ6kybR5+0U1hqDRAHDHj61vQajKgWOcn5uhNV/E0qG++0RZAVt1ZsupRyurc7R0HpWd+S6Je1z0LT9IiksQ5xvbmptKsis7oX4965+z1sG1CBjgDitWxvXMocngitbxZGppX1gVOT+narumSkx+U4ztqNr3zSmR1HNR2tzGk3mZC5POe9Q1ZjvdE94GDsEXIPQ1iTu0DsCcZraudRhEhx0PT3rD1N1lfcACc561z1o8y0NKcrbj1cFcsccdajOyN9/DEnPSmyOFgQjb05HWs+WfnDdR0Nc9TQ13NdZgF+amrOmTg5IrGmv/lAGAarDUQsoHSsuZt2GtEdI1wpUAdc80+3kyxx61zjamobP9atWGopJMAMVo4SstBKce505AKA1H0yB601H3RgjpinIDnioloNO5KZo4lBmfGeBnrRSJgjD7Tj1opqasJo8iuJzFKA5/IUjXchYKnC+tat7YMHztGKZBYF2DYGO9fV0sxjCCTPnK2XynNtGJL5kjk4yPWozAzgZAxXVrpQZvmwFP51bXR02gADFY1MxlL4UaQy6K3OLjsWx2qQ2TkcAcV2q6OmOB+lOOmIgwRmuOWOq9DrhgaaZxiWD8cZ9sVLHYybcFQDnrXXfYNowV496cLEIMkCuaeJqvS50Rw1OPQ45dNaSXPBFWU0plHCjg10sVqAeNuO5AqwIF2nn2zUKrUfUv2UE9jCtNPCYLKCamliVSVIAzWsIiGGOBiqt5FnJbr2qJNy3NUktjltfVVtyc4qhoFskrFn6njrV/X18yJgKx9GZopQoJ606DUXdmNbU2tQ0PepMQ9wTXNzW7wyFX429K9T0JRcRKjYyR3rH8V6IIg8qjFejUoKUeaJhGpyuzOBErLxn8BTg7uxAFIU2SMB3qRUxj+9XCm1odEbN3EdCcc446UwKTnuKmA4JPPalWLDncevahq+5utCi6YbDZGahmjyuVGD9K0blcxr0z6mq4Hrg/SspR7A9dzEkhZi4CtjqOaiu5VUpDbsXwASenzV0RjRMbvlz3rGuoIUkYRhsg8ZNZS00Zm4a3QaTJbCVWuwTCrBnH407U79b2eVkjVd7kgKMAen6VWQKtvJHjcWPUe1bGpW0EGnWEsC4Zlyx9TWkKcXG4pVJR0sYLoViZVBHP502QGNELDLA9Kn2FTncSc9x0qK9cMQF4P8AETUrexm4tK7KZJkYKT85PIpI0CLvGN2flzTxg5IHG7ioTgPhmwR0rReRyyNdtMK+HY9UF9ZmPz2gFuD++4/iI/u1kopkHygAYxmopQPl5P1zVpUWKNV4zzu571cncERRRMOCM46kGpyqkZU5HsetRRN8oK5BPOPWrMUaHgjayjIxWZrFNMs2KRtnK8n9afJb4cqnT1NLCdqI3QjjFG4eanpRzRRty3Ldsq208UrJmRMAY5A+taXinUYLy3ty0YjvVzv2jGR2NZj53oycsT9z1qpqPmSzvNtIDHO0/wANVz8sWkHK1sRwOOo+93p657kGq6YDY3c47VPFgE4OeM1ySVjphUvoTMC64HAxWjoMjLIFOAOmfWqsO1gCGA46VZ03Bmxxiqpvlki2rnSXDfKChzgcmkNyREMnt3FUHlYuEBJxVLVXkjK7ScntXVJqRk/c1NuPUngkUo9WrbUXkmdlIG73rBs7R7xV+bb9K6LSPDheRQ0pHrVwo1LaGMq8W9WNmuS+5XORVJdoJOAeegrqD4egztaQk9OuKoajo8dqAY8g5wc967MHgZV6nKzkxmNjQp85Utb1FgO4/Pn0q5Br8kNuqcYByDVWOzB5yM0rWYHX5v6V77ySCW588s/lfVGvbeKXSJlY9TwaZJ4kbDemc4rG8gsRhc464oWAHHBOfbrXNPJraJnVTztPoag14ujMXPtmrmm6wGB3MCB3PesJrByMhSB9KWOzeIrwR34rNZKk73KlnHkXtT1p0mURMSB2FVW1OSVt2TimfYwzjIOSadJEqYJAA71pHI4N3bM5Z5JKyQec7sCWOKcSWkGMk0+GNG+bsBmpVVTIAW27v5V3UsqoU+hx1c3rT0TIArlunH1qe1Dx3CuD0rae2gTYh2gAdfWn3KQqkZXGT1pYnD0ZUmrF4bE1vapyZpWN6zRqGParP2rLgLnpiqunCPyjjHFXrRYzljg818XOgm7XPsY1Loja5YetFaaRQPnOBiipWEj3L9qc3c267QVXAGcg1FCnPTC+1akkO5ATkmo1h2tyOK0U77GfKupCEGcNwpHpU4AwvXilMOOmSSfyp8gdQi447n0FLntuNpEnyBRgDOOtMkYEIDx3PFPSNSCBmjyiMZx6UOpdCS7DAgwTjNMK4HRue1W0ti/8WPQU/wCzqFJYnPtRGVwem5lovOMYzUkkRUDLgKaurbgdM/jTZI8Y3foabC5UULjAXOPaq18iYPHUVoyKw53fnWffkbDgZPrRYDldZiBU4Arl0/c3Hvmuu1EFt3HauZvUwxKg5qVKzJkjs/D18EUHrjHNXtbuo7+3AQHcwxjFcz4ZcSLtYnIxkVtIEgv0WT/Uk8fWvZoyUoWOGa9447U9Pa2kY4I/CqNsjE9ck4HrXrmr6FHqFoZYFGAOted3Fi1hfbZFCpnrXNWoWd1sb05XRQkt3HJTFNQduMfSupa0jmt9y8n1Fc7cxmN2yMYNYSp8p0Rn3KdyPk7Y+lQ2YTzAWxt68VI8qENkcimRzeXC6oBhzzxXPPcpMivmWZsBQOePasPUGPn8YwDz24rdSON+fQ9ay72BhO2VBzyKymmy23bQp6ddQoZVmj3q42qR2qzdSs1qIdxZI+VzVCZEBUqMbc5NS2xLJg9F4HPQVXPaNmYpSb1J4I90BByG6DiqMqbQQRuBOOfWt+eQJZw5Tax4+tZd8h/dr3ByahsuUbrUoJERjcDgHnFV54lWXegxk5GeorWiBODk4Ht1FN+zqQQ6/Mw4+tWmc8qZSil+0gIlvbh/+exXBI+nrSeVGIl6sxzkmobiPyplHIXPAHrUsIG1dvvwO9aud1ZmCjZixoFCg/dHXAySKcjAvnp7gdKauGxkkA0M2cYAx0rJvsbRRbgfbhiQR/d9OOtKwIk3DljyBRbFCnPXpn8KBhlGGz24HSs5PXU6YaosxBpCgyDx16GrKKY45IHCsknPI6H1pLIJDPEZsmPI3Y9K6S0uNLt7d5tQid7GYlSyj5lx0rWlHnW4pvl1OKktHgClxgONynHWnohKZBH4in3s6XN66wOxtV+WIN6VPbWxbaWzgDpmsKlk7Iqk7scIldQAMewFbOh2BLBtvPTpUdpZFiGHzcdK6eyjFrBu6MBk5p043fMzstYzJNN8uYYPzEelS32lKI1JbBxirUcm+48wsSBVuUNKN5XgDAzXRTjuZTOejie2YLC2B2NTpeaghLQzEEdx2p8g3TEY+bP4VZjVNh7EjrVOco6XOZ0432M2W91A7ne4bf7VMuqyPEouZmYgd6lmiDggHJ9qyrmyZ+g211YTGyw0+bc4MbhI4iHs9jdtr1CpLAZI6f1qZrxM5zx9a5yGynXZiT2JJ61tro5Fl5oyXJ5FfRQzuDjdo8CWRSvoyeO6i4yRz6da1NPMEjDO3APeuI8u4SdoxyoPUV0egRsbuFZshCckms457SlK1i45FNK9zqJngWNjhawbm5jUnaRXRa7aosRaPbs21wd1BO2cA+tKpnVOl01LWSynuxZdSCznLDaeMd6fLdh1Bz+VYv8AZ8skwLDvWhDpswQbVIHbNcKz531R0/2HHuXobkIvv705rtGOcc+1Z8thOAMnBFa66QTZxy4+cj8q2jnvNokZPI2uo1r1ztGWIx2pUu53cIrHnsa9C0HQ7ZvD8TSKhfHWsE6XHDdk4UgE0YnNL0rLqbYfKuSd29iGzllihAkOO9XY7qRFO1uD0FOnjRhhfmqP7MfQ18lVxFpaH0tOnoWItRkUHLc96KrNbtgYyKKj61I29ijZEnmIChJFMVwx5JqGUeSxeM5c8NjvUAlAk2g5z6VKrOJHsy+hLPgfd9aVwBx6Gq0Ttv6jFWlVh8xwc0nVbDksSxOOfemuwVRv6dqiCMzg/dHoKSZd/DZ47ZqXNj5EXbWTOD6VO4KqQDk9TVKz6Yzgg4qxKepTk4ralVaWplKN2MGRkkk5qMkO5UMMjtUN0ZFGRjPcGlt920NkIfato1bysS4WRZYDBrL1AAJ0xWm5PXqKzL8kjOMg103uiLGFdopTjnrmufvLfAJ4wR0rp3QHJxisvUokKHis0KSOWsLt7TUMgnBIBFdpI32m2VvT5hXFXcIS4DYOMity1u9lv5YPGODmu7DVLKzOOcdT0nwnq8L2TRMctjaQfWsfxbp6S5YYAPSuU0LUWs73IbIPUGusuL9bxAoIII+tdcakZx1Dks0zkbW6e2Jjc/KOlRXgSbcV70/WoispKjAPFVUfC4P+RXM3bRm8e5kXUIj3ZwarH5Ldj7/pWldAuTgjFUpx/o5BIz0ArnqRRqtTNim2sAM4JxTZpWZs9f6CpPLOeR0OcdKhKHzjvHbiuaaaWhqmU5sAbcYBPQ1d06yFzfQwoowzfMT6VBIjB9+Aec1asr8xXJKAbmPGKzjdNME0zc8aXdtcXsMVpGsaQIF4HBNcnN85G1iSP0rbiu7Gd2juYzHL1zWZMI2uNkJypNXJ88rg7BEm3JPUfrUix5XcSd3UGnLF+AyRVqCFTGfm+YHpimlqS1oYt7aExjHJB5461QjVk4I55yPQV0dxENhxisieLZLnd970FNuxjKn1IFXGeH3dhikKEOwkHI7elSxyKZAF+9nlj0NNuvmlK9M/xU20yErEsQAACjAHOTyelPjkKvlR8uR7VDHFIGAU/wCcVZwGHIw+OtQ0aQepbZx5YO3DY61WvZriW3W23ERK24LjgUecyR7RgnbwadZl2BBwxPPI7VLdloatc24yxtj5mSx6V0/h3SxfMxZisaD86h0OxFzeQQyMFDcE+lb72hsb4wW0oaIn5jThTv77No+7oizZ2KQjC9O5NU9bvVAWKLn2qXVL8wRlU4IFY9pC95PvfrT5vso0tpc1tLh32/qxI69q6CYpHZhThTisuzAttu7tVm7k8zvXZBWjcymc/MR9pO3uetWo42Kgk1DP8k+c4q3C5dCM8iuaWrMyszbJPm/vY/Co5/3jAgfhVm5t2PzbWNRrGAOeG71DTWpMrPQqSyqqKvIdelSpd3Kx7fNJX0pk0DMxIXPOaWJTu5xiiUmlYSimbOl6cJovMYAFua17eyQFenSsu3umt7dYwBtHetqwkEsY71m5pGnISJZBlO5iR6GqslgpYqBgD2rfgX90wwPxpBBl+ufbFFWWwkrHOf2UFfdgYHPSpntRlcgjit6eAYHFRSQDaF6+9YSm07Giimc/cQKq8jI96jiJYhSTt9K2b+3Kw9OnU1zMNwxvSh6A4FTzyKUEdDBNOIljWRgg7Zq/a2xfk859aZaRK0a8Z5zmte1jAUADpVKs3KzZLgkQR2aBTuXntimtbKG4/KtRUO3mmOnepnZscdDJ2Ko+YcdMGirksecUVlY1uQ3SAA8hfc1UNujShiQRjtW1LErKCBnHXnOaRbdQwJwOKuUNSVOxlwRkE/JiryxNjnOPpU4iUuQx4x2qVYjhQC2MYojDUUpFMRYYcHBqKWIDhl+Y9/athLchODUc0GIwGIq507bEKepQiCqOgxUh24yMEfrSGIhSQc/SmQxE/NwMnAzWSbWhZTuDskwV681JApJyRlafJBmTG7hT3qzEgQcYPPArWkm5XZM3oLCqkEkY4rMvx833R9K2ghI64FZ93FuZjnofSvRUdDmuY0kY25xzWVqMQPRfY10EkYVWJ7Vj3w5AAotYGcdqcAJZelVYQcAH6Vt30YB3e9ZScMSR0NVTepjIf5JAznB7VYsryS3nTJOM1ctE81WAHGMVBdWrI2dp49a2UbaoV76Grcqlym8nIrHnjHOB0qVJm5XJx2A6UnqT34xVyldXNI7mY59hiq9xGNg+XnPWr0sWW2gfjUcwXy1AU7uhrJq6NbGWQOQ3X1qu0WH+XofWtAw/Mdw496jwoyevtWco2EZLqsXLYIB7VBHCr3kQVhlmHFWL75TvRMc9Kz1lfzxtXHzdR1rGyvqTKVjovFOkf2XcQggAugPXOayLIBZwNm45rRuru91ZUMqNJ5YA3dcCqqQSRXG6RWTJOOMYpyScvd2KUrli428MvHfbVi0hLglATgAmqswI25yV/nVgXIgRSgO48A56UP4insQXAw4HQL2rNv0DZxjPPathnLEZIYEcsP8ACqtwm9PpyfeonG+qKsjno0EeCNrDjNWnVN/OORnHpSywAThP4e1NOCmBkkdqInNJakkTom0YyQDk1JbbBNhmzkcA1XVNzdDnGcj+VRMRGyNtJPT3qhXSNG9gClSBx25p+nhVBI6juartIGRPMBwOCatRBShUHj1Pr/hWctGbxetzVsyzzqY/lYYxiuq0234ctkt6msHR7RlZWGT0wRXUwHy4yDW1NG97mdqNokkoyAeKrQBbdwFxUuozmJiw781neeZD70dTQ0hKZ5Nx6A1oBCyE4HArJsk3Ebs4regX9yxAJFdUU2jCZg3W0TkHmrunRh5NoAwTVO5XNy3GcVo6WDHIh96xjG8iHsdrpWiwzOscgUEjvVLxD4TkWYNaxj1OK2bh3trKO5UZxzxWtoPiGC6s5TMq7jxz2r0XTi48rOOU5RfMjzW90mSCAsyNvUcjFY4WNRgrznOK9s1xbF9CZ/k3sPmIrw67YG9lA+4GI4rgxtJU7OJth6jnuPmn3KVHXtWzpNwFjTJwcVzzqqHrkZH41r22Nny5rxajfQ9GKujs7OVWXOetaMMO7npXK2dyUx1Ix0roLK43KvPNbxndK5lOJauYQgH5iq3lFlHHfNT3EmcAinoMRjuKUkm9BR0RUnhVoSpGR3FcVPa41gBVJG7tXoDKCOOpqkmmqJfMbk9ckVmVew62h2QAY5qeCXYSOmasSIFQYqEwdCuW75rGeki46rUuRvuHXil2BuAeKjgBWPLDp2q3Av61vF3sQ9ChLHhuDRWt9n3c7aK05COZFZI8pkgAn0o8oFgG4HvU33l4yKQKTKmDjAzVS2AgmgLYAYgr0I71PAuB85OPUip+c4Yc+1KFHOR8vvThEmT0HRKGjG0Hnvio54QQMglqnSZB8qj8McVLLgpnGPStmk0Zx0MaS356YGKgCYYl+T6Cttoc85H41AIVyx4GK5nSuzVT0Mt4VLZAx9aRExJ059B2q7Kitjacn0phi/vDqMZ9a2pwsyJaoaoyp7HHBxVG4Rgn7wgn1FaS5jQKFyvvVe6ICnvmu1LQwOdvGxwrZOehqlOh2ZJycHPFbM8Ic5Zee1VbhAEx68VLXUpPSxyGoR8Y71gXsbxk7Tye/aus1GEs5wOBWJfx4Bxg+woW5MkO0K4KqQwyMit3yPtAJbmuY01iNwJ2jOa6fR5WllEefSu2lrozJmJeQmOfABFMYkiuk1+x8sAscdyR6VzsgzGfLBK+tRUpuLKhK5TdiGGahmOenXsafK3zDcDjpTXBEeQCKyV2dF9CtI2UIJFVHBD/AC5x3NXCA/XpVaUAMRnH9KmQIpzpvQ+/Q1lTRsjnAIyetb0oyqkYb1xxiqksYbIPbtWM13FKF9iDSLu4tCUT5hIR9a0tQvprQjzoVZT0OOaxY5GimDLnKtnnjFaOv6ib2KNwACBjikrct2K7RVa4aR8sPlHQVZKllXK45rGycL1IUfnzWjaXmxgr/Mp4x6UPWzCMrk9y6QOpA4I5wKrh/Ozt54xTtS/eqGjIJUYFUbKUo+1idw7e9TJvZGi0Y8HEe5cjbwcjmoMATlRwTzn0qZZcsY2ORjtSINgEg7dzShd6MzqX3SBML6E1E4V5h0B6VZ3I5GQMdarg77wAE4BFbTWhlF3ZeMIWDLYAx/k1HarkYYgr0FPuidgPJ9valtSN2FOAO1c9U6ae51vhOYlfJc/cPB7V1UtvuTK49a4TRbgR3ar0z1ruLWXdF8pJ4ralK8ToUerOe1eDah3AkgcVn2qEkAKMVua1yh4P41i27gN1qV8RTRs2aYA6c1fncRWz7eCRVKyY5WrOqc27HJBPpXftG5zPR2McuWUMVAIPJxyau2jMsq55BI4qgH+Xb1bPetOwAadFbqa5or3hPZnoF5Og0JARwV5FcdcTTJbuLQlMHOBXQ7hLaeUcEDjBrM04wpdvbyMFcZOT6V6E1zWSOS9kS+GtRuLzRpYbpvuHAz1Oa5PULNvt8/lA7d2cVr3F3Ba3UnkPje3zYNaunwwSWjyNg7jkd81y17zjZ9DSk1HVHDSQuSAMjFa2m5+RT6Y+tWZbcea+FwM1LZWh85TzgHNeHUXvHowd0aiWg2qyfK1aVuPKXI7VDMwEW04/ChWL4XB+opN8uwWvuaIDTKCByKuxqxjxyDTbCNEVR1J4+laBiAxgflW8YtoxlJIqpbkYJOanSBsDGD7VOAMVJEvI4ocLE3ZWe3AUcVCw8vA2kjpkdq1GQsdoAqExHJzwOmKylDmZcWVVQ7Mnr1pYHxJznFWFjO0gjnpUPkFJF5+Y9Bmos4srRotxvuHQ/lRRGm0c/rRXSpOxk0QsCBgjB9BRID8uwAntUkgVRwx/KgKp2nOM0NXC5KgGRgH35pk5AI5PHI9Ke0TfKRn8+tRTbwCCMih6IEriQPuYg4z7CrhHABOR3qlbRgyDeSK0WhQgBWYHHOK0pJvUibsAQHIHOPWomQ85wSacw2LjewqtcSFAAMtk8H0q20iEmyOZAHzjp6UFSRwv0zTCSzZY4p5IK5BOKqDTYS0K5VgcseKrzkD+Hmr6xBskk+1U7uMtjtXR0IuUH5yep9Kp3Kbhkrg1rGMBe2fWql2o243UW0C5zF2nLetc/eJ8xx2611d2i/NgHiuf1GL5CQOe9StBt3Oehb/SCO2ea6nQtscyOSQPWuQfdFck54ziuwsSi2SNjJxmuqg7swlodFrZSWwz7YzXO2dgZrdjjjpip7m93ac+Dgj0rZ8Dxi7tGyMnmu2SUnZmalZHn9/EYpduOh6VLcW4NqT6CtPxnbG3vWGAB6isszbrLaD0WuOcVGTR1wldGNF1A96huV+c5GKnjB808cU2YfvST0xXPJaXNEyqeEz0xwKqSOcY7dqsyLhSc96z5HycFc7T3Fc1STWhaKlwGEZKk7y3fpj0FT6asEtxCL5ykZPzY/nUbQtJFhVIGefamTw7QoGR9F5IohdO9jKUUza1jw7HbK01jcCSEngE9axodoUiRSHAxmlieQIQHdR3XPSq6zEShXTdk4yP61UppsjlaROsvl7RuJHeoZXU7SGOTnPt70OYZI924g/3e9VpC2CuDUSTWo+doVpDG24Hn+dDyMyZOAuMkZqqoYPuOWGRzSEDeeD9SKErIjnb3LSXDIvHzZHQHpT4pDvVix5A61AyGNenHTOKkhA28H0PPam3cUb3J5rp0UxgEoxzgc1LbSFpNwAUddtRwWxlJKrnaOtKoKN83Cis56m9OT3Zvaew85CQQQPlPXNdbpl6c4PNeewXJV029hW7p94xAwTnHNKnK2h2RkmdZqKiWPcOfasNbbYxOc1ejlPl57Go35TIrXlu7jbJrBz5gU5/rWndRmWB9xIwKyLLInXnj0rdnB+yv9DXdS1g7nLU0kjmIAfMbPGDWxYY81McmsVWxI4PBB61f06bDLk5YVzxdpBe6O1EZjh385IFc1cn/TZJd5Vq6K4kP9nqw64rkdTcJOrk4+lddWTVjmexi3aSy6kz7mA+vFdf4euD9j2YJVemK5hn/fK2Cc8c1s2UjxwtjAz6VxVJW1NKeqsaUZHmPjkirVudpHcVl2uV6nmta2iyoIzyM15s7ydzti0ixcENyo46/WtDS4wYgW/KorOAN94cYpctBMUGcdquMLO7E5X0RqxOI5cZxWzbkMgGfyrGgUOA79M46VrRssa4B6V1QjoYTLXlgkED/wCvUyRZIIGB61FG+5Rt6jipIziTvk8YqlFMjVFqKA7unJ6U77MST0FXbSMnBPpxUk8RXbj1yeKr2XUSmZYtiqknn1qs8a7/ALvP8q2hjax71Ue0GSQME8k1lOnfYuMrbmekYye4oq1FF97tzRUKlYrmKUiqyrknI9KVYizLkqMUwSFACoUL2z6U1mDyoVOR1qXYC4wypAPHqapyLk4RuR61oRZcAdaYY134xnmqnC+iJUrFeBChwy5PUnNXjKFCoQcEZyO3tTlg2rhMAGpHAC4OB7gVtTjyoym7szrlsj5TgVTzzy2avXA54GQfWqwjGScD8q56quzWL0IAvJPYdc07OBjsPemzLg8g/nUEpJIC04PlYNXLO4kctgVFLlv4hzS26swJIzjinyrtwMDHrXfB3RztWZSlyPvEY9qq3QOCNvB71fmAxxVC56cjOaY0Y12u1QO9YOokLG24e1dFeBmJAPA9ulYOowHYePzrNjOSuwXbPvXR6C/n2yRZJbpXP3Ee1mzxzWx4ObbqUak8Z710YV+/ZmNXY19esHtNNckALjNSfD3V4rW2kSQ4Y8itHx5IBpfBBG2vLrO5ki5ViOe1ddaoqU0zOmuZanVeML1by8YocgVz4cLEwzkn0qGWdm3bjljz9KiRyRj+GuOpU5pXOmKsrEyr1Pp6VHNhiAPrU0WNu04xVe5lVeBgnNDWg+axBcxhUIJ+91FUlt0BBOQvpmppJPN++T1pwUlfl+hrncUyotke0BiAQBntTZlIG4DoDUphbYGAO4HtSbGPU8mh6FWKJj54BHsec1BPaEoHXBBOODzmtGWNse/rUXl4HQCs3C+43sYckZDq2VB5I9qlSZJBiQHcFNOvkzjbjIJqmoKtluvbFJ3WhgxSwyNg5PGKWVHxlQM44zUtlEsspweMZNWZABCwZtu32pkopm3HlpmfLH+HHSrlpp5R1BOVYUlgouLuNWKnnrj2rurjw6trZQzNMrFh0B6VSg2m0aU9NWc6IkiURxMBkVSubQFiSuDjqa0HtmW5IBDD1q2bYGIlhjjFY2OmyObWJmGMHoMVqWOVI3cZra0LS4r2/jgchNzAAmun+IXgq38MWFtcRXAkL4JANaRw7ceddCedRkkzCXa1spHUCmQkjKt0NQaRcLJIqu2AfetWe1TfuQ4ArRLmV0aqfRlWNWikBBPIzWxayGSLBaqMkXyZB5A6022uNrMAQTW8JchlN31K19bGKZyD15qDTpD9pPTirl85dSR3FUrRlWbAzzWG0heR6G+DooYkcL6dK4gMs9yBKcjd+ddZFmXRcDoOtcPdTBWIBwQcCuut7tmcq1TO3udHtU0pZCy5PIwayoUTytuelZ8DXj2ax7yw96ltkdWG85OayxMrpWRVG99zRERGCO1bdoQsYXGTVWPaUXp07VYgz1AzXlzVmdvQ2rRAsfPemzQhnGR+tSQYEK96UgSLVWvYm9h6SlF244z+VSrIy8luc1Eke4bR1qSWBwg3dfWt4qVhXTZPHqCJIAx61uWEguSZFHGa5i3sTNKp6Y/Wuw0m28mHb681VCL6k1WktDUsSC3Pb1q1cpkZHTFV4x5ZBUj0xV8r5kGD3rq5dDlvqc9HK73vkp17+lbxtgIhuAxiotK0xY7rzWXqa2LmHdhccVmo20ZU5p7HN3VuIyNoOKK3rqyBVc0U7J7ApHn0gyuSKhUESKQODVgx/usgkfjTBGdwJavPaOxPQtwBiOCRx0FT4II96bbqE9SR61PwBkZ/AVtFX1MJMkjUEYB/KllXCdvXrSQ/N90Yz+dLMrhcIAc9c1ukZFdwcZGD/SqzL1BGM96sIAgIHU0yQkZwM1DgmUpNFOdQA2fwrJlZvN2g4x/KtidmdeCBjtWdIAZOCK55x1NYsntTlcgsPrRMSfekTIQc5GPyqB5MPweK64OySIkuoTKQORVeRAR05NWHLMuc1XkVlYEdD05rUzM65jwGJHXisO/XcDt+ldBdbipBx+NY88W4uT0FQ9hnKX1vnJI9+lV9Cb7NqKyMcCtXVCVVyo4Fc/Hcnz+ABzRTkou4nG6Om8X3wubAIjZNcJFwcGtjUZWeEjNY8TgMfXNaV6nPK4qcVFWHvyMjrUsCZ681EPnkGelT7tiFelZw3uVJ2I7iTYW2nv0qAIXOTjFOEXmNzk5NadrYllAwK11k7CM5bfOMDvmrEdsee3NdRo3h97uQYUn6V2Nr4BmeBpCu0deRXRDDaXehLqxieWJANvK5qZrH5c9DXU6pootHdGwCvXFZFwWBwR24IpSpKDsy4z5tjCntcDjGetZkkBDHcBya6CUHb83WsudSWI5x9K5KsddDaOqMe6gUoQBgisaWNgXUEY+ldRJCWXkd+tUbqBeflFYyT3JlBM56AvAwMPfg1eiDXERC/wAfGKgaMGUjJB9B0q3YyGNSAMn1xUt2MVH7LLMViYIl2kbz6HmrMdxdMEV5XOBjk8ClGHiDZ+b0p6sI4gCOMU3q9DeCUUNV3Xq2T3qRblwOHzkY5qA4Z+FJPrir1pZFjuZePeiNMftB1lcXCSiReGGCD3rR1a8v9XWMXkrMsYwqk8VPZWQ4BGB7VpC0XH/1q3jTla19CXK7uculkUxtABHvVhDcR5wxx9a32tACcCq0saBTjGelVGny6IlyYy3vVMRVxg45rBuL14b1vm+WtKePZnFYuoxlvnOfyrKrfZBGVtzTXUY3GCeTSRHMuRyDXMCcrIcnpW3YTKRuDc44FRGV9xp3Z6Nplyo0dlJHeuGvFRrqQ9s1s2Nx/ozKWwCM1z18dlw7g9TiuqrNSSM2rXsdRoN4otxDKAXHSr17HtfK7QPQVjabEoslm3fNjmrUV0ZpEUrjJwfeoryvBIml8VzZgyEGea1LNAyD6VUgjyu0+nFXYz5S1wta3Oy5difgDFWbbrhhWbDP+8AJ7/nV9XG5dp5pLVj6Glbr+8XAGKt3iJ5QHT3qnbZkGRxjvVyUZjAY8Yrqi3y2MOoljGAwI7Vt2pL4yRx6GseIgKoHU9K0bFmDZIGO/FbR0JkjbiUnBJHHNaELgsqnoaxBcEHHGKmW8CugPU1V0Z8rOpKCOJdvHOanLoI9z4OKx7i7Y2w2tzjiiGZ5bYrxnAzWbp33JLzTh+aKzYpFQbZDg0VVkOzONV1YY4IHTNOAHGMfhUAIYjgfWpQxBwMYrzTrLkbndgDNSPKR0G2q8DHcOD065pJyF6tuz2reOxlJaluGXd6Zp9ywEZJJz1wKo2h5yTjn86u3OPKGOtbxd0ZvczjclCcj5etIbgvyMCqV9Gx4UsBVXeVOC/AridVxbR0xgmrl2eUs+OMe1QvGCQRUaEu4ywx6U+X5Vzu49Kpe8TsPwDFgHmqzx/NknpUsfK570hyJMnpVq9xMVjgAstRScfdH4064bjIbp2qLJZAe/wBa7EZFa4BKnd+dZUygbs9K2JpBtwvJPWsu4wVNEldCucpqpALgjNcpKVjmbC12eow72bArkdThMc2cVhZF3IZZMoSTms7/AJabQcHNWpG+Uj2zVCNsvjkinq2S5WJZGZHUAgk1egjaVASTiqAjzOpbtWvDIFUDIAqorUa11NXRtO+0ShVGB9K9A8OeEknUyTNgJwR61xGiXotZlLNkE9K7Cy8WPanEYyp4xXpUXFRuYVOboem+FtDs9MiLOFYk9SKk1vxHYWVo8Ssu8HoO9eXXnjK8aN1V2TdxxXNyarJOxLsxbqSe9Kbjz3k7kRpN7l7X9U+1XEjqMKTnmucmmDEnJq9NtlHJPP61l3aquc9axrVLu50QjYZ5qkkAZU8596hkVHPTmot+056elKkmSCfWufmTN72QyWLHJGKoXkRZMg4IrdkVZUGKoTRAZB705R00BO5zUluFb5gOapPtVioOB6V0F1AF+Y9Kx7mEDnPPtXLJWM2y1ajMKkcLjpUzNuIBx0rOgn2LtPpVyzxO6n6VSWoRl0NSytwzDFdBbWo4xVTT7VQqkfnWxAgXq3TpxXVCFkK5LFCEHFTbc8DvQi7nAU8GtO2gDAEitoq4mNg07zYd5HbtWLqNt5bso6V07XLW0JUcCsC7k81iW5rSpFJIiL1OfnXH1qleQDLKeR2rbuYSFZiBj2rKlX5jk8VxzNDmby02SMy0lpMY3K7v/wBVbNzCHB2jNY1zCY5DxjjriuVqzuhM3LeYlAAe3NQ3cWQWHNU7CchcA5I65FTy3PQDkg1qtg5kXrNZTEOW2g9BW1poZzyAcHrWdpN7EbUxsMPnjNbWlRhzuFOpayCF7m5buePar0ShgWLDFU7aMbgBWlEgVhx1Fc6TbOi6K5Ta24DvWhZZCZJz3JqKWLpirtpGNqgjioUPeHzKxc06VlODV6VvlJNUIEUH61NdPhTg4rotZWMuo61nBlxnjPetkTxqAVxk+9cgxaN94zjrUEmqMk4HzKD3NHteVal8nNsdfLeKJQD0NUbrUcSjk4U8Cubnv3fAz9CKSaYlM8k4rmq4jsdEaNjtJvEKyQKIyd2ORmtTTtXEluDu7YPNeXwzAcngj9a6HTW+QOpxx0pUsXJ7kzoJKx2byF/mUnB70VlW9zmAEnvRXT7ZHP7NlUHI4HWpR8rgY/E9Kp7+Rkktk1ZjcYzzknNYKxZOpxKEZwCRwKhuCdwGc4pkzbioKgc5BFOmjBcMCc/Wqv7pNtSaxBDZYcehrRmy8YyMY/Ssy3IVup/Gr7Mvl8ZxW1OWhlU3KF2gZSuTmspovm49c1s3KblwcgVUjh+bDfWsKkeaWhpCVkQww7WywFOlj+TNWwoQnPaopJVKEYrZQtEhz1KkCOMgj8aZLwwxyKmhdeec+1RyjLEggZojGwN3K0vUe9L/AAHHbrUFy4UZByQaYs3yD5jmnGr73KDjpcbMc5B+lUpTuBAHNWnkXBzyfWqcz7QQDW9roi9mZUnDkMOa57XLcsC2M10U4CtuLYJrKvJFbcOTTo0JVZcsSK1aMFzM4qcOw2Y4HAqS2txGAX/OtKSJQWbA61nytJPLtj5HQ1vVwssL8ZzxxCrfAMKhpCR0zxU3l/L70xYzE+HGDV1IWZQQK5d2dSdkS2Sk49auSSvCMNyB2ptigVzvOFq3fWymAkdxx610Rh7rJctTMl1Hdwar/bMEnnH1rPmgkVyCT1qq5dSfSuZtrctM6KG73DazD1qK4cOSR2rCjmaMk5NSi6JwDnmpc7otFt3PGR+NOQAr04qsswYDJ46Yq5bkHgcA0ILk9u+BjvSyoWwTUsagEk9KA2c47Vu9hp6mbdKfK5rnbwEA4PPpXWzKHJI6nisTVbbyvmPPeuerGyuinZ6GIVOwKpx6+ta/h6Mtgt1HBrPeJuME8jmtjw+mGx34qaSuzJqzOrtV+QAccVeiGAAe3SqkR2uM1dj+YgdiOa7r20GX7CMv0H0rpdL0tijM/wCA9Kr+FtIecGRt2ztXaWVqI0ZNuPeuyFOyOeVS2hwus2qxBuucd65phknINej61YKVJPI55rhtQtihOBU1YdQpyujHvW+Rs9cVizLuBxWjeH52Vu3es6dyoOOuK4Z6myuVn+TIqpcBWXGeT7ZqSaTIOeTUVniS528gAZrBK427Gv4Psre6vvJuAokJ4yetW/GnhKW1xcWiEpnLqO49qwdQnFo6zRNskXkFetd54J8Z2+sqLDU2UT4wrEcN7V3UlTmvZy3OOs5J80TzjTMqxRhyOcHsa7HSrhYlwxAJ9K1/Evh+ztZmurYKrd09a5e6jYN+6OD1IrWrlVVU/aQdzOlmVH2nspaM7exYMgcZP0rSRgcY61z/AIfu8QKrdQK24X3nI5FeZyNaM9K9y6ELjPpVu3XaADVMS4IBB9OtWUlJxxStcC1Gvz8UOuSc0sTfLntSljtPpT5Rc1ihdMqrhzWVdwoxyMZ+tT6kW80EdKz3ZlIyc5rjqaux201pcsQw7iox71oRRBlzioNNXeRuHethYQuCBk1i4aFc9mc7eWbxsSvOeauWrMkaEE7h2rVuIg2CF9qfbW8aryK5+SzNHUViNZZRCoyQetFXHVFUcUVfL5mfMC54xhj61NGx28kZqvkH+8MVMGwgxyK6jAlVsLlgMk+tOOW6A1AGyQAMEn8qsZ7cn3qovQWxIgPmHA4HtVhi2znpVWDO85bH1qzJkKAHrphGxjN3GTZZRhgf6VEgGPvjI6+1JMcrls1QkkAbA6dhUyspBFXRdkZQ5GTVaaZUyAM96rtJ8xPI/GopZ8r0BAqudC5WSAhjnNV7iUISd3I4qB59qnOATVKWYOep6dKxnVsrGih3GXcwLHDdDRbzqy7cc+tULpwuTjHqPWn2Um4jAyawpSbqGk0uU0GUknnAqrcny13HGc4qaWTCnndisHVr4klAegr2aVNyaSOCc0tSC8uQ5wrd6zXLytwDgcnAzVUytJJlgalMxVSFPJGOK+wy/Axow5pLU+OzPMJVanJDYz79jsYJ09ao6bOIZWD8fXpW4lp50ZDJknpWVqdn9n3Ecf1rw85rKVa0eh7eVUZU6N5dSe4kWU7htb2FbPh+KGXIdh+NcdFIYyDk4PaprbUWiZmRipB7V5UKiUuZo9h6o6vWoBbMXhPFZkWoyH5CeBWdJqz3JIc/nUMbZbPrTqVeZ3iKK7mhO2RnOcnNUXUMxqQuQB254p2VJyRzWMtTRaFSZNgBx0qmTkDvWnd4eOqKgJ2yDUcqE2RZOQ3PArQ06QbgGJ59az5Hx2GKcLgKF5x9KLApHROw2fK1RkELuz1rPiuxs2kg5FXrYiWPAGKtO5dyWD5zwOB2qPVbYyQ5wM9uKntVKE44rY060+3yGAfM3YVvCnzrlE5JanBpEBnd1rR0JAlxgn8at+KNIl0m5Tdja/pWfpzmOdeAFNcyg6dRJlyfMro6ph8yfNWlpqiSUKBnnHNYJnLMoPFb2iuUkDMRnNdEPemZt6HrXh3Zb2CjAHAqeW9jRGJIGTxWDp1+DAFLcY9aydYvHH3M7c16fKtzid72Lut6koVjuxXI3l8kmOQc9TVHVNSeSM5Oe3JrnZbgluSc/WuWtWtojohCyJtSf96WU9fSsq6Y7eCc0+4l3Pk+mMVTuJQK86Um3c2vZakUkmVwSB71CZxCOHGcZ9jUc0qbSxxkVmXk3mnaAduakhyRLqNwblsKcj1p1lazRSR7C24chgehq3o9ouQzLkAVt2durzHYMDsarqpLcjlvuaX9s3c1oiXEm7GASeppEHm/MKZNZFVyBS27eTwTX2eU4yNan7OW58lm+EnSm6sS7ZTGMheldVp7NImccj8q5FcFdynkHINa+n6lsURZxJ6561hmeWxt7SCOnKM0bfsqjOniw7FgenaraOvykkCseC4VyACRmtGBwQMjNfLOFnY+m5+ppI+1ORxU8BDLk96puVEZ3GiOVlHTio2di07oZfxDccDr3qklupPStCeTcMkVVLbeMEVzTjqdMJ6E9nCFf2rWjA71l2bbuG5Hoa01I4HAJpcugSk2x4QKvTOTVZ32Px0q2zgoSCOKoO2W579DWVSCtoCkySSXKiiqMsnH40VyS3N09DSVx03dfanlgCuec8cVWUoD1x7VKHU4AXjrmuu9zFkvV8Lke5qzEMqQTxVNzh85zjtU9vJlvmGATWkFZkS2LqxqoGQM+tKz4UHKg9qYWVkHGCaikXKrhc47ntXYkc9xLuVtuSM4rn7q4Pm/eAxWlqDYiI53VgTAljgqenGea4MTOz0OmjHTUkF2Qx+amvPkHLc+1U3T58dD6etPVWXPy81jCTaNJJLUSQkqCSeetVvM5ODnHrSTK7S7jI20cbcVAxbfjtT5XcnmRYkAkAO3ipYU8sHHf2qJWOwDAJFNmnEYwxOa7qFG7uc9WpoN1SYrC2xST35rlJpmmkYYIYHBBHStW4maZmAJHbrVRoGVOgz3r7LLMAo2qVD5PNcwf8KnuUXG1SR2q1p9i0nzsD6k1bs7BpnGehPSus07TkiiKsAeO9a5hj1BezgZ5blzl+8qmPaWQVcFcnsazNcsQyE456dK66aEofkGBis+6hMiMrDPrXytS8m77n1UEktDynU7SSMHAIA9O9ZT70Unnk816VfWG5SAFI6VyeoaYwY8EVh5MmSe5gee3pjFTW90ytgnNR3NtKh5B2+1VmgkVxyfXg0yVJrc3451YDJ+b0pzSgZyelYgaZR0JxxmmNdvkjJBycA0F+0NZ7jdyTUMswAGeAayUnkZtxBAzmnzecFVo+TSsT7QumdCByD2pss4XaEHA68VmmV1+8Pvc5qNbglgoyPcmixHOjWhk8zp1BzWzZTFEGMg1zUMhUZxwe9bVlMGiU5HGeDT2NoyTN5GLhTnGa2/Ddyba/SUAZHFctFMeP8AGtiykw3XkiuijNplT2L3jWX+0nQwrnBJOPWuRMTxyoApJHWuv06VBeGKbBR+cUt39js7iR2QbWHAq6lL2j57iU7KxzqyZlUNkYrpdGk82QKOK5W6uEmvGeMYX2rc0V2jOawhK07FPY7iMrBH1P51k6trMSwlSwDLxiqV3qDCIrnrXMXku98tzmuqpX0sjKNO2rHXdyWGe5yaoGQkgnoetLNJnOKqzybFPBwB1ricmaX5R00qgktkVSu5lxuU1n3l6zSFF7DrSRxySrycfWosZynfQilkeSQqDke1PWEMMfN+VWI7RXZSc5HYVfjiSPGRx6VL0Eotk1shSIAfKK39OiMeHI471RgjR1GMc+tbUACoFwM1N+p0JWVjRSJJE5GCarXmnooO1ecZqxbjHqRjpVqPLOd2SprqoYh05Jx3MatBVIOMjmRmI4b8BUgI3B1OGqzrljIJQ0S/L/Kqdqro48wY55r67A5lDELknufI4/K54d+0pbGzY3DKylmA9zXSWchZRzgZrlJ2KKCu3jpV7Tr/AHkKeD6Vw5hlm9Wmd+W5mpJUqm51rEkcHNTqdqHI5qlazJ8o3ZPfNXiQ6jnB618/Kk1ue/Gegwv8h4qjNMFOCCT0q64yOKpzW5LZzxXJNWZ1U5JovWJ3HdwKv7vnI7/Wsu2Vk49KuRSKvB4FK2gNlxiU+6KikX5WbqwpxfeOuBUZkCntWU0VFlKVSTRU0hRuciiuVwVzVNkiElARjOalHqxx+NZymRYiEYbveraMXjw+M4/CqTCW5OGwQV+nNWEYZJYqf51RLbSuT3q3HtOCuDW9MznsXB8yjBwAOKa8rJEQCSaI23ZIGPamvgxnIxzXakczKF8W2HPWshlTdk8Gti6XMROax5OJCDjjmuCvH3tTopvQrsEWTnJJFDNwQMc9KbISp+XmmksRxgEUoR6IqTIJg5HUU1Yieo596nKHHPUio5JFQFsc110aLkzmqVOVDHIRSxyD6Vj3s5kk+Uc+9SX14WbC/hUNnGxbc4B9q+oy3L7+/M+ezLMVTXLHcdFbrGCSctUmwSkYDGn9XC962NMsxtBda9PGYlUIcsdzzcvwjrz9rMm0mzQBWPBHatVUAJ25oVAo+VcD2NAye/FfL1Kjk7s+ojGysitdPwwXj6VWKZjbNWJjtJA5qJn3AgDiudq7NuhizoC5GAtY2qW64JFb1yhBJrNvELDFZNF3Ry1xZbhkAZNUJtL6sBx2FdU0AKkEdKozgx8cVKCUUznRbBcoQBVa6sA+cAdc9OtbNwm5iQOcVEoGPmFFxcmhzzWjKOPX0qxZwF8Dv6nvWoIhubAzmq1vCy3OBxk0r2JcbEFxao8bbgMjpisWSyYPnaSR2FdRqEGzHUn+VVUQAYbPPpV81yJR7HMtKVQr0IPA9Kt6XMynLE9OKhvYfKmKEZwDzUULMrALzwelIlOzOmt5gxBBrSgu9hGeB6muUtbggYYkd601u8hRgke1Vd9DaMu504YviQEj3p08RvmSIty3Ums6wuMoBxmrMsdw8bPbAkqMgjtWyk7DmVNQs47CVEQ8n9a2tPkVYQxPIFcU9xcz34W6cllPT3rdiuSIyAelYymubQKaurM0LqfcPvVkzzjPXIps84RdzNxWXcXAGee9K9xzlZWNJZFK5x+NUL2bcCsbZJGOapyXLhAAc59Kakcj/vG579KLmPPcm+ygAtIOcdhU9vEGUZ4waeoZ0GQRmrkESbCSKhvUuEBkSIw44NSRoWAB6g5BzTgABgdzVy3hCsOM+lZPVmxJYANIAea3UhHY81mRxCM7gOvStKzcsfm4NCQy7aYAIJ5FWED+cBxgc5qONAeatwKF5PWrSsxN6Fn7NvPzkEHmqd5paMpZF/KryTEfKQM1bR0kT0PpXbRnyu6Zz1I8y1ODu4nic8HaKihkOQ6nkGut1bT43QtjBNcnd25t3yvToa+pwGPjWXs6m58tmOAlCXtaRtaLqAaUCTrXTi8RgAD27V53E+0hlOD7VettRkTajtj3qcflya56Ztl+Z3fJVO8jnzjaOKeTg8d6paNLG9uu4hj61elURqJP4T3r5arQlDc+kpVU9iSH5jzx705o/mFMiZWHB61PwMHk4rmlE6Oa4PKEHU59MVVuJcpwaWQkscU1yNuGArjqs2iVt7AdQVopJOBRXJY0LIYhyG49+1TrL2WnXMJUcg9KiUYJ4IBrVpxC6ZIXO4EYz061agJ78HvzWecBj8351ct9uwYHXqc1dN62IlsacTZ+71x+dDkkGooj0BGKldgF5NelBXRyyepn3ZIVia5+5f8AeFgPbOa2r1wysCcVkPAHY7WP4VzV4tvQ1ptJFbfl9rKcetO4YZ71IINrndu4HrVe7fy0+Xgd6uhRbIqVLDpLgRrjisW/vsZC/So7u7PPOaoIHlkLSZ254r6rLsuv78kfOZjmappxi9S7aW0k5MztgDoD3q0X7Akc4pVlRLcAMFbHTFGnRG6nyQcZr2qlSNGDZ4VCnLFVE5GjpVp5khdhkV0McIRVxjI4FLY2ypEMYB45x0qYxqMjdn3r5jEVnUk2z62hRVOCiis+8krxn2p0SMEOeCOuanRBj6mmSkDgA1wvU6uhTlQbjjkd6pzKQcrwB+tXXG1jVeRWbIyMVDKKU4ytUpY9xrUmTahDEVTZVJ6HI4qGhozXVYwd3asm7iD7imTnmty8A6Yqg6jOKiSNIu5lLCFX5hWfLETMcDity5XEZXHHrVF4x5nPB9PWoasUZEhKOew+tQkkSAirt7alZeDgHkk1UuABGp6NSJYt0zOq5J571BMmxVw351adPNthnIIqhcOAFDdAaoixl6pGokBLfrVaC3IYZareoDlG29aME4bHQZppmTRnNEUkbtjgVKknlyAHJ/GrVwjSEuR8oHFRrCpQswJOMCqTJ1NG1lAwVbn0z0rcs9XNrauhGd3NcpGGVSVOeKd9obYAR83T60Kck/dLcrrUfPK8t205GAxyRitGKYLGWfNQ6dC0oU7c/XoTVa+aVSyt1HXiiVOduZrQFVina+pHe3gd2UE44AxVMM8rlSRx2HWnRIWduQT61pwwqFyoA6HJqVoK7kyGGEgKT19K0SAIgO2KFjMhyo/GnyKNhDk4HtU3NVBIjiRpBkH6Vcit5Fi3MRyabaN5abeDmrDbmxk8DtSbRaRBbg/asEZFa6bQQRjpVUwqCGTqanjxnnrioSKNC3AkAFWUiMZBHANV7U7cGtFF8xQeuKtWAfHu2Dbmpoi4cA5qS2Ve1SFMk+o4q+XqRz9CVip5BxUkMhPemoSOMUwBgTjAFNXT0EttS3I4kTGc1jahaLLkAZ71pKr4J/KmbSQS3I9K3pznF3RE4RkrM4u4ha3c4X5R15puQ3PatzVYFZDweawJUaFtp6E19fl2OjXjySep8jmWAdGXPHZmjZXstoRskIB7Gte98RNcxQxIDgde1c/GDJjaKbJC8MnzZAzRjcBGvB8u4Zfms6MlGpseg6Nc+bCmcZrQllPOD+Nch4euijbSSBXVb90Y9cV8XWg6bcHuj7GnNVFzrYRpPkPr61Rd2Jzk1aYMYzjINVowwJDDLVwTi5Ox1RdhjkkDDGiiRGDfu6Kj6uy+dHTzbJIw2OvT29qqMpY8du1TXDBQdigZOTiolckjOK0qx1MYysiNlBYDaKtQRquMqc+xqFxl8r8pq5ACOpzRThcJT0Hx7gTuz7A025kIUYzk9h2qToctycc0kh+U449a7Y6I527sypm3n5gPxpioOdoGAKttGC4GBzUvkhVxx+FChd3HKWmhlSqQTzjiuX1qZkZsHIrsblflO4+3FcZrsJYsM16WEgudcxwYmT5G4mCGMjhj27CtLzAFUADjtWcqBGx2FDs7OEU4ya+yhZQTR8PVUp1GnuW4A89zhSdmfSu20OzWNAzDt6Vh6HZLwTjNdjZxBABXgZliOeXKj6jLsP7KF3uW1K7NuOKa6IcdalA2qD61HK3TFeQ0eqmQFsE89OgqNGBf1p+QMnFQox8w1nY1Q6dQR05qo8a4Jzj8atSscEnpVdgBnik9g3KU65UrnPvVJwQOOOa0JsLkgc1nzuCT2rNq5SZXniDgHvVKSLbJ0x9auvkcg1XfLNyazkilKxTnTcRtH5d6pNbNuy2K02XHSq0jHJHapt1Kb0M65iBByfwqlJaiVQAORWrMVEbZHNV4W2ws2OemaTJuzFcNG+xuAP1qG6g/cbwe9XJ23S+3Tmq1yc/ICakb2M25XfEvA4GahCOyjAySO1XWVcAHJIBpiOwi2jvwaZmtCNbWRoz8u3jvTRA0kZKoFCDBxUy/MQMnnrUcku12VcgDtnrSQEZh2Kc/ie9QbB5gPUdKshsgk5Oad5a/KQBWkN7mVTVGzpaKsG0DGRk1W1O3GN2NxXkZrQ0xVKrjPSpr6NSjcc19x7GFXCWt0PkHWnSxWr6nIQKWnZiASTyBxWikZC8gEEYAz0qIoqTMAP0qVuI+Ovavh6keRtH2VJ3VyS3OHAYng1LdqDIAOhqHPCEipd26P3BrI2TFKBUBWrETDyxkcg1CrZG31qa3j3ArnoaTRRdQBkGO9PaMjPy80lthcgVbgXLZ7k0WsFy1bKq24BHzVbt8gDmq23D4qeJgCABVpCuaUDptHPNToykkVmiTb2q3ESVJzWqXYzv3LEpAPBqOFtznnrUbZx160+2fAIxRyu429DTgjDdsinywooxj8KbaPjdStuIOT34rrUVynO5O5j3UHmE44HpWNqlg3lkhcYrqgoLVXv0UxtuGeKqlJ0pc8RVYqrHkkcVp8v2a6xNjGce1bF80cqoi4O7uOlVbyyDZcEA5z0qOwgJdcseD0r6OnjYypKTep89PLZRrcvQ1dNtCg35IWujtSCp557VDZxL5IHap1i2dK8DFUeduZ9DRqcsVBErKSuKakTeYOKmhcDGRmpZHU4wuDXneySZ2e0FWBMDr+FFTJyoxgUUchHMz/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This picture shows the hand-sewn completed ileoanal pouch anastomosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_17_43282=[""].join("\n");
var outline_f42_17_43282=null;
var title_f42_17_43283="Gadopentetate dimeglumine: Patient drug information";
var content_f42_17_43283=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Gadopentetate dimeglumine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/45/24277?source=see_link\">",
"     see \"Gadopentetate dimeglumine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F175098\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Magnevist&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F4663222\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Magnevist&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10029166\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700368",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, this drug may cause a very bad health problem. Call your doctor right away if you have joint stiffness, muscle weakness, very bad bone pain in the hips or ribs, yellow eyes, or very bad skin irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10029168\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691292",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used during an MRI (magnetic resonance imaging) test.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10029167\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702183",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to gadopentetate dimeglumine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703827",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have very bad kidney disease.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10029171\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697173",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have asthma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697341",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have sickle cell disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10029172\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698333",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Short-term pain after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696432",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bad taste in your mouth. This most often goes back to normal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698328",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Unsafe allergic effects may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10029174\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698968",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Joint stiffness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699012",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad bone pain in the hips or ribs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10029170\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695991",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10029176\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11743 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-210.101.131.232-947418B5B9-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_17_43283=[""].join("\n");
var outline_f42_17_43283=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F175098\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4663222\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029166\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029168\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029167\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029171\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029172\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029174\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029170\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029176\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?23/45/24277?source=related_link\">",
"      Gadopentetate dimeglumine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_17_43284="Linear porokeratosis 2";
var content_f42_17_43284=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F50928&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F50928&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Linear porokeratosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Slightly atrophic erythematous plaques with peripheral keratotic rims are present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_17_43284=[""].join("\n");
var outline_f42_17_43284=null;
var title_f42_17_43285="Bupivacaine: Pediatric drug information";
var content_f42_17_43285=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"19\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Bupivacaine: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?33/60/34758?source=see_link\">",
"    see \"Bupivacaine: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?0/51/820?source=see_link\">",
"    see \"Bupivacaine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708636\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F142923\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Bupivacaine Spinal;",
"     </li>",
"     <li>",
"      Marcaine&reg;;",
"     </li>",
"     <li>",
"      Marcaine&reg; Spinal;",
"     </li>",
"     <li>",
"      Sensorcaine&reg;;",
"     </li>",
"     <li>",
"      Sensorcaine&reg;-MPF;",
"     </li>",
"     <li>",
"      Sensorcaine&reg;-MPF Spinal",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F142924\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Marcaine&reg;;",
"     </li>",
"     <li>",
"      Sensorcaine&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1057024\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Local Anesthetic, Injectable",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F11442152\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Dose varies with procedure, depth of anesthesia, vascularity of tissues, duration of anesthesia, and condition of patient. Continuous epidural (caudal or lumbar) infusion: Limited data available (Berde, 1992):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Loading dose: 2-2.5 mg/kg (0.8-1 mL/kg of 0.25% bupivacaine)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infusion dose:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dose: 0.2-0.25 mg/kg/",
"     <b>",
"      hour",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dose (using 0.25% solution): 0.08-0.1 mL/kg/",
"     <b>",
"      hour",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dose (using 0.125% solution): 0.16-0.2 mL/kg/",
"     <b>",
"      hour",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dose (using 0.05% solution): 0.4-0.5 mL/kg/",
"     <b>",
"      hour",
"     </b>",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1057018\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?33/60/34758?source=see_link\">",
"      see \"Bupivacaine: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Dose varies with procedure, depth of anesthesia, vascularity of tissues, duration of anesthesia, and condition of patient.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     Caudal block (with or without epinephrine,",
"     <b>",
"      preservative free",
"     </b>",
"     ):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children: 1-3.7 mg/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 15-30 mL of 0.25% or 0.5%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Epidural block,",
"     <b>",
"      preservative free",
"     </b>",
"     (other than caudal block):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children: 1.25 mg/kg/dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 10-20 mL of 0.25%, 0.5%, or 0.75%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Peripheral nerve block: 5 mL dose of 0.25% or 0.5% (12.5-25 mg); maximum dose: 400 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Sympathetic nerve block: 20-50 mL of 0.25% (no epinephrine) solution",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Continuous epidural (caudal or lumbar) infusion: Limited information in infants and children:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Loading dose: 2-2.5 mg/kg (0.8-1 mL/kg of 0.25% bupivacaine)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infusion dose: See table",
"    </p>",
"    <table border=\"1\" frame=\"border\" rules=\"all\">",
"     <caption style=\"text-align:center;\">",
"      Bupivacaine Infusion Dose",
"     </caption>",
"     <col align=\"left\" width=\"85\">",
"     </col>",
"     <col align=\"center\" width=\"105\">",
"     </col>",
"     <col align=\"center\" width=\"105\">",
"     </col>",
"     <col align=\"center\" width=\"105\">",
"     </col>",
"     <col align=\"center\" width=\"100\">",
"     </col>",
"     <thead valign=\"middle\">",
"      <tr>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Age",
"        </p>",
"       </th>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Dose",
"        </p>",
"       </th>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Dose",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         (using 0.25% solution)",
"        </p>",
"       </th>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Dose",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         (using 0.125% solution)",
"        </p>",
"       </th>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Dose",
"        </p>",
"        <p style=\"text-indent:0em;\">",
"         (using 0.05% solution)",
"        </p>",
"       </th>",
"      </tr>",
"     </thead>",
"     <tbody valign=\"middle\">",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         Infants &le;4 mo",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         0.2-0.25 mg/kg/h",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         0.08-0.1 mL/kg/h",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         0.16-0.2 mL/kg/h",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         0.4-0.5 mL/kg/h",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         Infants &gt;4 mo and children",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         0.4-0.5 mg/kg/h",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         0.16-0.2 mL/kg/h",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         0.32-0.4 mL/kg/h",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         0.8-1 mL/kg/h",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         Adults",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         5-20 mg/h",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         2-8 mL/h",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         4-16 mL/h",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         10-40 mL/h",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F142906\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as hydrochloride: 0.25% [2.5 mg/mL] (20 mL, 50 mL); 0.5% [5 mg/mL] (20 mL, 50 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Marcaine&reg;: 0.5% [5 mg/mL] (50 mL) [contains methylparaben]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Sensorcaine&reg;: 0.25% [2.5 mg/mL] (50 mL); 0.5% [5 mg/mL] (50 mL) [contains methylparaben]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as hydrochloride [preservative free]: 0.25% [2.5 mg/mL] (10 mL, 20 mL, 30 mL); 0.5% [5 mg/mL] (10 mL, 20 mL, 30 mL); 0.75% [7.5 mg/mL] (10 mL, 30 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Marcaine&reg;: 0.25% [2.5 mg/mL] (10 mL, 30 mL, 50 mL); 0.5% [5 mg/mL] (10 mL, 30 mL); 0.75% [7.5 mg/mL] (10 mL, 30 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Sensorcaine&reg;-MPF: 0.25% [2.5 mg/mL] (10 mL, 30 mL); 0.5% [5 mg/mL] (10 mL, 30 mL); 0.75% [7.5 mg/mL] (10 mL, 30 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, premixed in D",
"     <sub>",
"      8.25",
"     </sub>",
"     W, as hydrochloride [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Bupivacaine Spinal: 0.75% [7.5 mg/mL] (2 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Marcaine&reg; Spinal: 0.75% [7.5 mg/mL] (2 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Sensorcaine&reg;-MPF Spinal: 0.75% [7.5 mg/mL] (2 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F142891\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1057028\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Solutions containing preservatives should not be used for epidural or caudal blocks; for epidural infusion, may use undiluted or diluted with preservative free NS",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F142968\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in NS.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Buprenorphine, clonidine, clonidine with morphine, fentanyl, fentanyl with ketamine, hydromorphone, ketamine, iohexol, morphine, sufentanil.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Clonidine with fentanyl, sodium bicarbonate.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1057021\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at room temperature; solutions containing epinephrine should be protected from light; bupivacaine 0.4375 mg/mL when mixed with epinephrine 0.6875 mcg/mL and fentanyl 1.25 mcg/mL is stable refrigerated for 20 days and at room temperature for 48 hours; bupivacaine 625 mcg/mL or 1250 mcg/mL mixed with morphine sulfate 100 mcg/mL or 500 mcg/mL in NS is stable for 72 hours at room temperature",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1057027\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Local anesthetic (injectable) for peripheral nerve block, infiltration, sympathetic block, caudal or epidural block, retrobulbar block",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F142970\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Bupivacaine may be confused with mepivacaine, ropivacaine",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Marcaine&reg; may be confused with Narcan&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication (epidural administration) among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F142967\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Most effects are dose related, and are often due to accelerated absorption from the injection site, unintentional intravascular injection, or slow metabolic degradation. The development of any central nervous system symptoms may be an early indication of more significant toxicity (seizure).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     Cardiovascular: Bradycardia, cardiac arrest, heart block, hypotension, palpitation, ventricular arrhythmia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Anxiety, dizziness, restlessness, seizure; rare symptoms (usually associated with unintentional subarachnoid injection during high spinal anesthesia) include cranial nerve palsies, headache, paralysis, paresthesia, persistent anesthesia, and septic meningitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Nausea, vomiting; rare symptoms (usually associated with unintentional subarachnoid injection during high spinal anesthesia) include fecal incontinence and loss of sphincter control",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Rare symptoms (usually associated with unintentional subarachnoid injection during high spinal anesthesia) include loss of perineal sensation, loss of sexual function,  and urinary incontinence",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Chondrolysis (continuous intra-articular administration), weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Blurred vision, pupillary constriction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Otic: Tinnitus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Apnea, hypoventilation (usually associated with unintentional subarachnoid injection during high spinal anesthesia)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic reactions (angioedema, pruritus, urticaria), anaphylactoid reactions",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1057032\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to bupivacaine hydrochloride, other amide-type anesthetics, or any component; not recommended for I.V. regional anesthesia (Bier block); obstetrical paracervical block anesthesia (use is associated with fetal bradycardia and death); 0.75% concentration in obstetrical anesthesia",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1057017\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with liver disease and impaired cardiovascular function; when used for epidural anesthesia, a smaller test dose is recommended to evaluate the patient's response",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1057016\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Convulsions due to systemic toxicity leading to cardiac arrest have been reported, presumably following unintentional I.V. injection; some products contain sulfites which may cause allergic reactions in susceptible individuals;",
"     <b>",
"      do not use solutions containing preservatives for caudal or epidural block.",
"     </b>",
"     Infants may be at greater risk for bupivacaine toxicity because &alpha;",
"     <sub>",
"      1",
"     </sub>",
"     -acid-glycoprotein, the major serum protein to which bupivacaine is bound, is lower in infants compared with older children; use epidural infusions with caution in infants and monitor closely; increased toxicity may be minimized by limiting the duration of infusion to &le;48 hours (McCloskey, 1992). Reduce epidural infusion dosage in patients with seizure disorders or at increased risk for seizures (eg, electrolyte imbalance) (Berde, 1992). Chondrolysis has been reported following continuous intra-articular infusion; intra-articular administration of local anesthetics is not an FDA-approved route of administration.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F142957\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP1A2 (minor), CYP2C19 (minor), CYP2D6 (minor), CYP3A4 (minor);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F142900\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: May increase the serum concentration of Bupivacaine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: May enhance the adverse/toxic effect of Local Anesthetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F142902\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F2233562\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Decreased pup survival and embryocidal effects were observed in animal studies. Bupivacaine is approved for use at term in obstetrical anesthesia or analgesia.",
"     <b>",
"      [U.S. Boxed Warning]: The 0.75% is not recommended for obstetrical anesthesia.",
"     </b>",
"     Bupivacaine 0.75% solutions have been associated with cardiac arrest following epidural anesthesia in obstetrical patients and use of this concentration is not recommended for this purpose. Use in obstetrical paracervical block anesthesia is contraindicated.",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F1057026\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Toxicity: 2-4 mcg/mL (however, some experts have suggested that the rate of rise of the serum level is more predictive of toxicity than the actual value; Scott, 1975)",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1057015\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blocks both the initiation and conduction of nerve impulses by decreasing the neuronal membrane's permeability to sodium ions, which results in inhibition of depolarization with resultant blockade of conduction",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1057030\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of anesthetic action: Dependent on total dose, concentration, and route administered, but generally occurs within 4-10 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: 1.5-8.5 hours (depending upon route of administration)",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1057031\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     :",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants: 3.9 &plusmn; 2 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children: 2.7 &plusmn; 0.2 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 84% to 95%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: In the liver",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life (age-dependent):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neonates: 8.1 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 2.7 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: Caudal, epidural, or peripheral nerve block: 30-45 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Small amounts (&sim;6%) excreted in urine unchanged",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Clearance:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Infants: 7.1 &plusmn; 3.2 mL/kg/minute",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children: 10 &plusmn; 0.7 mL/kg/minute",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1057023\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?0/51/820?source=see_link\">",
"      see \"Bupivacaine: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May experience temporary loss of sensation and motor activity, usually in the lower half of the body following caudal or lumbar epidural anesthesia",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1057033\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     For epidural infusion, lower dosages of bupivacaine may be effective when used in combination with narcotic analgesics",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Berde CB, &ldquo;Convulsions Associated With Pediatric Regional Anesthesia,&rdquo;",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 1992, 75(2):164-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/17/43285/abstract-text/1632529 /pubmed\" id=\"1632529 \" target=\"_blank\">",
"        1632529",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Desparmet J, Meistelman C, Barre J, et al, &ldquo;Continuous Epidural Infusion of Bupivacaine for Postoperative Pain Relief in Children,&rdquo;",
"      <i>",
"       Anesthesiology",
"      </i>",
"      , 1987, 67(1):108-10.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/17/43285/abstract-text/ 3605712 /pubmed\" id=\" 3605712 \" target=\"_blank\">",
"        3605712",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Luz G, Innerhofer P, Bachmann B, et al, &ldquo;Bupivacaine Plasma Concentrations During Continuous Epidural Anesthesia in Infants and Children,&rdquo;",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 1996, 82(2):231-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/17/43285/abstract-text/8561318 /pubmed\" id=\"8561318 \" target=\"_blank\">",
"        8561318",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      McCloskey JJ, Haun SE, and Deshpande JK, &ldquo;Bupivacaine Toxicity Secondary to Continuous Caudal Epidural Infusion in Children,&rdquo;",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 1992, 75(2):287-90.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/17/43285/abstract-text/1340763/pubmed\" id=\"1340763\" target=\"_blank\">",
"        1340763",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Scott DB, &ldquo;Evaluation of Clinical Tolerance of Local Anaesthetic Agents,&rdquo;",
"      <i>",
"       Br J Anaesth",
"      </i>",
"      , 1975, 47:328-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/17/43285/abstract-text/1148109 /pubmed\" id=\"1148109 \" target=\"_blank\">",
"        1148109",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13100 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-8BB6C55152-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_17_43285=[""].join("\n");
var outline_f42_17_43285=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708636\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F142923\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F142924\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057024\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11442152\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057018\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F142906\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F142891\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057028\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F142968\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057021\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057027\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F142970\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F142967\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057032\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057017\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057016\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F142957\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F142900\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F142902\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2233562\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057026\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057015\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057030\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057031\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057023\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057033\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13100\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13100|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?33/60/34758?source=related_link\">",
"      Bupivacaine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?0/51/820?source=related_link\">",
"      Bupivacaine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_17_43286="Amobarbital: Pediatric drug information";
var content_f42_17_43286=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Amobarbital: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?36/7/36982?source=see_link\">",
"    see \"Amobarbital: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?31/53/32596?source=see_link\">",
"    see \"Amobarbital: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F134276\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Amytal&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F134277\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Amytal&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F997927\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Anticonvulsant, Barbiturate",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Barbiturate",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       General Anesthetic",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Hypnotic",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Sedative",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F997962\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?36/7/36982?source=see_link\">",
"      see \"Amobarbital: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Dosage should be individualized with consideration of patient's age, weight, and medical condition.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Sedative: I.M., I.V.: 6-12 years: Manufacturer's dosing range: 65-500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hypnotic: I.M.: 2-3 mg/kg/dose given before bedtime (maximum: 500 mg)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hypnotic: I.M., I.V.: 65-200 mg at bedtime (mean range: I.M.: 65-500 mg; maximum single dose: 1000 mg)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Sedative: I.M., I.V.: 30-50 mg 2-3 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosing adjustment in renal/hepatic impairment:",
"     </b>",
"     Dosing should be reduced; specific recommendations not available; drug is contraindicated in patients with marked hepatic impairment; avoid use in patients with premonitory signs of hepatic coma",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F134255\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution, as sodium:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Amytal&reg;: 0.5 g",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F134239\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block csi drugH1Div\" id=\"F134302\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Controlled Substance",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C-II",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F997967\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.M.: Administer deeply into a large muscle. Do not use more than 5 mL at any single site (may cause tissue damage)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V.: Use only when I.M. administration is not feasible. Administer by slow I.V. injection (maximum: 50 mg/minute in adults)",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F997954\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     LR, D",
"     <sub>",
"      5",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     W, D",
"     <sub>",
"      10",
"     </sub>",
"     W, D",
"     <sub>",
"      20",
"     </sub>",
"     W, LR, NS",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility when admixed: Compatible:",
"     </b>",
"     Amikacin, aminophylline, sodium bicarbonate.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Cefazolin, cimetidine, clindamycin, diphenhydramine, droperidol, hydroxyzine, insulin (regular), levorphanol, meperidine, morphine, norepinephrine, pancuronium, pentazocine, penicillin G potassium, procaine, streptomycin, vancomycin.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Atracurium, dimenhydrinate, hydrocortisone sodium succinate, isoproterenol, metaraminol, methyldopate, norepinephrine, succinylcholine",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F997950\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Powder should be stored at 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F). Reconstitute with SWI to make a 10% I.V. solution; a 20% solution may be made for I.M. use. Rotate vial to dissolve, do not shake. Do not use unless a clear solution forms within 5 minutes. Following reconstitution, solution should be used within 30 minutes.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F997928\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypnotic in short-term treatment of insomnia; to reduce anxiety and provide sedation preoperatively. Has been used as an alternative agent for treatment of refractory tonic-clonic seizures. See Additional Information for special uses.",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F13930080\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - high; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F134305\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reported as barbiturate use (not specifically amobarbital).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Bradycardia, hypotension, syncope",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Agitation, anxiety, ataxia, confusion, CNS depression, dizziness, fever, hallucinations, headache, insomnia, nightmares, nervousness, psychiatric disturbances, somnolence, thinking abnormal",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Constipation, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Megaloblastic anemia (following chronic phenobarbital use)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Liver damage",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Injection site reaction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Hyperkinesia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Apnea, atelectasis (postoperative), hypoventilation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Hypersensitivity reaction (including angioedema, rash, and exfoliative dermatitis)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F997935\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to barbiturates or any component; marked hepatic impairment; dyspnea or airway obstruction; porphyria",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F5717314\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with acute or chronic pain (paradoxical excitement may occur or important symptoms may be masked), hepatic dysfunction (decreased dosage may be needed; avoid use in patients with premonitory signs of hepatic coma), hypoadrenalism (effects of exogenous or endogenous corticosteroids may be decreased), pregnancy (fetal abnormalities may occur; infants may experience withdrawal symptoms with chronic maternal use), CHF, renal impairment (decreased dosage may be needed), hypovolemic shock, or in children (barbiturates may produce paradoxical excitement). Safety and efficacy have not been established in children &lt;6 years of age.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F997936\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Tolerance and/or psychological and physical dependence may occur; abrupt discontinuation after prolonged use may result in withdrawal symptoms or seizures; withdraw gradually if used over extended periods of time; use with caution in patients with depression or suicidal tendencies, or in patients with a history of drug abuse. When used as a hypnotic for the treatment of insomnia, effectiveness is limited to &le;2 weeks. Rapid I.V. administration may cause respiratory depression, apnea, laryngospasm, or hypotension. Solution for injection is highly alkaline and extravasation may cause local tissue damage. Solution for injection is highly alkaline; extravasation may cause local tissue damage and necrosis may occur; avoid inadvertent intra-arterial injection (various reactions ranging from transient pain to gangrene of the limb may occur); stop injection if patient complains of pain in limb. May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving). Effects with other sedative drugs or ethanol may be potentiated. \"",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F134296\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Induces",
"     </b>",
"     CYP2A6 (strong)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F134248\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetaminophen: Barbiturates may increase the metabolism of Acetaminophen. This may 1) diminish the effect of acetaminophen; and 2) increase the risk of liver damage.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: Barbiturates may decrease the serum concentration of Beta-Blockers.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Atenolol; Levobunolol; Metipranolol; Nadolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers: Barbiturates may increase the metabolism of Calcium Channel Blockers.  Management: Monitor for decreased therapeutic effects of calcium channel blockers with concomitant barbiturate therapy. Calcium channel blocker dose adjustments may be necessary. Nimodipine Canadian labeling contraindicates concomitant use with phenobarbital.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Clevidipine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Chloramphenicol: Barbiturates may increase the metabolism of Chloramphenicol. Chloramphenicol may decrease the metabolism of Barbiturates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Contraceptives (Estrogens): Barbiturates may diminish the therapeutic effect of Contraceptives (Estrogens). Contraceptive failure is possible.  Management: Use of a non-hormonal contraceptive is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Contraceptives (Progestins): Barbiturates may diminish the therapeutic effect of Contraceptives (Progestins). Contraceptive failure is possible.  Management: Use of alternative, nonhormonal contraceptives is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): Barbiturates may decrease the serum concentration of Corticosteroids (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSPORINE (Systemic): Barbiturates may increase the metabolism of CycloSPORINE (Systemic).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2A6 Substrates: CYP2A6 Inducers (Strong) may increase the metabolism of CYP2A6 Substrates.  Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Disopyramide: Barbiturates may increase the metabolism of Disopyramide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Divalproex: May decrease the metabolism of Barbiturates. Barbiturates may decrease the serum concentration of Divalproex.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Doxycycline: Barbiturates may decrease the serum concentration of Doxycycline.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Etoposide: Barbiturates may decrease the serum concentration of Etoposide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Etoposide Phosphate: Barbiturates may decrease the serum concentration of Etoposide Phosphate. Barbiturates may increase the metabolism, via CYP isoenzymes, of etoposide phosphate.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Felbamate: Barbiturates may decrease the serum concentration of Felbamate. Felbamate may increase the serum concentration of Barbiturates.  Management: Monitor for elevated barbiturate concentrations/toxicity if felbamate is initiated/dose increased, or reduced concentrations/effects if felbamate is discontinued/dose decreased. Refer to phenobarbital dosing guidelines for patients receiving that agent.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: Barbiturates may enhance the CNS depressant effect of Fosphenytoin. Barbiturates may decrease the serum concentration of Fosphenytoin. Fosphenytoin may increase the serum concentration of Barbiturates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Griseofulvin: Barbiturates may decrease the serum concentration of Griseofulvin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of Barbiturates. Management: Consider a decrease in the barbiturate dose, as appropriate, when used together with hydroxyzine.  With concurrent use, monitor patients closely for excessive response to the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     LamoTRIgine: Barbiturates may decrease the serum concentration of LamoTRIgine.  Management: See lamotrigine prescribing information for specific age-dependent dosing guidelines regarding concurrent use with a barbiturate, as well as for adjusting lamotrigine dosing if concurrent barbiturate therapy is discontinued.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Meperidine: Barbiturates may enhance the CNS depressant effect of Meperidine. Barbiturates may increase serum concentrations of the active metabolite(s) of Meperidine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methadone: Barbiturates may enhance the CNS depressant effect of Methadone. Barbiturates may decrease the serum concentration of Methadone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): May decrease the serum concentration of Barbiturates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: May enhance the CNS depressant effect of Barbiturates. Barbiturates may decrease the serum concentration of Phenytoin. Phenytoin may increase the serum concentration of Barbiturates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Primidone: May enhance the adverse/toxic effect of Barbiturates. Primidone is converted to phenobarbital, and thus becomes additive with existing barbiturate therapy.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Propafenone: Barbiturates may decrease the serum concentration of Propafenone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pyridoxine: May increase the metabolism of Barbiturates. Apparent in high pyridoxine doses (eg, 200 mg/day)",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNIDine: Barbiturates may enhance the hepatotoxic effect of QuiNIDine. Barbiturates may decrease the serum concentration of QuiNIDine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rifamycin Derivatives: May increase the metabolism of Barbiturates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Teniposide: Barbiturates may decrease the serum concentration of Teniposide.  Management: Consider alternatives to combined treatment with barbiturates and teniposide due to the potential for decreased teniposide concentrations.  If the combination cannot be avoided, monitor teniposide response closely.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Theophylline Derivatives: Barbiturates may decrease the serum concentration of Theophylline Derivatives.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Dyphylline.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: Barbiturates may enhance the orthostatic hypotensive effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tricyclic Antidepressants: Barbiturates may increase the metabolism of Tricyclic Antidepressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Valproic Acid: May decrease the metabolism of Barbiturates. Barbiturates may decrease the serum concentration of Valproic Acid.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Barbiturates may increase the metabolism of Vitamin K Antagonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Voriconazole: Barbiturates may decrease the serum concentration of Voriconazole.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F5717427\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     High doses of pyridoxine may decrease drug effect; barbiturates may increase the metabolism of vitamins D and K; dietary requirements of vitamins D, K, C, B",
"     <sub>",
"      12",
"     </sub>",
"     , folate, and calcium may be increased with long-term use",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F134250\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     D (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F134263\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Barbiturates cross the placenta and distribute in fetal tissue. Teratogenic effects have been reported with 1st trimester exposure. Exposure during the 3rd trimester may lead to symptoms of acute withdrawal following delivery; symptoms may be delayed up to 14 days.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F997970\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Vital signs should be monitored during injection and for several hours after administration. If using I.V., monitor patency of I.V. access; extravasation may cause local tissue damage. Monitor hematologic, renal, and hepatic function with prolonged therapy.",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F997956\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Therapeutic: 1-5 mcg/mL (SI: 4-22 &mu;mol/L)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Toxic: &gt;10 mcg/mL (SI: &gt;44 &mu;mol/L)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Lethal: &gt;50 mcg/mL",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F997955\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Intermediate-acting barbiturate with sedative, hypnotic, and anticonvulsant properties; interferes with transmission of impulses from the thalamus to the cortex of the brain resulting in an imbalance in central inhibitory and facilitatory mechanisms",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F5088052\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Rapid, within minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Maximum effect: Hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Variable",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F997957\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Readily crosses placenta; small amounts enter breast milk",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Primarily hepatic via microsomal enzymes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: Adults: 15-40 hours (mean: 25 hours)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Metabolites are eliminated in the urine and feces; negligible amounts excreted unchanged in urine",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F997971\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?31/53/32596?source=see_link\">",
"      see \"Amobarbital: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Patient instructions and information are determined by patient condition and therapeutic purpose. Drug may be habit-forming; avoid abrupt discontinuation after prolonged use. While using this medication, avoid alcohol, limit caffeine; do not use other prescription or nonprescription medications (especially pain medications, sedatives, antihistamines, or hypnotics) without consulting prescriber. Medication may cause drowsiness, dizziness, or blurred vision and impair ability to perform activities requiring mental alertness or physical coordination (use caution when driving or engaging in tasks requiring alertness until response to drug is known). May cause nausea, vomiting, or loss of appetite (small, frequent meals, frequent mouth care, chewing gum, or sucking lozenges may help); constipation. Report skin rash or irritation; CNS changes (eg, confusion, depression, increased sedation, excitation, headache, insomnia, or nightmares); respiratory difficulty or shortness of breath; changes in urinary pattern or menstrual pattern; muscle weakness or tremors; or difficulty swallowing or feeling of tightness in throat.",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F5717429\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Amobarbital has also been used for therapeutic or diagnostic &ldquo;amobarbital interviewing&rdquo; (Kavirajan, 1999) and the &ldquo;Wada test&rdquo; (ie, intracarotid amobarbital procedure) to lateralize speech and memory functions prior to brain surgery, in order to prevent or predict the degree of impact of  the surgery (Breier, 2001; Grote, 2005; Hamer, 2000; Szabo, 1993).",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Bengner T, Haettig H, Merschhemke M, et al, \"Memory Assessment During the Intracarotid Amobarbital Procedure: Influence of Injection Order,\"",
"      <i>",
"       Neurology",
"      </i>",
"      , 2003, 61(11):1582-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/17/43286/abstract-text/14663046/pubmed\" id=\"14663046\" target=\"_blank\">",
"        14663046",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Breier JI, Simos PG, Wheless JW, et al, \"Language Dominance in Children as Determined by Magnetic Source Imaging and the Intracarotid Amobarbital Procedure: A Comparison,\"",
"      <i>",
"       J Child Neurol",
"      </i>",
"      , 2001, 16(2):124-30.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/17/43286/abstract-text/11292218/pubmed\" id=\"11292218\" target=\"_blank\">",
"        11292218",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Grote CL and Meador K, \"Has Amobarbital Expired? Considering the Future of the Wada,\"",
"      <i>",
"       Neurology",
"      </i>",
"      , 2005, 65(11):1692-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/17/43286/abstract-text/16344509/pubmed\" id=\"16344509\" target=\"_blank\">",
"        16344509",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hamer HM, Wyllie E, Stanford L, et al, \"Risk Factors for Unsuccessful Testing During the Intracarotid Amobarbital Procedure in Preadolescent Children,\"",
"      <i>",
"       Epilepsia",
"      </i>",
"      , 2000, 41(5):554-63.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/17/43286/abstract-text/10802761/pubmed\" id=\"10802761\" target=\"_blank\">",
"        10802761",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kavirajan H, &ldquo;The Amobarbital Interview Revisited: A Review of the Literature Since 1966,&rdquo;",
"      <i>",
"       Harv Rev Psychiatry",
"      </i>",
"      , 1999, 7(3):153-65.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/17/43286/abstract-text/10483934/pubmed\" id=\"10483934\" target=\"_blank\">",
"        10483934",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kim HS, Wan X, Mathers DA, et al, \"Selective GABA-Receptor Actions of Amobarbital on Thalamic Neurons,\"",
"      <i>",
"       Br J Pharmaco",
"      </i>",
"      l, 2004, 143(4):485-94.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/17/43286/abstract-text/15381635/pubmed\" id=\"15381635\" target=\"_blank\">",
"        15381635",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Redmond GP, Bell JJ, and Perel JM, \"Effect of Human Growth Hormone on Amobarbital Metabolism in Children,\"",
"      <i>",
"       Clin Pharmacol Ther",
"      </i>",
"      , 1978,  24(2):213-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/17/43286/abstract-text/679599/pubmed\" id=\"679599\" target=\"_blank\">",
"        679599",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Szab&oacute; CA and Wyllie E, \"Intracarotid Amobarbital Testing for Language and Memory Dominance in Children,\"",
"      <i>",
"       Epilepsy Res",
"      </i>",
"      , 1993, 15(3):239-46.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?42/17/43286/abstract-text/8223420/pubmed\" id=\"8223420\" target=\"_blank\">",
"        8223420",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13391 Version 46.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-222.177.238.124-77F64FB33D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_17_43286=[""].join("\n");
var outline_f42_17_43286=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134276\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134277\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F997927\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F997962\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134255\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134239\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134302\">",
"      Controlled Substance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F997967\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F997954\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F997950\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F997928\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13930080\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134305\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F997935\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5717314\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F997936\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134296\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134248\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5717427\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134250\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F134263\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F997970\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F997956\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F997955\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5088052\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F997957\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F997971\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5717429\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13391\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13391|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?36/7/36982?source=related_link\">",
"      Amobarbital: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?31/53/32596?source=related_link\">",
"      Amobarbital: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_17_43287="Benign pigmented skin lesions other than melanocytic nevi (moles)";
var content_f42_17_43287=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Benign pigmented skin lesions other than melanocytic nevi (moles)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/17/43287/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/17/43287/contributors\">",
"     Julie V Schaffer, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/17/43287/contributors\">",
"     Jean L Bolognia, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/17/43287/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/17/43287/contributors\">",
"     Moise L Levy, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/17/43287/contributors\">",
"     Robert P Dellavalle, MD, PhD, MSPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/17/43287/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/17/43287/contributors\">",
"     Rosamaria Corona, MD, DSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?42/17/43287/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 8, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Benign pigmented skin lesions and melanocytic nevi (moles) are common in children and adolescents. Benign pigmented skin lesions including lentigines, caf&eacute;-au-lait macules, Becker's nevi, and dermal melanocytosis (Mongolian spots, nevus of Ota, and nevus of Ito) will be discussed below. Melanocytic nevi and melanocytic nevi variants are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/17/7447?source=see_link\">",
"     \"Congenital melanocytic nevi and speckled lentiginous nevi\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/1/44056?source=see_link\">",
"     \"Acquired melanocytic nevi (moles)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     LENTIGO",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lentigines are benign pigmented macules that result from increased activity of epidermal melanocytes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43287/abstract/1\">",
"     1",
"    </a>",
"    ]. In contrast to the ephelides (freckles) that are commonly seen in lightly pigmented children and fade in the absence of sun exposure, lentigines are persistent. There are two major types of lentigines: simple lentigo and solar lentigo. The mucosal melanotic macule is a variant of simple lentigo that is located on mucosal surfaces, in particular the lower lip.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Simple lentigo",
"    </span>",
"    &nbsp;&mdash;&nbsp;Simple lentigines often appear during childhood as sharply circumscribed, round-to-oval, uniformly brown or brownish-black macules that are usually &lt;5 mm in diameter. There are typically few lesions, with no predilection for sun-exposed sites. However, multiple lentigines may be seen in a variety of disorders (",
"    <a class=\"graphic graphic_table graphicRef66428 \" href=\"mobipreview.htm?27/19/27966\">",
"     table 1",
"    </a>",
"    ), and lentigines may increase in number or darken in patients with Addison's disease or other syndromes associated with elevated circulating levels of adrenocorticotropic hormone. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/52/23369?source=see_link\">",
"     \"Causes and clinical manifestations of primary adrenal insufficiency in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Mucosal melanotic macule",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mucosal melanotic macules, which most commonly develop on the vermilion portion of the lower lip, have a predilection for white adolescent girls and young women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43287/abstract/2\">",
"     2",
"    </a>",
"    ]. Mucosal melanotic macules may also occur on the oral mucosa and genitalia. Patients present with one or more brown to black macules, sometimes with irregular borders and mottled pigmentation. Genital lesions are occasionally &gt;1 cm in diameter.",
"   </p>",
"   <p>",
"    Multiple perioral and oral mucosal melanotic macules characterize disorders such as Peutz-Jeghers and Laugier-Hunziker syndromes. Multiple genital melanotic macules are a feature of Bannayan-Riley-Ruvalcaba syndrome (a type of PTEN hamartoma-tumor syndrome) (",
"    <a class=\"graphic graphic_table graphicRef66428 \" href=\"mobipreview.htm?27/19/27966\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/6/37990?source=see_link\">",
"     \"Overview of Peutz-Jeghers syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Solar lentigo",
"    </span>",
"    &nbsp;&mdash;&nbsp;In contrast to simple lentigines, the distribution of solar lentigines is limited to sun-exposed areas, in particular sites of greatest cumulative exposure such as the face, dorsal hands, extensor forearms, and upper trunk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43287/abstract/3\">",
"     3",
"    </a>",
"    ]. Because the incidence of solar lentigines increases with age, they are most often seen in adults. However, solar lentigines can develop in fair-skinned children who have had significant sun exposure, especially on the shoulders following severe sunburns. Multiple tan to dark brown macules, often with irregular borders, are typically present; the lesions range from a few millimeters to &gt;1 cm in diameter (",
"    <a class=\"graphic graphic_picture graphicRef70005 \" href=\"mobipreview.htm?14/60/15301\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Children with xeroderma pigmentosum develop numerous solar lentigines at an unusually early age (",
"    <a class=\"graphic graphic_table graphicRef66428 \" href=\"mobipreview.htm?27/19/27966\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/37/602?source=see_link&amp;anchor=H25#H25\">",
"     \"Hereditary neuropathies associated with generalized disorders\", section on 'Xeroderma pigmentosum'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/56/25482?source=see_link&amp;anchor=H16#H16\">",
"     \"Epidemiology and risk factors for cutaneous squamous cell carcinoma\", section on 'Xeroderma pigmentosum'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Large, jagged solar lentigines are a characteristic finding in children with type 2 oculocutaneous albinism. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/0/24586?source=see_link&amp;anchor=H19#H19\">",
"     \"The genodermatoses\", section on 'Oculocutaneous albinism (OCA)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major consideration in the clinical differential diagnosis of a simple lentigo is a junctional melanocytic nevus. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/1/44056?source=see_link&amp;anchor=H6#H6\">",
"     \"Acquired melanocytic nevi (moles)\", section on 'Common acquired melanocytic nevi'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The differential diagnosis of a genital melanotic macule that has irregular borders and pigmentation may include early acral lentiginous melanoma. However, acral lentiginous melanoma is unusual in children and adolescents; if there is no palpable component, a shave biopsy can be performed to make the distinction. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/31/22009?source=see_link&amp;anchor=H10#H10\">",
"     \"Pathologic characteristics of melanoma\", section on 'Acral lentiginous melanoma'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Ephelides are the major consideration in the differential diagnosis of solar lentigines, since both are characterized by multiple pigmented macules in sun-exposed areas. However, ephelides fade in the winter, whereas solar lentigines are present year-round [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43287/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some variants of solar lentigines, such as ink-spot lentigines and tanning bed-induced lentigines, have dark pigmentation and a stellate outline that may result in consideration of early melanoma. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/20/16713?source=see_link&amp;anchor=H81531006#H81531006\">",
"     \"Skin examination and clinical features of melanoma\", section on 'Clinical features'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/20/16713?source=see_link&amp;anchor=H6082563#H6082563\">",
"     \"Skin examination and clinical features of melanoma\", section on 'Introduction'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Solar lentigines that are of cosmetic concern can be treated with liquid nitrogen cryotherapy, lasers that target melanin (eg, the Q-switched ruby laser), or intense pulsed light [broadband light]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/9/9370?source=see_link&amp;anchor=H3044621#H3044621\">",
"     \"Laser and light therapy for cutaneous hyperpigmentation\", section on 'Lentigines'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although solar lentigines themselves have no malignant potential, they represent a sign of photodamage that indicates an increased risk for the development of melanoma and nonmelanoma skin cancers during adulthood. In children and adolescents with solar lentigines, a skin examination should be included in the annual physical examination performed by the primary care provider. If the patient also has atypical or numerous nevi",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a family history of melanoma, then referral to a dermatologist is often warranted. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/53/24410?source=see_link&amp;anchor=H6#H6\">",
"     \"Risk factors for the development of melanoma\", section on 'Sun exposure and UV radiation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/53/24410?source=see_link&amp;anchor=H12#H12\">",
"     \"Risk factors for the development of melanoma\", section on 'Typical nevi'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/39/14970?source=see_link&amp;anchor=H4#H4\">",
"     \"Epidemiology and clinical features of basal cell carcinoma\", section on 'UV light exposure'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/56/25482?source=see_link&amp;anchor=H7#H7\">",
"     \"Epidemiology and risk factors for cutaneous squamous cell carcinoma\", section on 'UV light exposure'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CAF&Eacute;-AU-LAIT MACULE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Caf&eacute;-au-lait macules (CALM) are flat pigmented lesions that may be present at birth or appear during early childhood, often first becoming noticeable following sun exposure (",
"    <a class=\"graphic graphic_picture graphicRef57807 graphicRef73651 graphicRef50599 \" href=\"mobipreview.htm?34/38/35434\">",
"     picture 2A-C",
"    </a>",
"    ). They represent localized areas of increased melanogenesis, the etiology of which is not known except when associated with conditions such as McCune-Albright syndrome (mosaic disorder due to a somatic mutation in the GNAS gene encoding the stimulatory G protein&rsquo;s alpha subunit) or neurofibromatosis type 1 (NF1; results from loss-of-function mutations in the NF1 tumor suppressor gene). Although several studies have shown that a single CALM can be found in 25 to 35 percent of children, &lt;1 percent of children have &ge;3 CALM [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43287/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/5/19546?source=see_link&amp;anchor=H3989453#H3989453\">",
"     \"Definition, etiology, and evaluation of precocious puberty\", section on 'McCune-Albright syndrome'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/50/36650?source=see_link\">",
"     \"Neurofibromatosis type 1 (von Recklinghausen's disease)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    CALM range from a few millimeters to &gt;15 cm in size, and they enlarge in proportion to the growth of the child. Their color varies from tan to dark brown and is usually uniform, although in some cases perifollicular hypopigmentation or a few darker macules may be apparent within the lesions. In general, the color of CALM is a few shades darker than that of the uninvolved skin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43287/abstract/6\">",
"     6",
"    </a>",
"    ]. Interestingly, CALM that occur within a Mongolian spot are often surrounded by a halo of normally pigmented skin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43287/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/13/22745?source=see_link&amp;anchor=H16#H16\">",
"     \"Benign skin and scalp lesions in the newborn and young infant\", section on 'Congenital dermal melanocytosis (Mongolian spot)'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients with &ldquo;pigmentary mosaicism&rdquo; (including the small subset with McCune-Albright syndrome), CALM may have a block-like distribution with midline demarcation and an irregular, jagged outline (\"coast of Maine\") (",
"    <a class=\"graphic graphic_picture graphicRef80844 \" href=\"mobipreview.htm?41/51/42815\">",
"     picture 3",
"    </a>",
"    ). In contrast, CALM in patients with NF1 and related conditions classically have a relatively smooth border (\"coast of California\") (",
"    <a class=\"graphic graphic_picture graphicRef50599 \" href=\"mobipreview.htm?28/46/29411\">",
"     picture 2C",
"    </a>",
"    ). Patients with NF1 also tend to have greater numbers of CALM in a more widespread distribution (with the exception of segmental NF1). Larger block-like CALM in individuals with NF1 should be palpated to exclude the possibility of an underlying plexiform neurofibroma. Histologic features cannot differentiate among CALM in patients with McCune-Albright syndrome, other forms of &ldquo;pigmentary mosaicism&rdquo;, and NF1. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Hyperpigmented patches over the posterior axis are occasionally associated with underlying spinal dysraphism, especially in the presence of additional cutaneous findings such as focal hypertrichosis or a lipoma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a neonate, the differential diagnosis of a CALM includes the initial stage of a speckled lentiginous nevus (ie, before the appearance of superimposed \"spots\") or a relatively flat congenital melanocytic nevus (which will likely become more elevated over time). Additional diagnostic considerations may include postinflammatory hyperpigmentation, phytophotodermatitis, and a mastocytoma. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/17/7447?source=see_link\">",
"     \"Congenital melanocytic nevi and speckled lentiginous nevi\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/8/29831?source=see_link&amp;anchor=H16#H16\">",
"     \"Approach to the patient with macular skin lesions\", section on 'Postinflammatory hyperpigmentation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/63/18426?source=see_link&amp;anchor=H23#H23\">",
"     \"Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment\", section on 'Phytophotodermatitis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A Becker's nevus should be considered for large, solitary lesions that break up into smaller macules at their periphery (with or without associated hypertrichosis), particularly when located on the upper lateral trunk or when onset occurs around the time of puberty. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Becker nevus'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The key question in the evaluation of a child with multiple CALM is whether they represent a cutaneous marker of an underlying systemic disorder. In a longitudinal study of 41 children with &ge;6 CALM, 24 (60 percent) were found to have NF1, six had segmental NF1, and three were diagnosed with other syndromes (",
"    <a class=\"graphic graphic_table graphicRef66428 \" href=\"mobipreview.htm?27/19/27966\">",
"     table 1",
"    </a>",
"    ); only eight (20 percent) had no manifestations of an associated condition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43287/abstract/8\">",
"     8",
"    </a>",
"    ]. In another retrospective study of 110 children (median age three years) who presented with CALM but no other features of NF1, 34 of 44 (77 percent) of those with &ge;6 &ldquo;typical&rdquo; CALM (distinct regular borders, uniform pigmentation) eventually met criteria for NF1 (almost all before age six years). In contrast, 2 of 15 (15 percent) of those with &ge;6 &ldquo;atypical&rdquo; CALM (irregular borders, nonhomogeneous pigmentation) and zero of 51 of those with &lt;6 CALM eventually met criteria for NF1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43287/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The presence of &ge;6 CALM (measuring &ge;1.5 cm in adults and &ge;0.5 cm in prepubertal children) is a criterion for the diagnosis of NF1 that is met by 90 percent of patients by early adulthood. Segmental NF1 (due to mosaicism for a mutation in the NF1 gene) can present with multiple CALM",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    &ldquo;freckling&rdquo; (multiple small lentigines) in a block-like distribution pattern or along the lines of Blaschko. In contrast to NF1, multiple CALM are found in a minority of patients with neurofibromatosis type 2 (NF2; bilateral vestibular schwannomas), making their presence less useful in establishing the diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/50/36650?source=see_link\">",
"     \"Neurofibromatosis type 1 (von Recklinghausen's disease)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/14/20712?source=see_link&amp;anchor=H7#H7\">",
"     \"Neurofibromatosis type 2\", section on 'Vestibular schwannomas'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The NF1-like Legius syndrome, which is secondary to a loss-of-function germline mutation in the SPRED1 gene, has a cutaneous phenotype that partially overlaps with that of NF1 (CALM, freckling) but lacks neurofibromas or Lisch nodules [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43287/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/50/36650?source=see_link\">",
"     \"Neurofibromatosis type 1 (von Recklinghausen's disease)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Familial CALM, unassociated with other abnormalities, may also occur outside the setting of Legius syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43287/abstract/11-13\">",
"     11-13",
"    </a>",
"    ]. Pigmentary disorders that can present with multiple CALM include piebaldism (CALM in leukodermic and uninvolved skin) and familial progressive hyper- and hypopigmentation. Other conditions associated with multiple CALM include Noonan syndrome, LEOPARD syndrome, constitutional mismatch repair deficiency syndrome (childhood tumor syndrome with NF1 phenotype), ataxia-telangiectasia, PTEN hamartoma tumor syndrome, Russell-Silver syndrome, and Bloom syndrome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/18/10537?source=see_link&amp;anchor=H19#H19\">",
"     \"Causes of short stature\", section on 'Noonan syndrome'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/60/23497?source=see_link\">",
"     \"Ataxia-telangiectasia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/18/10537?source=see_link&amp;anchor=H20#H20\">",
"     \"Causes of short stature\", section on 'Russell-Silver syndrome'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/42/35493?source=see_link\">",
"     \"Bloom syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;If desired for cosmetic reasons, CALM can be treated with pigment-specific lasers such as the Q-switched ruby laser and Q-switched Nd:YAG laser. However, multiple treatment sessions are usually required, responses are variable, recurrences are common, and there is a risk of side effects such as persistent hyperpigmentation or hypopigmentation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/9/9370?source=see_link&amp;anchor=H3044628#H3044628\">",
"     \"Laser and light therapy for cutaneous hyperpigmentation\", section on 'Cafe-au-lait macules'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Infants and young children with &ge;6 CALM should be evaluated for other manifestations of NF1 (eg, plexiform neurofibromas, sphenoid or tibial dysplasia, and Lisch nodules) and followed with annual physical examinations that include examination of the skin and eyes during the first decade of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43287/abstract/14\">",
"     14",
"    </a>",
"    ]. Referral to a pediatric dermatologist or specialized NF1 clinic can also be considered. Of note, comprehensive testing of the NF1 gene is clinically available and can identify the underlying mutation in &ge;95 percent of non-founder patients who meet the diagnostic criteria for NF1, allowing an accurate diagnosis to be made in young children who do not (yet) meet these criteria. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/50/36650?source=see_link\">",
"     \"Neurofibromatosis type 1 (von Recklinghausen's disease)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     BECKER NEVUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Becker's nevus, also called Becker's melanosis, is a fairly common benign cutaneous hamartoma with epidermal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    dermal elements [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43287/abstract/14\">",
"     14",
"    </a>",
"    ]. Becker's nevi can be present at birth, but the majority are first noticed around puberty. This timing, along with the male to female ratio of 5:1, increased the number of terminal hairs seen within many lesions, and reports of acne vulgaris localized to Becker's nevi has raised the possibility of androgenic stimulation as an underlying factor in their pathogenesis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43287/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A Becker's nevus classically manifests unilaterally on the shoulder and upper trunk as a tan to brown patch or thin plaque. Less often, lesions occur on the lower trunk, thigh, or in other sites. The margins are usually irregular and break up into \"islands\" at the periphery (",
"    <a class=\"graphic graphic_picture graphicRef68895 \" href=\"mobipreview.htm?38/43/39600\">",
"     picture 4",
"    </a>",
"    ); the average diameter is &gt;10 cm. Hypertrichosis is present in approximately one-half of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43287/abstract/16\">",
"     16",
"    </a>",
"    ], and there is often an associated smooth muscle hamartoma (sometimes evident clinically by perifollicular papules that are accentuated by rubbing). Associated developmental abnormalities, such as hypoplasia of the ipsilateral breast or pectoralis major muscle, occur infrequently.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several considerations in the differential diagnosis of Becker's nevi:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Clinically, a Becker's nevus can be confused with a congenital melanocytic nevus; however, histologically, there are no nevus cells in a Becker's nevus. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/17/7447?source=see_link\">",
"       \"Congenital melanocytic nevi and speckled lentiginous nevi\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Smooth muscle hamartomas have significant clinical and histologic overlap with Becker's nevi.",
"     </li>",
"     <li>",
"      Plexiform neurofibromas, which often have hyperpigmentation and even hypertrichosis of the overlying skin, may be considered in the differential diagnosis of Becker's nevi with an associated smooth muscle hamartoma. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/50/36650?source=see_link\">",
"       \"Neurofibromatosis type 1 (von Recklinghausen's disease)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A Becker's nevus without hypertrichosis can be difficult to distinguish from a CALM. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Caf&eacute;-au-lait macule'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with Becker's nevi should be examined clinically for associated soft tissue and bony abnormalities. If desired for cosmetic reasons, the hyperpigmented component of Becker's nevi can be treated with the Q-switched ruby laser, Q-switched Nd:YAG laser, or fractional resurfacing (although responses are variable and recurrence rates are high), and the associated hypertrichosis with laser-assisted hair removal. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/9/9370?source=see_link&amp;anchor=H3044635#H3044635\">",
"     \"Laser and light therapy for cutaneous hyperpigmentation\", section on 'Becker's nevus'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/9/37014?source=see_link&amp;anchor=H11#H11\">",
"     \"Removal of unwanted hair\", section on 'Laser and intense pulsed light'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     DERMAL MELANOCYTOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In normal skin, only melanocytes in the epidermis and hair follicles produce melanin. In dermal melanocytosis, melanocytes in the dermis actively synthesize melanin. The blue color of such skin (ceruloderma) is due to the preferential scattering of shorter wavelengths of light by the dermal melanin, a phenomenon known as the Tyndall effect.",
"   </p>",
"   <p>",
"    The spectrum of dermal melanocytosis includes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mongolian spots (sacral and extrasacral)",
"     </li>",
"     <li>",
"      Nevus of Ota-like",
"      <span class=\"nowrap\">",
"       macules/acquired",
"      </span>",
"      dermal melanocytosis (grayish-brown macules in a bilateral, symmetric distribution on the malar cheeks and forehead, seen primarily in middle-aged Asian women)",
"     </li>",
"     <li>",
"      Nevus of Ota",
"     </li>",
"     <li>",
"      Nevus of Ito",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Nevus of Ito has some overlap with patch-type blue nevi, which represent dermal melanocytomas (ie, a proliferation of melanin-producing dermal melanocytes). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/1/44056?source=see_link&amp;anchor=H21#H21\">",
"     \"Acquired melanocytic nevi (moles)\", section on 'Blue nevi'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Mongolian spots",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mongolian spots typically appear as congenital blue-grey patches with indefinite borders (",
"    <a class=\"graphic graphic_picture graphicRef77805 \" href=\"mobipreview.htm?29/11/29875\">",
"     picture 5",
"    </a>",
"    ), most often on the sacral area and buttocks in Asian and black children. They are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/13/22745?source=see_link&amp;anchor=H16#H16\">",
"     \"Benign skin and scalp lesions in the newborn and young infant\", section on 'Congenital dermal melanocytosis (Mongolian spot)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Nevus of Ota",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nevus of Ota (oculodermal melanocytosis, nevus fuscocaeruleus ophthalmomaxillaris) is a type of dermal melanocytosis that preferentially involves the areas innervated by the first and second divisions of the trigeminal nerve [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43287/abstract/17\">",
"     17",
"    </a>",
"    ]. These lesions differ from Mongolian spots clinically in their mottled rather than uniform pigmentation, and histologically in their greater density of melanocytes within the upper reticular dermis.",
"   </p>",
"   <p>",
"    Nevus of Ota occurs most commonly in Asians and blacks. The incidence in Japan, for example, is 1 to 2 per 1000. The female to male ratio is approximately 4:1. Up to 15 percent of lesions harbor somatic activating mutations in the",
"    <em>",
"     GNAQ",
"    </em>",
"    and",
"    <em>",
"     GNA11",
"    </em>",
"    genes encoding G protein alpha subunits [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43287/abstract/18\">",
"     18",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    The pigmentation is present at birth or within the first year of life in more than one-half of cases, and in the remainder it becomes apparent around puberty; in both instances, the lesions persist. Patients present with speckled or mottled, grayish-brown to blue-black patches involving the skin, conjunctiva, sclera, tympanic membrane,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    oral and nasal mucosa of the affected dermatomes (",
"    <a class=\"graphic graphic_picture graphicRef77921 \" href=\"mobipreview.htm?1/55/1909\">",
"     picture 6",
"    </a>",
"    ). Approximately 10 percent of patients have bilateral involvement. Superimposed elevated areas with the histologic features of blue nevi occasionally develop, and iris mammillations may be seen. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/1/44056?source=see_link&amp;anchor=H21#H21\">",
"     \"Acquired melanocytic nevi (moles)\", section on 'Blue nevi'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Symptomatic or asymptomatic neurocutaneous melanosis can occur, typically with central nervous system (CNS) involvement ipsilateral to the skin lesions. Approximately 10 percent of patients develop glaucoma, and ipsilateral sensorineural hearing loss has also been described. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/17/7447?source=see_link&amp;anchor=H8#H8\">",
"     \"Congenital melanocytic nevi and speckled lentiginous nevi\", section on 'Neurocutaneous melanosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    More than 50 cases of melanoma have been reported to develop in association with nevus of Ota. Although the prevalence of nevus of Ota is higher in Asians, the majority of melanoma cases have occurred in white patients, with a mean age at diagnosis of approximately 50 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43287/abstract/19\">",
"     19",
"    </a>",
"    ]. The uveal tract (ie, the ocular choroid) was the most common primary site, followed by the CNS, orbit, and skin. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/59/8122?source=see_link\">",
"     \"Ocular melanoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with nevus of Ota should be followed with yearly ophthalmologic examinations and educated regarding the clinical signs of ocular and cutaneous melanoma (eg, pain or visual changes and a new papule or nodule, respectively). If patients are unable to perform cutaneous self-examinations, they should have longitudinal dermatologic evaluation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/16/16650?source=see_link\">",
"     \"Screening and early detection of melanoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The cutaneous discoloration of nevus of Ota can be treated with the Q-switched ruby laser or the Q-switched Nd:YAG laser; this typically requires several sessions, but the outcomes are usually good to excellent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43287/abstract/20\">",
"     20",
"    </a>",
"    ]. Hypo- or hyperpigmentation are potential side effects. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/9/9370?source=see_link&amp;anchor=H3044649#H3044649\">",
"     \"Laser and light therapy for cutaneous hyperpigmentation\", section on 'Nevus of Ota'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Nevus of Ito",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nevus of Ito (nevus fuscocaeruleus acromiodeltoideus) is a type of congenital dermal melanocytosis involving areas of skin innervated by the posterior supraclavicular and lateral brachiocutaneous nerves; it is otherwise clinically and histopathologically similar to nevus of Ota.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lentigines are persistent benign pigmented macules (usually &lt;5 mm in diameter) that result from increased activity of epidermal melanocytes. Multiple lentigines may be seen in a variety of disorders (",
"      <a class=\"graphic graphic_table graphicRef66428 \" href=\"mobipreview.htm?27/19/27966\">",
"       table 1",
"      </a>",
"      ). Solar lentigines occur only in sun-exposed areas and represent a sign of photo-damage that indicates an increased risk for the development of melanoma and nonmelanoma skin cancers during adulthood. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Lentigo'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Caf&eacute;-au-lait macules are flat, tan to dark brown pigmented lesions that may be present at birth or appear during early childhood (",
"      <a class=\"graphic graphic_picture graphicRef57807 \" href=\"mobipreview.htm?4/56/4993\">",
"       picture 2A",
"      </a>",
"      ). The presence of &ge;6 caf&eacute;-au-lait macules is a criterion for the diagnosis of NF1. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Caf&eacute;-au-lait macule'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/50/36650?source=see_link\">",
"       \"Neurofibromatosis type 1 (von Recklinghausen's disease)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Becker nevus is a benign cutaneous hamartoma with epidermal",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      dermal elements. Most Becker nevi are first noticed around puberty (",
"      <a class=\"graphic graphic_picture graphicRef68895 \" href=\"mobipreview.htm?38/43/39600\">",
"       picture 4",
"      </a>",
"      ), but some are apparent at birth. Considerations in the differential diagnosis of Becker nevus include caf&eacute;-au-lait macule, congenital melanocytic nevus, smooth muscle hamartoma, and plexiform neurofibroma. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Becker nevus'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Mongolian spots typically appear as congenital blue-grey pigmented patches with indefinite borders (",
"      <a class=\"graphic graphic_picture graphicRef77805 \" href=\"mobipreview.htm?29/11/29875\">",
"       picture 5",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/13/22745?source=see_link&amp;anchor=H16#H16\">",
"       \"Benign skin and scalp lesions in the newborn and young infant\", section on 'Congenital dermal melanocytosis (Mongolian spot)'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Nevus of Ota primarily involves the areas of skin innervated by the first and second divisions of the trigeminal nerve (",
"      <a class=\"graphic graphic_picture graphicRef77921 \" href=\"mobipreview.htm?1/55/1909\">",
"       picture 6",
"      </a>",
"      ). Potential complications include symptomatic or asymptomatic neurocutaneous melanosis, glaucoma, sensorineural hearing loss, and melanoma. Patients with nevus of Ota should be followed with yearly ophthalmologic examinations and educated regarding the clinical signs of ocular and cutaneous melanoma. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Nevus of Ota'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Nevus of Ito is clinically and histopathologically similar to nevus of Ota, but involves the areas of skin innervated by the posterior supraclavicular and lateral brachiocutaneous nerves. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Nevus of Ito'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43287/abstract/1\">",
"      Ber Rahman S, Bhawan J. Lentigo. Int J Dermatol 1996; 35:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43287/abstract/2\">",
"      Gupta G, Williams RE, Mackie RM. The labial melanotic macule: a review of 79 cases. Br J Dermatol 1997; 136:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43287/abstract/3\">",
"      HODGSON C. Senile lentigo. Arch Dermatol 1963; 87:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43287/abstract/4\">",
"      Bastiaens M, ter Huurne J, Gruis N, et al. The melanocortin-1-receptor gene is the major freckle gene. Hum Mol Genet 2001; 10:1701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43287/abstract/5\">",
"      Landau M, Krafchik BR. The diagnostic value of caf&eacute;-au-lait macules. J Am Acad Dermatol 1999; 40:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43287/abstract/6\">",
"      Boyd KP, Gao L, Feng R, et al. Phenotypic variability among caf&eacute;-au-lait macules in neurofibromatosis type 1. J Am Acad Dermatol 2010; 63:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43287/abstract/7\">",
"      Ahn JS, Kim SD, Hwang JH, et al. Halo-like disappearance of mongolian spot combined with caf&eacute; au lait spot. Pediatr Dermatol 1998; 15:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43287/abstract/8\">",
"      Korf BR. Diagnostic outcome in children with multiple caf&eacute; au lait spots. Pediatrics 1992; 90:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43287/abstract/9\">",
"      Nunley KS, Gao F, Albers AC, et al. Predictive value of caf&eacute; au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1. Arch Dermatol 2009; 145:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43287/abstract/10\">",
"      Pasmant E, Sabbagh A, Hanna N, et al. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype. J Med Genet 2009; 46:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43287/abstract/11\">",
"      Arnsmeier SL, Riccardi VM, Paller AS. Familial multiple cafe au lait spots. Arch Dermatol 1994; 130:1425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43287/abstract/12\">",
"      Charrow J, Listernick R, Ward K. Autosomal dominant multiple caf&eacute;-au-lait spots and neurofibromatosis-1: evidence of non-linkage. Am J Med Genet 1993; 45:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43287/abstract/13\">",
"      Abeliovich D, Gelman-Kohan Z, Silverstein S, et al. Familial caf&eacute; au lait spots: a variant of neurofibromatosis type 1. J Med Genet 1995; 32:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43287/abstract/14\">",
"      Williams VC, Lucas J, Babcock MA, et al. Neurofibromatosis type 1 revisited. Pediatrics 2009; 123:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43287/abstract/15\">",
"      Person JR, Longcope C. Becker's nevus: an androgen-mediated hyperplasia with increased androgen receptors. J Am Acad Dermatol 1984; 10:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43287/abstract/16\">",
"      Tymen R, Forestier JF, Boutet B, Colomb D. [Late Becker's nevus. One hundred cases (author's transl)]. Ann Dermatol Venereol 1981; 108:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43287/abstract/17\">",
"      Hori Y, Takayama O. Circumscribed dermal melanoses. Classification and histologic features. Dermatol Clin 1988; 6:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43287/abstract/18\">",
"      Van Raamsdonk CD, Griewank KG, Crosby MB, et al. Mutations in GNA11 in uveal melanoma. N Engl J Med 2010; 363:2191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43287/abstract/19\">",
"      Shaffer D, Walker K, Weiss GR. Malignant melanoma in a Hispanic male with nevus of Ota. Dermatology 1992; 185:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43287/abstract/20\">",
"      Watanabe S, Takahashi H. Treatment of nevus of Ota with the Q-switched ruby laser. N Engl J Med 1994; 331:1745.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5560 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-91.202.164.29-FFA7B79098-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_17_43287=[""].join("\n");
var outline_f42_17_43287=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      LENTIGO",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Simple lentigo",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Mucosal melanotic macule",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Solar lentigo",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CAF&Eacute;-AU-LAIT MACULE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      BECKER NEVUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      DERMAL MELANOCYTOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Mongolian spots",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Nevus of Ota",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Nevus of Ito",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/5560\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/5560|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?14/60/15301\" title=\"picture 1\">",
"      Solar lentigines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?4/56/4993\" title=\"picture 2A\">",
"      Cafe-au-lait macule",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?33/8/33928\" title=\"picture 2B\">",
"      Cafe-au-lait macule 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?28/46/29411\" title=\"picture 2C\">",
"      Cafe-au-lait macule 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?41/51/42815\" title=\"picture 3\">",
"      Cafe au lait spots",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?38/43/39600\" title=\"picture 4\">",
"      Beckers nevus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?29/11/29875\" title=\"picture 5\">",
"      Mongolian spots",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?1/55/1909\" title=\"picture 6\">",
"      Nevus of Ota",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/5560|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?27/19/27966\" title=\"table 1\">",
"      Disorders with lentigines",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/1/44056?source=related_link\">",
"      Acquired melanocytic nevi (moles)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/8/29831?source=related_link\">",
"      Approach to the patient with macular skin lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/60/23497?source=related_link\">",
"      Ataxia-telangiectasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/13/22745?source=related_link\">",
"      Benign skin and scalp lesions in the newborn and young infant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/42/35493?source=related_link\">",
"      Bloom syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/52/23369?source=related_link\">",
"      Causes and clinical manifestations of primary adrenal insufficiency in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/18/10537?source=related_link\">",
"      Causes of short stature",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/17/7447?source=related_link\">",
"      Congenital melanocytic nevi and speckled lentiginous nevi",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/5/19546?source=related_link\">",
"      Definition, etiology, and evaluation of precocious puberty",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/39/14970?source=related_link\">",
"      Epidemiology and clinical features of basal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/56/25482?source=related_link\">",
"      Epidemiology and risk factors for cutaneous squamous cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/37/602?source=related_link\">",
"      Hereditary neuropathies associated with generalized disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/9/9370?source=related_link\">",
"      Laser and light therapy for cutaneous hyperpigmentation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/50/36650?source=related_link\">",
"      Neurofibromatosis type 1 (von Recklinghausen's disease)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/14/20712?source=related_link\">",
"      Neurofibromatosis type 2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/59/8122?source=related_link\">",
"      Ocular melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/6/37990?source=related_link\">",
"      Overview of Peutz-Jeghers syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/31/22009?source=related_link\">",
"      Pathologic characteristics of melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/63/18426?source=related_link\">",
"      Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/9/37014?source=related_link\">",
"      Removal of unwanted hair",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/53/24410?source=related_link\">",
"      Risk factors for the development of melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/16/16650?source=related_link\">",
"      Screening and early detection of melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/20/16713?source=related_link\">",
"      Skin examination and clinical features of melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/0/24586?source=related_link\">",
"      The genodermatoses",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_17_43288="Abnormal growth in a child with Cushings disease";
var content_f42_17_43288=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F87007&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F87007&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 634px\">",
"   <div class=\"ttl\">",
"    Abnormal growth in a child with Cushing's disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 614px; height: 794px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Growth chart of a girl diagnosed with Cushing's disease at age 11.25 years. The patient had poor height velocity since age 9.6 years in conjunction with a 2.25-year delayed bone age (leftward arrow from height point at actual age 11.25 years), and excessive weight gain over the same time period. An ACTH-producing pituitary adenoma was discovered and removed by trans-sphenoidal surgery at age 11.5 years. The patient subsequently had full biochemical recovery, initially followed by a significant improvement in height velocity and a significant reduction in weight (loss of 16 pounds over 6 months). With progressive puberty, the patient's bone age delay decreased (1.25 years at actual age 12.25 years, and 0.5 years at actual age 14 years) in association with physiological height plateauing. The progressive acceleration in bone age was likely due to the effects of pubertal estrogen. The bracket at the far right of the height curve represents the mid-parental target height range (&plusmn;1 SD). As is typical in patients with childhood Cushing's disease, the mid-parental target height was not achieved.",
"    <sup>",
"     [1]",
"    </sup>",
"    <div class=\"footnotes\">",
"     ACTH: adrenocorticotropic hormone; GnRH: gonadotropin hormone releasing hormone; SD: standard deviation; %: percent.",
"    </div>",
"    <div class=\"reference\">",
"     Reference:",
"     <br/>",
"     <ol>",
"      <li>",
"       Chan LF, Storr HL, Grossman AB, Savage MO. Pediatric Cushing's syndrome: Clinical features, diagnosis, and treatment. Arq Bras Endocrinol Metabol 2007; 51:1261-1271.",
"      </li>",
"     </ol>",
"     <br/>",
"     Courtesy of Mitchell Geffner, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_17_43288=[""].join("\n");
var outline_f42_17_43288=null;
var title_f42_17_43289="Immunology of tuberculosis";
var content_f42_17_43289=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Immunology of tuberculosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/17/43289/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/17/43289/contributors\">",
"     Lee W Riley, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/17/43289/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/17/43289/contributors\">",
"     C Fordham von Reyn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?42/17/43289/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?42/17/43289/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?42/17/43289/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 13, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The human host serves as the only natural reservoir for Mycobacterium tuberculosis. The ability of the organism to efficiently establish latent infection has enabled it to spread to nearly one-third of the world's population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/1\">",
"     1",
"    </a>",
"    ]. From this infected reservoir, eight million new TB cases occur each year and about three million infected patients die. Given the magnitude of the health problem and the emergence of drug-resistant strains of the organism, the development of an effective vaccine is highly desirable. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/13/18649?source=see_link\">",
"     \"Epidemiology of tuberculosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The immunology of M. tuberculosis will be reviewed here. The microbiology and pathogenesis of this infection, including virulence factors, tropism for the lungs, and latency factors, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/54/22378?source=see_link\">",
"     \"Microbiology and pathogenesis of tuberculosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     IMMUNOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of individuals in the general population who become infected with M. tuberculosis never develop clinical disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/2\">",
"     2",
"    </a>",
"    ]. This demonstrates that the innate and adaptive immune response of the host in controlling TB infection is effective. Mycobacterial and host factors that adversely affect these two arms of the immune system contribute to latent tuberculosis infection (LTBI) and active disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5272211\">",
"    <span class=\"h2\">",
"     Host factors",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11164598\">",
"    <span class=\"h3\">",
"     Innate immunity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathophysiology of innate immunity early in the course of infection is uncertain. In the average human alveolus there are more than 28,000 epithelial cells (pneumocytes) and about 50 macrophages [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Mouse studies have shown that after about 14 days of infection, the predominant cell type infected with M. tuberculosis is the myeloid dendritic cell rather than the alveolar macrophage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/5\">",
"     5",
"    </a>",
"    ]. Thus, in the very early phase of lung infection, the interaction of M. tuberculosis with epithelial cells may influence clinical outcomes. Little is known about what happens during this early phase.",
"   </p>",
"   <p>",
"    The tubercle bacillus ultimately gets taken up by macrophages and has evolved several strategies to evade early intracellular killing mechanisms inside these target cells. Some of the mechanisms previously thought to contribute to these strategies include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Resistance to reactive oxygen intermediates (ROIs)",
"     </li>",
"     <li>",
"      Inhibition of phagosome-lysosome fusion",
"     </li>",
"     <li>",
"      Inhibition of phagosome acidification",
"     </li>",
"     <li>",
"      Escape from the phagosomal compartment into the cytoplasmic space",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    During the initial stages of infection, tubercle bacilli stimulate the migration of neutrophils and mononuclear phagocytes to the site of infection. M. tuberculosis possesses a variety of products that enable it to constitutively resist ROIs produced by these cells, which are usually toxic to other pathogens. Lipoarabinomannan (LAM) serves as a scavenger for oxygen intermediates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/6\">",
"     6",
"    </a>",
"    ]. Entry of the organism into macrophages via complement receptors (CR1 and CR3) does not stimulate ROI production [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Cyclopropanated mycolic acids of the cell wall may help the organism resist",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?40/41/41617?source=see_link\">",
"     hydrogen peroxide",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In Escherichia coli and Salmonella, the oxyR gene serves as a regulatory element in response to oxidative stress. In contrast, the oxyR homologue in M. tuberculosis contains numerous deletions and is believed to be nonfunctional [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. The constitutive anti-ROI products of M. tuberculosis described above may obviate the need for such a gene in this organism.",
"   </p>",
"   <p>",
"    M. tuberculosis taken up by macrophages can interfere with phagosome maturation. Phagosome maturation requires the conversion of Rab5 into GTP-bound Rab7 and the production of phosphatidylinositol 3-phosphate (PI3P) in the phagosomal membrane [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/12\">",
"     12",
"    </a>",
"    ]. Two secreted bacterial products PtpA (a tyrosine phosphatase) and NdkA (a GTPase) are believed to be involved in Rab7 inactivation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/13,14\">",
"     13,14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fusion of lysosomes with phagosomes leads to the release of microbicidal lysosomal contents. However, M. tuberculosis can inhibit phagosome-lysosome fusion inside murine peritoneal macrophages more than one week after infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. When the macrophages were observed only two hours after infection in another study, 85 percent of the phagosomes containing M. tuberculosis or BCG strains were fused, but the number of such phagosomes declined over time in cells infected with live H37Rv or Ra strains of M. tuberculosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/17\">",
"     17",
"    </a>",
"    ]. M. tuberculosis strains incubated with an antibody raised against BCG did not inhibit fusion, but they remained viable inside macrophages [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/16\">",
"     16",
"    </a>",
"    ]. Thus, while there is evidence that M. tuberculosis can inhibit phagosome-lysosome fusion, the relevance of this mechanism in ensuring intracellular survival is not clear.",
"   </p>",
"   <p>",
"    Both M. avium and M. tuberculosis can inhibit vacuolar acidification [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. They do this by selectively excluding the proton-ATPase from the phagosome. While this inhibitory mechanism may be important during the initial encounter of the organism with macrophages, it is not clear how much of a role this plays in the ultimate intracellular fate of the pathogen. Macrophages activated by cytokines can acidify phagosomes, but the acidification itself may not contribute to significant killing of mycobacteria inside such cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    M. tuberculosis is also known to interfere with antigen presentation by MHC class II molecules, which is important for priming CD4 T cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/21\">",
"     21",
"    </a>",
"    ]. Such interference could lead to resistance of M. tuberculosis to acquired immunity in the host, and hence may contribute to bacterial persistence, a characteristic feature of this organism. M. tuberculosis products suggested to inhibit macrophage presentation of MHC class II molecules include lipoarabinomannan, 25 kDa glycoprotein, and a 19 kDa lipoprotein [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/6,22,23\">",
"     6,22,23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The traditional view is that when M. tuberculosis is engulfed by macrophages or dendritic cells, it resides inside the phagosomal compartment and that it does not escape into the cytosol. However, data suggest that the organism can enter the cytosol and that this is dependent on two major secreted M. tuberculosis proteins, ESAT-6 and CFP-10, encoded by the Esx-1 locus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/24\">",
"     24",
"    </a>",
"    ]. ESAT-6 has been shown to have a membranolytic effect in vitro [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. In the cytosol, mycobacterial cell wall component N-glycolyl muramyl dipeptide is believed to induce the production of type I interferons by binding to the intracellular pattern recognition receptor called nucleotide oligomerization domain 2 (NOD2), and that the induction of type I interferons is dependent on intact Esx-1 system [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. ESAT-6 may promote access to the cytosol of other M. tuberculosis immunostimulatory products that activate the NLRP3 inflammasome complex that promotes caspase-I-dependent secretion of type I interferons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/29\">",
"     29",
"    </a>",
"    ]. The effect of type I interferon production on outcome M. tuberculosis infection outcome is not clear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h4\">",
"     Reactive nitrogen intermediates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies have focused on the role of reactive nitrogen intermediates (RNI) in clearing infection before acquired immunity develops. In mice, RNIs are the only macrophage effector molecules associated with killing of M. tuberculosis. A murine macrophage cell line expressing RNI but defective in ROI expression was able to kill a virulent strain of M. tuberculosis after stimulation with interferon (IFN)-gamma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Additional evidence for the importance of RNI in controlling M. tuberculosis infection in mice is illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mortality in mice infected with M. tuberculosis is increased when inducible nitric oxide synthase (NOS2 or iNOS), which leads to RNI expression, is blocked by nitric oxide synthase inhibitors [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      IFN-gamma is a potent stimulus of NOS2 expression in mice. Mice with disrupted IFN-gamma or NOS2 genes become highly susceptible to M. tuberculosis infections [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/32,33\">",
"       32,33",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Human macrophages do not express NOS2 when exposed to IFN-gamma, and NOS2 expression in peripheral blood-derived macrophages is difficult to demonstrate. However, several studies have provided evidence for NOS2 expression by alveolar macrophages obtained from bronchial alveolar lavage (BAL) fluid of patients with TB [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/34-36\">",
"     34-36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thus, human NOS2 may require factors other than those that stimulate NOS2 expression in murine macrophages. RNIs may play an important role in the initial (innate immunity) as well as the later control (acquired immunity) of M. tuberculosis infection.",
"   </p>",
"   <p>",
"    There is epidemiologic evidence supporting the importance of RNIs in TB control. A study in New York City found that the most common drug-susceptible strain of M. tuberculosis circulating in the city (C strain) during the early 1990s was resistant to RNIs generated in vitro and was associated with injection drug use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/37\">",
"     37",
"    </a>",
"    ]. This strain was used to identify a novel gene called noxR1. Expression of this gene in nonpathogenic strains of E. coli or M. smegmatis led to increased resistance to RNIs and ROIs in vitro [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another protein, alkyl hydroperoxidase subunit protein, expressed by gene ahpC of M. tuberculosis also protects human cells from necrosis and apoptosis caused by RNIs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/39\">",
"     39",
"    </a>",
"    ]. AhpC is believed to detoxify peroxynitrite, a potent oxidant generated from the reaction of nitric oxide and superoxide anion (O2-) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/40\">",
"     40",
"    </a>",
"    ]. Peroxynitrite-induced damage has been suggested to be repaired by methionine sulfoxide reductase encoded by msrA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/41\">",
"     41",
"    </a>",
"    ]. Another gene noxR3 of M. tuberculosis has been reported to protect Salmonella typhimurium against oxidative and nitrosative stress [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h4\">",
"     Interferon gamma",
"    </span>",
"    &nbsp;&mdash;&nbsp;In human macrophages, the effect of interferon (IFN)-gamma in killing M. tuberculosis has not been definitively demonstrated. In one study, for example, cells preincubated with IFN-gamma enhanced the intracellular proliferation of M. tuberculosis; in comparison, killing of another intracellular organism, Leishmania, was increased [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/43\">",
"     43",
"    </a>",
"    ]. However, the coadministration of IFN-gamma with calcitriol (the most active metabolite of vitamin D), which causes monocytes to mature in vitro, leads to intracellular killing of M. tuberculosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/44\">",
"     44",
"    </a>",
"    ]. Calcitriol independently stimulates NOS2 production and suppresses growth of M. tuberculosis inside the human macrophage-like cell line, HL-60 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h4\">",
"     Other cytokines",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the role that IFN-gamma plays in M. tuberculosis control described above, other cytokines also contribute. One important cytokine is tumor necrosis factor alpha (TNF-alpha). Its role in controlling latent infection with M. tuberculosis in humans has been dramatically demonstrated by multiple reports of reactivation TB occurring in individuals treated for rheumatoid arthritis or Crohn's disease with anti-TNF-alpha (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/6/28776?source=see_link\">",
"     infliximab",
"    </a>",
"    ) or TNF-alpha receptor (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/31/28151?source=see_link\">",
"     etanercept",
"    </a>",
"    ) antibodies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/46-48\">",
"     46-48",
"    </a>",
"    ]. TNF-alpha is also important for proper granuloma formation (see below). Persistently infected mice treated with neutralizing anti-TNF-alpha antibody develop granuloma disorganization, which eventually kill the mice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/49\">",
"     49",
"    </a>",
"    ]. IFN-gamma and IL12 levels in these mice are not affected. Mice deficient in this cytokine or TNF-alpha receptor are highly susceptible to M. tuberculosis infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/50,51\">",
"     50,51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The role of other cytokines in outcome after M. tuberculosis infection is less clear. IL10 produced by macrophages has an anti-inflammatory effect. However, IL-10-disrupted mice are not any more resistant to M. tuberculosis infection than wild type mice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/52\">",
"     52",
"    </a>",
"    ]. The role of another suppressive cytokine transforming growth factor-beta (TGF-beta) in infection outcome in mice or humans remains unresolved [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h4\">",
"     Toll-like receptors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Toll-like receptors (TLR) is a family of transmembrane proteins in mammalian cells that mediate immune response against infectious agents by activating the NF-kB pathway, which elicits a pro-inflammatory response [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    TLR is a mammalian homologue of the Toll receptor in the insect Drosophila that plays a role in conferring immunity of the insect against yeast infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/55\">",
"     55",
"    </a>",
"    ]. TLRs exhibit pattern recognition of organism group characteristic molecules, such as the lipopolysaccharide of gram-negative organisms, peptidoglycan of gram-positive organisms, double-stranded RNA of viruses, and lipoteichoic acids of yeasts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/56-58\">",
"     56-58",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/54/23401?source=see_link\">",
"     \"Toll-like receptors: Roles in disease and therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    TLR2 and TLR4 are important for the recognition of M. tuberculosis products [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/56,59\">",
"     56,59",
"    </a>",
"    ]. M. tuberculosis was killed by activation of the TLR2 by the bacterial lipoprotein (19-kD) in both mouse and human macrophages [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/60\">",
"     60",
"    </a>",
"    ]. However, the killing in the mouse macrophage was dependent on the intracellular nitric oxide pathway, while in the human macrophage, it was independent of this pathway [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/60\">",
"     60",
"    </a>",
"    ]. That is, the human TLR2 activation by the 19-kD lipoprotein killed M. tuberculosis, but no nitric oxide production could be demonstrated.",
"   </p>",
"   <p>",
"    Further characterization of the mechanism of killing of M. tuberculosis in human macrophages has identified that",
"    <span class=\"nowrap\">",
"     TLR1/2",
"    </span>",
"    activation up-regulates expression of the vitamin D receptor, as well as vitamin D-1-hydroxylase [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/61\">",
"     61",
"    </a>",
"    ]. The expression of vitamin D receptor-related genes leads to an increased expression of cathelicidin, an antimicrobial peptide, which is then responsible for inhibition of growth of M. tuberculosis.",
"   </p>",
"   <p>",
"    TLR2 and TLR4 require MyD88, an intracellular adapter protein required for inducing early innate immune response to pathogens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/62\">",
"     62",
"    </a>",
"    ]. However, in murine macrophages, M. tuberculosis can activate macrophages via an MyD88-independent pathway [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/63\">",
"     63",
"    </a>",
"    ]. Furthermore, M. tuberculosis infection of MyD88-deficient",
"    <span class=\"nowrap\">",
"     C57BL/6",
"    </span>",
"    mouse is fatal despite an intact adaptive immune response [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/64\">",
"     64",
"    </a>",
"    ]. When the mice were vaccinated with M. bovis-BCG, they were protected from M tuberculosis infection, indicating that the adaptive immune response functioned normally in this MyD88 deficient mouse. The adaptive immune response was not sufficient to compensate for the innate immune defect in unvaccinated mice, suggesting that the innate immune response plays a substantive role in protection against tuberculosis, at least in the mouse model [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h4\">",
"     Other factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;LRG-47, a member of the 47-kilodalton (p47) guanosine triphosphate family, may play a role independent of RNIs in controlling M. tuberculosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/65\">",
"     65",
"    </a>",
"    ]. Mice that lacked LRG-47 were unable to halt M. tuberculosis replication due to impaired maturation of phagosomes containing the organism, despite the presence of IFN-gamma-activated macrophages.",
"   </p>",
"   <p>",
"    In a mouse model of tuberculosis, the Intracellular pathogen resistance 1 (Ipr1) gene mediates innate immunity to tuberculosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/66\">",
"     66",
"    </a>",
"    ]. The expression of the Ipr1 transgene in a highly susceptible mouse strain limited multiplication of M. tuberculosis in the lungs and macrophages and switched a cell death pathway of the infected macrophages from necrosis to apoptosis. The closest human homologue is SP110; polymorphisms in SP110 have been associated with susceptibility to hepatitis C virus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/67\">",
"     67",
"    </a>",
"    ]. SP110 might be a candidate gene for testing for association with susceptibility to tuberculosis in human populations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11165131\">",
"    <span class=\"h3\">",
"     Adaptive immunity",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h4\">",
"     Cellular immunity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two to six weeks after infection with M. tuberculosis, T cells that specifically recognize M. tuberculosis antigens appear; this response can be demonstrated clinically by the development of a delayed-type hypersensitivity (DTH) response to intradermally injected tuberculin or PPD. One study of T cell responses in persistently anergic patients with documented pulmonary TB demonstrated that T cells produced interleukin (IL)-10 but not IFN-gamma and failed to proliferate in vitro following stimulation with PPD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/68\">",
"     68",
"    </a>",
"    ]. By contrast, T cells from PPD positive patients produced both IL-10 and IFN-gamma, and displayed a dramatic proliferative response to PPD stimulation.",
"   </p>",
"   <p>",
"    The DTH response per se does not correlate with protection against TB, since numerous BCG vaccination trials have demonstrated that disease can occur in those who mount a DTH response [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/69\">",
"     69",
"    </a>",
"    ]. As a result, the protective T cell response must be distinguished from the T cell response associated with DTH.",
"   </p>",
"   <p>",
"    Interferon-gamma release assays have been developed; these are in vitro, whole blood-based tests to measure T cell activation. The assays are an alternative to the",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/35/15924?source=see_link\">",
"     tuberculin skin test",
"    </a>",
"    (TST) for detection of latent M. tuberculosis infection in human hosts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/70-74\">",
"     70-74",
"    </a>",
"    ]. The test measures interferon-gamma released into blood from T cells when they are activated by M. tuberculosis antigens in vitro. The tests use antigens specific to M. tuberculosis including the early secretory antigenic target 6 (ESAT-6) and culture filtrate protein (CFP-10) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/70,71\">",
"     70,71",
"    </a>",
"    ]. These proteins are encoded by genes located within the region of difference 1 (RD1) of the M. tuberculosis genome, and are absent in vaccine strain BCG, or M. bovis. This enables the test to differentiate those latently infected with M. tuberculosis from those vaccinated with BCG. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/18/37160?source=see_link\">",
"     \"Interferon-gamma release assays for diagnosis of latent tuberculosis infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The importance of T cells in the protective immune response against TB was first demonstrated in mice; adoptive transfer of T cells from BCG-immunized mice protected irradiated recipient mice from infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/75,76\">",
"     75,76",
"    </a>",
"    ]. Other animal studies showed that this protective response was mediated by CD4-bearing T cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/77,78\">",
"     77,78",
"    </a>",
"    ]. If it is assumed that the DTH response is mediated by CD4+ Th1 cells, the wide range of protection (0 to 80 percent) demonstrated by numerous BCG trials suggest that CD4+ T cells are not sufficient for protection, and that other cells must be involved [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/69\">",
"     69",
"    </a>",
"    ]. However, the greatly increased risk of TB with HIV infection, in which CD4+ T cells become depleted, suggests that these cells are important for protection against TB in humans. CD4+ T cells exert their effector function by producing IFN-gamma, which activates macrophages. This response is important, particularly during early phase of an infection. In one study, in CD4-disrupted mice, levels of IFN-gamma in the lungs, while diminished early in infection, reached levels found in wild type mice after about three weeks, suggesting that other cell types (CD8+ cells), can compensate for the decreased cytokine expression by CD4 T cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/79\">",
"     79",
"    </a>",
"    ]. Finally, in addition to the role of cytokines produced by CD4+ cells, apoptosis of infected cells by CD4+ T cells may contribute to controlling infection. However, published reports on the role of apoptosis in M. tuberculosis infection control remain equivocal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/80,81\">",
"     80,81",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cytotoxic T lymphocytes (CTLs) have been implicated in protection against M. tuberculosis, and active investigation into the details of this mechanism is ongoing.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mice with disruption of the &szlig;2-microglobulin gene fail to control infection with a virulent strain of M. tuberculosis (Erdman) despite having intact CD4+ and cytolytic gamma-delta T cells [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/82\">",
"       82",
"      </a>",
"      ]. This gene inhibits expression of functional class I major histocompatibility complex (MHC-I) molecules which is a feature of CD8+ CTLs.",
"     </li>",
"     <li>",
"      Another study using different strains of gene-disrupted mice found: perforin contributed only partially to the protective ability of CTLs; there were &szlig;2-microglobulin-dependent T cells which exerted a protective effect distinct from CTLs; and transporter associated with antigen processing (TAP) pathways were predominant in mediating protection against M. tuberculosis, but TAP-independent mechanisms also played a role [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/83\">",
"       83",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Mice immunized with Mycobacterium vaccae can generate CD8+ T cells that express IFN-gamma and that are lytic to macrophages infected with M. tuberculosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/84\">",
"       84",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Live mycobacteria activate more CD8+ T cells than dead organisms or PPD [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/85\">",
"       85",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Antigen-presenting pathways other than MHC class I or class II that stimulate this type of CTL response have been explored. One such pathway, CD1-restricted CTL stimulation, involves MHC-like cell surface molecules that process and present nonpeptide antigens to T cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/86\">",
"     86",
"    </a>",
"    ]. In patients with active TB, two types of T cells that recognize M. tuberculosis lipid and lipoglycan antigens presented by CD1b-bearing cells were found, \"double negative\" (DN)",
"    <span class=\"nowrap\">",
"     CD4-/CD8-",
"    </span>",
"    T cells and CD8+ T cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/81\">",
"     81",
"    </a>",
"    ]. These cells were both capable of lysing macrophages (CD-1 bearing cells) infected with M. tuberculosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, cell lysis would not necessarily lead to protection in the absence of bacterial killing. CTL-mediated cell lysis involves two pathways: a degranulation pathway that generates perforin and granzymes; and a Fas-FasL-dependent pathway that induces apoptosis of the target cell [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/87,88\">",
"     87,88",
"    </a>",
"    ]. Studies with perforin gene-disrupted mice showed that this pathway was not essential for early protection against M. tuberculosis infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/89,90\">",
"     89,90",
"    </a>",
"    ]. Another study showed that perforin-disrupted mice eventually did succumb to infection at a later time point, suggesting that the protection is partially dependent on perforin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/83\">",
"     83",
"    </a>",
"    ]. Coculturing DN and CD8+ T cell lines with CD1 cells infected with M. tuberculosis revealed that DN CD1-restricted cells had no effect on the viability of the organism, while CD8+ CD1-restricted T cells reduced the number of colony forming units (CFU) by 35 to 50 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This bacterial killing is mediated by granulysin, a protein found in the granules of human CTLs and natural killer (NK) cells, but not in murine cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/75\">",
"     75",
"    </a>",
"    ]. Granulysin is present in CD1-restricted CD8+ T cells but not in CD1-restricted DN T cells. Granulysin, a member of the saposin-like protein family, induce blister-like lesions on the surface of M. tuberculosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/91\">",
"     91",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There also appears to be a role for CD8+ alpha beta TCR+ cells which recognize antigens bound to MHC class I. In one study, for example, two human TCR alpha beta+ CD8+ T cell lines specific for M. tuberculosis antigens recognized lipid antigens when presented by CD1a or CD1c antigen-presenting cells and displayed both cytotoxicity and cytokine responses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/92\">",
"     92",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    5'-adendomsinephosphosulfate reductase (CysH), an enzyme essential for the production of reduced-sulfur-containing metabolites, has been shown to be important for M. tuberculosis during the chronic infection phase [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/93\">",
"     93",
"    </a>",
"    ]. Resistance to nitrosative and oxidative stress (RNI and ROI) may be the mechanism of this protection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/93\">",
"     93",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5272080\">",
"    <span class=\"h4\">",
"     Granuloma formation",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the specific cell-mediated protective response involved in M. tuberculosis elimination, granuloma formation is an important mechanism of the host to control infection. Granuloma formation requires balanced expression of cytokines and chemokines, including RANTES, M1P1-alpha, M1P1-beta, MCP-1, MCP-3, MCP-5, and IP10 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/94,95\">",
"     94,95",
"    </a>",
"    ]. Chemokine receptors also determine proper formation of granulomas, and with M. tuberculosis infection, the expression of CCR5 (receptor for RANTES, M1P1-alpha, and M1P1-beta) increases in macrophages [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/96\">",
"     96",
"    </a>",
"    ]. CCR2-disrupted mice are more susceptible to M. tuberculosis than the wild type mice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/97\">",
"     97",
"    </a>",
"    ]. CCR2 is a receptor for MCP-1, 3, and 5. MCP-1-disrupted mice, however, are not susceptible [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/98\">",
"     98",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    M. tuberculosis disrupted in an operon called mce1 was shown to become hypervirulent in the mouse model of TB [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/99\">",
"     99",
"    </a>",
"    ]. This hypervirulence was associated with aberrant pro-inflammatory cell migration to the site of infection in the mouse lungs and poor granuloma formation. The mce1 operon mutant was unable to stimulate MCP-1 and TNF-alpha expression by murine macrophages [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/99\">",
"     99",
"    </a>",
"    ]. Disruption of the mce1 operon may alter the cell wall architecture and thus an effect on host granulomatous response [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/100\">",
"     100",
"    </a>",
"    ]. The cma2A mutant, noted above, induced larger sized granulomas in mouse lungs than did the wild type M. tuberculosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/101\">",
"     101",
"    </a>",
"    ]. These observations suggested that alteration in the cell wall lipid composition or its remodeling can greatly affect host immune response, and that a certain level of proinflammatory response induced by M. tuberculosis itself is necessary for proper granuloma formation, that is protective both to the host and the bacterium. Thus, the role of the granuloma as a host protective factor needs a revision in thinking as it may also play a role in protecting the tubercle bacilli for its long-term survival in the host.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11165213\">",
"    <span class=\"h4\">",
"     Humoral immunity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of the humoral immune response in protection against M. tuberculosis is controversial. The range of findings can be illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Passive transfer experiments of serum from BCG-vaccinated animals or M. tuberculosis-infected animals and humans to other animals have provided conflicting evidence of protection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/102\">",
"       102",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Antibodies against a variety of mycobacterial antigens, including lipid and carbohydrate products, can be demonstrated in both asymptomatic PPD-positive persons and in patients who develop active disease.",
"     </li>",
"     <li>",
"      M. tuberculosis strains incubated with an antibody raised against BCG promoted phagosome-lysosome fusion, but the viability of such strains inside macrophages was not affected [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Transgenic mice unable to make IgM become more susceptible to M. tuberculosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/103\">",
"       103",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, unequivocal evidence for the protective role of humoral immunity against TB does not exist. In the absence of detailed studies, it is difficult to conclude how much of the protective response against TB, if any, is mediated by humoral immunity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11164663\">",
"    <span class=\"h2\">",
"     Pathogen factors",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11164831\">",
"    <span class=\"h3\">",
"     Mycobacterial lipids",
"    </span>",
"    &nbsp;&mdash;&nbsp;M. tuberculosis lipid products have been associated with tuberculosis pathogenesis since 1947, when Middlebrook suggested that a growth morphology called \"cording\" was associated with virulent tubercle bacilli [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/104\">",
"     104",
"    </a>",
"    ]. Subsequently, the toxic effect of petroleum ether extractable \"cord factor\" from M. tuberculosis was characterized in a murine model [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/105\">",
"     105",
"    </a>",
"    ]. This cord factor was eventually identified as glycolipid trehalose dimycolate (TDM) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/106\">",
"     106",
"    </a>",
"    ]. Although studies have shown that \"cording\" is not necessarily restricted to virulent Mycobacteria, structural changes in TDM elicit distinct mammalian host immune responses.",
"   </p>",
"   <p>",
"    TDM is comprised of mycolic acids covalently bound to trehalose. Mycolic acids are beta-hydroxyl fatty acids with an alpha-alkyl side chain; the M. tuberculosis cell wall contains three classes of this fatty acid &mdash; alpha-, keto-, and methoxy-mycolates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/107\">",
"     107",
"    </a>",
"    ]. Alpha mycolic acid has two cyclopropane rings, which are in the cis configuration, while the keto- and methoxymycolates have one ring in either cis or trans configuration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/108\">",
"     108",
"    </a>",
"    ]. The cyclopropanation status of mycolic acids is important for pathogenesis in the mouse model as illustrated by the following findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      M. tuberculosis strains lacking keto-mycolates grow poorly inside THP-1 cells [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/109\">",
"       109",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Absence of keto- or methoxy-mycolates in M. tuberculosis leads to attenuation of infection in a murine model [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/110\">",
"       110",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      M. tuberculosis strains disrupted in the cyclopropane synthase gene, pcaA, are attenuated in mice. pcaA is required for cord formation and for the synthesis of the proximal cyclopropane ring of alpha-mycolic acid. TDM prepared from this mutant is less inflammatory [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/111\">",
"       111",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      M. tuberculosis disrupted in cyclopropane-mycolic acid synthase 2 (cmaA2), a gene responsible for the transcyclopropanation of mycolic acid in the cell wall, is hypervirulent in",
"      <span class=\"nowrap\">",
"       BALB/c",
"      </span>",
"      mice [",
"      <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/101\">",
"       101",
"      </a>",
"      ]. Lipid extracted from this mutant is hyperproinflammatory.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, phthiocerol dimycocerosates (PDIM), are important for growth of M. tuberculosis in mouse lungs (although not in mouse spleen or liver) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/112\">",
"     112",
"    </a>",
"    ]. PDIM is thought to protect M. tuberculosis against the bactericidal activity of reactive nitrogen intermediates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/113\">",
"     113",
"    </a>",
"    ]. A mutation in a lipoprotein (LppX), needed for the export of PDIM, led to attenuation of the mutant in a mouse infection model [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/114\">",
"     114",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These observations suggest that M. tuberculosis cell wall lipids play an important role in the early interaction of this organism with the host immune response, and that the cell wall lipids ultimately determine clinical outcomes. Clinical isolates of M. tuberculosis with changes in lipid composition can affect the distribution of organisms in a community, as illustrated by a large outbreak of tuberculosis in Tennessee and Kentucky in 1994 through 1996 caused by strain CDC1551 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/115\">",
"     115",
"    </a>",
"    ]. CDC1551 produced an enhanced proinflammatory cytokine response in mice which was traced to changes in its cell wall lipids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/116\">",
"     116",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another outbreak-associated strain, HN878, expresses a highly active lipid species called phenolic glycolipid (PGL), not detected in M. tuberculosis strain CDC1551 or laboratory strain H37Rv [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/117\">",
"     117",
"    </a>",
"    ]. PGL inhibits proinflammatory cytokine release by macrophages [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/117,118\">",
"     117,118",
"    </a>",
"    ], but a later study showed that PGL itself does not mediate hypervirulence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/119\">",
"     119",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H252006710\">",
"    <span class=\"h1\">",
"     VACCINE DEVELOPMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The World Health Organization guidelines recommend that Bacille Calmette-Guerin (BCG) be administered as part of routine newborn immunization to protect against TB, although its efficacy is limited. The development of new vaccines has been hampered by lack of good understanding of correlates of protection and difficulty identifying surrogate endpoints of protective immunity against active disease that can be used in vaccine trials. Experimental animal models have not been reliable in predicting vaccine protection against human infection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/12/40136?source=see_link\">",
"     \"BCG vaccination\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite these obstacles, there are many candidate vaccines undergoing clinical trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/120\">",
"     120",
"    </a>",
"    ]. Trial results for the modified vaccinia virus Ankara-expressing mycobacterial antigen 85A (MVA85A) were disappointing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/121-123\">",
"     121-123",
"    </a>",
"    ]. Other candidates include AERAS-402",
"    <span class=\"nowrap\">",
"     /",
"    </span>",
"    Crucell Ad35, based on replication-deficient adenovirus expressing M. tuberculosis antigen 85A, 85B, and TB10.4 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/124\">",
"     124",
"    </a>",
"    ], recombinant BCG expressing M. tuberculosis antigens (VPM1002, rBCG30), recombinant subunit or fusion proteins (M72, Hybrid-1+IC31; Hybrid-1+CAF01, Hyvac4, AERAS-404 + IC-31), fragmented M. tuberculosis cells (RUTI), and non-tuberculosis attenuated mycobacteria (M. vaccae) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/125\">",
"     125",
"    </a>",
"    ]. Many of these candidates advanced to human trials after they were shown in nonhuman animal models to confer better protection than BCG.",
"   </p>",
"   <p>",
"    Many of the new vaccines are designed to be given through &ldquo;heterologous prime-boost strategy&rdquo; in which the new vaccine expressing M. tuberculosis antigens is given as a booster in those primed with BCG or a recombinant BCG vaccine. The M. tuberculosis antigens are delivered in a viral or some non-mycobacterial vector. Other strategies for TB vaccine application include therapeutic vaccine or immunotherapy, designed to be administered to those already infected with M. tuberculosis to prevent them from progressing to active disease, and adjunctive vaccine designed to be given together with a short-course drug regimen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/126,127\">",
"     126,127",
"    </a>",
"    ]. The idea of an adjunctive vaccine is to reduce the bacterial burden with standard drugs to a level that can then be cleared by vaccine-induced immunity, which may facilitate shorter course drug regimens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?42/17/43289/abstract/127\">",
"     127",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Major obstacles to development of safe, effective, and affordable TB vaccines remain. These include our need to better understand the immunology of TB, especially the component associated with protection from a vaccine and natural infection; identification of biomarkers for vaccine efficacy and protection; selection of clinical trial sites with appropriate target populations; regulatory and ethical constraints associated with clinical trials; and limited resources and funding available for vaccine development, clinical trials, and implementation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The majority of individuals in the general population who become infected with M. tuberculosis never develop clinical disease; this demonstrates that the innate and adaptive immune response of the host in controlling TB infection is effective. Factors that adversely affect the immune system contribute to development of latent tuberculosis infection and active disease. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Immunology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Components of innate immunity thought to be involved with defense against TB infection include killing via reactive nitrogen intermediates, interferon gamma and other cytokines, use of Toll-like receptors for recognition of M. tuberculosis molecules, and other factors. (See",
"      <a class=\"local\" href=\"#H11164598\">",
"       'Innate immunity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The role of cellular immunity is important in the protective response against TB, and diagnostic tools have been developed based upon this cellular response including the",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/35/15924?source=see_link\">",
"       tuberculin skin test",
"      </a>",
"      (TST) and the interferon-gamma release assay (IGRA). The TST measures the delayed-type hypersensitivity response to intradermally injected tuberculin. The IGRA is an in vitro, whole blood-based test which measures T cell activation by M. tuberculosis antigens. The role of humoral immunity in the protective response against TB is uncertain. (See",
"      <a class=\"local\" href=\"#H11165131\">",
"       'Adaptive immunity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Granuloma formation is also an important mechanism of the host to control infection; it requires expression of cytokines and chemokines. In addition, it may play a role in protecting the tubercle bacilli for its long-term survival in the host. (See",
"      <a class=\"local\" href=\"#H5272080\">",
"       'Granuloma formation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      M. tuberculosis cell wall lipids play an important role in the early interaction of the organism with the host immune response and determination of clinical outcome. (See",
"      <a class=\"local\" href=\"#H11164831\">",
"       'Mycobacterial lipids'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The efficacy of BCG vaccination is limited; the development of new vaccines has been hampered by lack of good understanding of correlates of protection, and difficulty identifying surrogate endpoints of protective immunity against active disease that can be used in vaccine trials. In addition, experimental animal models have not been reliable in predicting vaccine protection against human infection. (See",
"      <a class=\"local\" href=\"#H252006710\">",
"       'Vaccine development'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/1\">",
"      Kunnath-Velayudhan S, Gennaro ML. Immunodiagnosis of tuberculosis: a dynamic view of biomarker discovery. Clin Microbiol Rev 2011; 24:792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/2\">",
"      Comstock GW. Epidemiology of tuberculosis. Am Rev Respir Dis 1982; 125:8.",
"     </a>",
"    </li>",
"    <li>",
"     Schneeberger EE. Alveolar type II cells. In: The lung: Scientific foundations, Crystal RJ, West JB (Eds), Raven Press, New York 1991. p.736.",
"    </li>",
"    <li>",
"     Crystal RJ. Alveolar macrophages. In: The lung: Scientific foundations, Crystal RJ, West JB (Eds), Raven Press, New York 1991. p.527.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/5\">",
"      Wolf AJ, Linas B, Trevejo-Nu&ntilde;ez GJ, et al. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J Immunol 2007; 179:2509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/6\">",
"      Chan J, Fan XD, Hunter SW, et al. Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect Immun 1991; 59:1755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/7\">",
"      Schlesinger LS, Bellinger-Kawahara CG, Payne NR, Horwitz MA. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J Immunol 1990; 144:2771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/8\">",
"      Schlesinger LS. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J Immunol 1993; 150:2920.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/9\">",
"      Yuan Y, Lee RE, Besra GS, et al. Identification of a gene involved in the biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 1995; 92:6630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/10\">",
"      Deretic V, Philipp W, Dhandayuthapani S, et al. Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: implications for sensitivity to isoniazid. Mol Microbiol 1995; 17:889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/11\">",
"      Sherman DR, Sabo PJ, Hickey MJ, et al. Disparate responses to oxidative stress in saprophytic and pathogenic mycobacteria. Proc Natl Acad Sci U S A 1995; 92:6625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/12\">",
"      Philips JA. Mycobacterial manipulation of vacuolar sorting. Cell Microbiol 2008; 10:2408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/13\">",
"      Bach H, Papavinasasundaram KG, Wong D, et al. Mycobacterium tuberculosis virulence is mediated by PtpA dephosphorylation of human vacuolar protein sorting 33B. Cell Host Microbe 2008; 3:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/14\">",
"      Sun J, Wang X, Lau A, et al. Mycobacterial nucleoside diphosphate kinase blocks phagosome maturation in murine RAW 264.7 macrophages. PLoS One 2010; 5:e8769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/15\">",
"      Armstrong JA, Hart PD. Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J Exp Med 1971; 134:713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/16\">",
"      Armstrong JA, Hart PD. Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. J Exp Med 1975; 142:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/17\">",
"      McDonough KA, Kress Y, Bloom BR. Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages. Infect Immun 1993; 61:2763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/18\">",
"      Sturgill-Koszycki S, Schlesinger PH, Chakraborty P, et al. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 1994; 263:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/19\">",
"      Xu S, Cooper A, Sturgill-Koszycki S, et al. Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium-infected macrophages. J Immunol 1994; 153:2568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/20\">",
"      Schaible UE, Sturgill-Koszycki S, Schlesinger PH, Russell DG. Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. J Immunol 1998; 160:1290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/21\">",
"      Pancholi P, Mirza A, Schauf V, et al. Presentation of mycobacterial antigens by human dendritic cells: lack of transfer from infected macrophages. Infect Immun 1993; 61:5326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/22\">",
"      Wadee AA, Kuschke RH, Dooms TG. The inhibitory effects of Mycobacterium tuberculosis on MHC class II expression by monocytes activated with riminophenazines and phagocyte stimulants. Clin Exp Immunol 1995; 100:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/23\">",
"      Noss EH, Pai RK, Sellati TJ, et al. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immunol 2001; 167:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/24\">",
"      van der Wel N, Hava D, Houben D, et al. M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell 2007; 129:1287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/25\">",
"      de Jonge MI, Pehau-Arnaudet G, Fretz MM, et al. ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity. J Bacteriol 2007; 189:6028.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/26\">",
"      Smith J, Manoranjan J, Pan M, et al. Evidence for pore formation in host cell membranes by ESX-1-secreted ESAT-6 and its role in Mycobacterium marinum escape from the vacuole. Infect Immun 2008; 76:5478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/27\">",
"      Pandey AK, Yang Y, Jiang Z, et al. NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathog 2009; 5:e1000500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/28\">",
"      Stanley SA, Johndrow JE, Manzanillo P, Cox JS. The Type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis. J Immunol 2007; 178:3143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/29\">",
"      Mishra BB, Moura-Alves P, Sonawane A, et al. Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome. Cell Microbiol 2010; 12:1046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/30\">",
"      Chan J, Xing Y, Magliozzo RS, Bloom BR. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 1992; 175:1111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/31\">",
"      Chan J, Tanaka K, Carroll D, et al. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect Immun 1995; 63:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/32\">",
"      MacMicking JD, North RJ, LaCourse R, et al. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci U S A 1997; 94:5243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/33\">",
"      Cooper AM, Dalton DK, Stewart TA, et al. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 1993; 178:2243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/34\">",
"      Nicholson S, Bonecini-Almeida Mda G, Lapa e Silva JR, et al. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med 1996; 183:2293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/35\">",
"      Nozaki Y, Hasegawa Y, Ichiyama S, et al. Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages. Infect Immun 1997; 65:3644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/36\">",
"      Wang CH, Liu CY, Lin HC, et al. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages. Eur Respir J 1998; 11:809.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/37\">",
"      Friedman CR, Quinn GC, Kreiswirth BN, et al. Widespread dissemination of a drug-susceptible strain of Mycobacterium tuberculosis. J Infect Dis 1997; 176:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/38\">",
"      Ehrt S, Shiloh MU, Ruan J, et al. A novel antioxidant gene from Mycobacterium tuberculosis. J Exp Med 1997; 186:1885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/39\">",
"      Chen L, Xie QW, Nathan C. Alkyl hydroperoxide reductase subunit C (AhpC) protects bacterial and human cells against reactive nitrogen intermediates. Mol Cell 1998; 1:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/40\">",
"      Bryk R, Griffin P, Nathan C. Peroxynitrite reductase activity of bacterial peroxiredoxins. Nature 2000; 407:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/41\">",
"      St John G, Brot N, Ruan J, et al. Peptide methionine sulfoxide reductase from Escherichia coli and Mycobacterium tuberculosis protects bacteria against oxidative damage from reactive nitrogen intermediates. Proc Natl Acad Sci U S A 2001; 98:9901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/42\">",
"      Ruan J, St John G, Ehrt S, et al. noxR3, a novel gene from Mycobacterium tuberculosis, protects Salmonella typhimurium from nitrosative and oxidative stress. Infect Immun 1999; 67:3276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/43\">",
"      Douvas GS, Looker DL, Vatter AE, Crowle AJ. Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria. Infect Immun 1985; 50:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/44\">",
"      Rook GA, Steele J, Fraher L, et al. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 1986; 57:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/45\">",
"      Rockett KA, Brookes R, Udalova I, et al. 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun 1998; 66:5314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/46\">",
"      Gardam MA, Keystone EC, Menzies R, et al. Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 2003; 3:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/47\">",
"      Long R, Gardam M. Tumour necrosis factor-alpha inhibitors and the reactivation of latent tuberculosis infection. CMAJ 2003; 168:1153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/48\">",
"      Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001; 345:1098.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/49\">",
"      Mohan VP, Scanga CA, Yu K, et al. Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect Immun 2001; 69:1847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/50\">",
"      Flynn JL, Goldstein MM, Chan J, et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995; 2:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/51\">",
"      Bean AG, Roach DR, Briscoe H, et al. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J Immunol 1999; 162:3504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/52\">",
"      North RJ. Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis. Clin Exp Immunol 1998; 113:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/53\">",
"      Hirsch CS, Ellner JJ, Blinkhorn R, Toossi Z. In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta. Proc Natl Acad Sci U S A 1997; 94:3926.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/54\">",
"      Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/55\">",
"      Belvin MP, Anderson KV. A conserved signaling pathway: the Drosophila toll-dorsal pathway. Annu Rev Cell Dev Biol 1996; 12:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/56\">",
"      Means TK, Wang S, Lien E, et al. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 1999; 163:3920.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/57\">",
"      Yang RB, Mark MR, Gray A, et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 1998; 395:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/58\">",
"      Schwandner R, Dziarski R, Wesche H, et al. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 1999; 274:17406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/59\">",
"      Underhill DM, Ozinsky A, Smith KD, Aderem A. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci U S A 1999; 96:14459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/60\">",
"      Thoma-Uszynski S, Stenger S, Takeuchi O, et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 2001; 291:1544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/61\">",
"      Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311:1770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/62\">",
"      Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/63\">",
"      Shi S, Nathan C, Schnappinger D, et al. MyD88 primes macrophages for full-scale activation by interferon-gamma yet mediates few responses to Mycobacterium tuberculosis. J Exp Med 2003; 198:987.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/64\">",
"      Fremond CM, Yeremeev V, Nicolle DM, et al. Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. J Clin Invest 2004; 114:1790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/65\">",
"      MacMicking JD, Taylor GA, McKinney JD. Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science 2003; 302:654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/66\">",
"      Pan H, Yan BS, Rojas M, et al. Ipr1 gene mediates innate immunity to tuberculosis. Nature 2005; 434:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/67\">",
"      Saito T, Ji G, Shinzawa H, et al. Genetic variations in humans associated with differences in the course of hepatitis C. Biochem Biophys Res Commun 2004; 317:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/68\">",
"      Boussiotis VA, Tsai EY, Yunis EJ, et al. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 2000; 105:1317.",
"     </a>",
"    </li>",
"    <li>",
"     McKinney JD, Jacobs WR, Bloom BR. Persisting problems in tuberculosis. In: Emerging Infections, Krause RM (Ed), Academic Press, San Diego 1998.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/70\">",
"      Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet 2000; 356:1099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/71\">",
"      Barnes PF. Diagnosing latent tuberculosis infection: turning glitter to gold. Am J Respir Crit Care Med 2004; 170:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/72\">",
"      Dockrell HM, Weir RE. Whole blood cytokine assays--a new generation of diagnostic tests for tuberculosis? Int J Tuberc Lung Dis 1998; 2:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/73\">",
"      Lalvani A. Spotting latent infection: the path to better tuberculosis control. Thorax 2003; 58:916.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/74\">",
"      Lein AD, Von Reyn CF. In vitro cellular and cytokine responses to mycobacterial antigens: application to diagnosis of tuberculosis infection and assessment of response to mycobacterial vaccines. Am J Med Sci 1997; 313:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/75\">",
"      Lefford MJ. Transfer of adoptive immunity to tuberculosis in mice. Infect Immun 1975; 11:1174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/76\">",
"      Orme IM, Collins FM. Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. Requirement for T cell-deficient recipients. J Exp Med 1983; 158:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/77\">",
"      Pedrazzini T, Louis JA. Functional analysis in vitro and in vivo of Mycobacterium bovis strain BCG-specific T cell clones. J Immunol 1986; 136:1828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/78\">",
"      Orme IM. The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J Immunol 1987; 138:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/79\">",
"      Caruso AM, Serbina N, Klein E, et al. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J Immunol 1999; 162:5407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/80\">",
"      Oddo M, Renno T, Attinger A, et al. Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J Immunol 1998; 160:5448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/81\">",
"      Stenger S, Mazzaccaro RJ, Uyemura K, et al. Differential effects of cytolytic T cell subsets on intracellular infection. Science 1997; 276:1684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/82\">",
"      Flynn JL, Goldstein MM, Triebold KJ, et al. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A 1992; 89:12013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/83\">",
"      Sousa AO, Mazzaccaro RJ, Russell RG, et al. Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. Proc Natl Acad Sci U S A 2000; 97:4204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/84\">",
"      Skinner MA, Yuan S, Prestidge R, et al. Immunization with heat-killed Mycobacterium vaccae stimulates CD8+ cytotoxic T cells specific for macrophages infected with Mycobacterium tuberculosis. Infect Immun 1997; 65:4525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/85\">",
"      Turner J, Dockrell HM. Stimulation of human peripheral blood mononuclear cells with live Mycobacterium bovis BCG activates cytolytic CD8+ T cells in vitro. Immunology 1996; 87:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/86\">",
"      Beckman EM, Porcelli SA, Morita CT, et al. Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. Nature 1994; 372:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/87\">",
"      K&auml;gi D, Vignaux F, Ledermann B, et al. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994; 265:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/88\">",
"      Lowin B, Hahne M, Mattmann C, Tschopp J. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 1994; 370:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/89\">",
"      Cooper AM, D'Souza C, Frank AA, Orme IM. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms. Infect Immun 1997; 65:1317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/90\">",
"      Laochumroonvorapong P, Wang J, Liu CC, et al. Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice. Infect Immun 1997; 65:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/91\">",
"      Stenger S, Hanson DA, Teitelbaum R, et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 1998; 282:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/92\">",
"      Rosat JP, Grant EP, Beckman EM, et al. CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool. J Immunol 1999; 162:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/93\">",
"      Senaratne RH, De Silva AD, Williams SJ, et al. 5'-Adenosinephosphosulphate reductase (CysH) protects Mycobacterium tuberculosis against free radicals during chronic infection phase in mice. Mol Microbiol 2006; 59:1744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/94\">",
"      Orme IM, Cooper AM. Cytokine/chemokine cascades in immunity to tuberculosis. Immunol Today 1999; 20:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/95\">",
"      Rhoades ER, Cooper AM, Orme IM. Chemokine response in mice infected with Mycobacterium tuberculosis. Infect Immun 1995; 63:3871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/96\">",
"      Fraziano M, Cappelli G, Santucci M, et al. Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection. AIDS Res Hum Retroviruses 1999; 15:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/97\">",
"      Peters W, Scott HM, Chambers HF, et al. Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 2001; 98:7958.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/98\">",
"      Lu B, Rutledge BJ, Gu L, et al. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 1998; 187:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/99\">",
"      Shimono N, Morici L, Casali N, et al. Hypervirulent mutant of Mycobacterium tuberculosis resulting from disruption of the mce1 operon. Proc Natl Acad Sci U S A 2003; 100:15918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/100\">",
"      Chitale S, Ehrt S, Kawamura I, et al. Recombinant Mycobacterium tuberculosis protein associated with mammalian cell entry. Cell Microbiol 2001; 3:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/101\">",
"      Rao V, Gao F, Chen B, et al. Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis -induced inflammation and virulence. J Clin Invest 2006; 116:1660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/102\">",
"      Glatman-Freedman A, Casadevall A. Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis. Clin Microbiol Rev 1998; 11:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/103\">",
"      Vordermeier HM, Venkataprasad N, Harris DP, Ivanyi J. Increase of tuberculous infection in the organs of B cell-deficient mice. Clin Exp Immunol 1996; 106:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/104\">",
"      Middlebrook G, Dubos RJ, Pierce C. VIRULENCE AND MORPHOLOGICAL CHARACTERISTICS OF MAMMALIAN TUBERCLE BACILLI. J Exp Med 1947; 86:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/105\">",
"      BLOCH H. Studies on the virulence of tubercle bacilli; isolation and biological properties of a constituent of virulent organisms. J Exp Med 1950; 91:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/106\">",
"      NOLL H, BLOCH H, ASSELINEAU J, LEDERER E. The chemical structure of the cord factor of Mycobacterium tuberculosis. Biochim Biophys Acta 1956; 20:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/107\">",
"      Brennan PJ, Nikaido H. The envelope of mycobacteria. Annu Rev Biochem 1995; 64:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/108\">",
"      Barry CE 3rd, Lee RE, Mdluli K, et al. Mycolic acids: structure, biosynthesis and physiological functions. Prog Lipid Res 1998; 37:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/109\">",
"      Yuan Y, Zhu Y, Crane DD, Barry CE 3rd. The effect of oxygenated mycolic acid composition on cell wall function and macrophage growth in Mycobacterium tuberculosis. Mol Microbiol 1998; 29:1449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/110\">",
"      Dubnau E, Chan J, Raynaud C, et al. Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice. Mol Microbiol 2000; 36:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/111\">",
"      Glickman MS, Cox JS, Jacobs WR Jr. A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. Mol Cell 2000; 5:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/112\">",
"      Cox JS, Chen B, McNeil M, Jacobs WR Jr. Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature 1999; 402:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/113\">",
"      Rousseau C, Sirakova TD, Dubey VS, et al. Virulence attenuation of two Mas-like polyketide synthase mutants of Mycobacterium tuberculosis. Microbiology 2003; 149:1837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/114\">",
"      Sulzenbacher G, Canaan S, Bordat Y, et al. LppX is a lipoprotein required for the translocation of phthiocerol dimycocerosates to the surface of Mycobacterium tuberculosis. EMBO J 2006; 25:1436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/115\">",
"      Valway SE, Sanchez MP, Shinnick TF, et al. An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis. N Engl J Med 1998; 338:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/116\">",
"      Manca C, Tsenova L, Barry CE 3rd, et al. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J Immunol 1999; 162:6740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/117\">",
"      Reed MB, Domenech P, Manca C, et al. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 2004; 431:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/118\">",
"      Constant P, Perez E, Malaga W, et al. Role of the pks15/1 gene in the biosynthesis of phenolglycolipids in the Mycobacterium tuberculosis complex. Evidence that all strains synthesize glycosylated p-hydroxybenzoic methyl esters and that strains devoid of phenolglycolipids harbor a frameshift mutation in the pks15/1 gene. J Biol Chem 2002; 277:38148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/119\">",
"      Sinsimer D, Huet G, Manca C, et al. The phenolic glycolipid of Mycobacterium tuberculosis differentially modulates the early host cytokine response but does not in itself confer hypervirulence. Infect Immun 2008; 76:3027.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/120\">",
"      Brennan MJ, Thole J. Tuberculosis vaccines: a strategic blueprint for the next decade. Tuberculosis (Edinb) 2012; 92 Suppl 1:S6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/121\">",
"      Sander CR, Pathan AA, Beveridge NE, et al. Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals. Am J Respir Crit Care Med 2009; 179:724.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/122\">",
"      Hawkridge T, Scriba TJ, Gelderbloem S, et al. Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa. J Infect Dis 2008; 198:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/123\">",
"      Tameris MD, Hatherill M, Landry BS, et al. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet 2013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/124\">",
"      Abel B, Tameris M, Mansoor N, et al. The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults. Am J Respir Crit Care Med 2010; 181:1407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/125\">",
"      Hawkridge T, Mahomed H. Prospects for a new, safer and more effective TB vaccine. Paediatr Respir Rev 2011; 12:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/126\">",
"      Aagaard C, Hoang T, Dietrich J, et al. A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat Med 2011; 17:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?42/17/43289/abstract/127\">",
"      Miyata T, Cheigh CI, Casali N, et al. An adjunctive therapeutic vaccine against reactivation and post-treatment relapse tuberculosis. Vaccine 2012; 30:459.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8026 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-201.77.166.39-CA557B663F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_17_43289=[""].join("\n");
var outline_f42_17_43289=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      IMMUNOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5272211\">",
"      Host factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11164598\">",
"      - Innate immunity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Reactive nitrogen intermediates",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Interferon gamma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Other cytokines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Toll-like receptors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Other factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11165131\">",
"      - Adaptive immunity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Cellular immunity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H5272080\">",
"      Granuloma formation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H11165213\">",
"      Humoral immunity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11164663\">",
"      Pathogen factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11164831\">",
"      - Mycobacterial lipids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H252006710\">",
"      VACCINE DEVELOPMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/12/40136?source=related_link\">",
"      BCG vaccination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/13/18649?source=related_link\">",
"      Epidemiology of tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/18/37160?source=related_link\">",
"      Interferon-gamma release assays for diagnosis of latent tuberculosis infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/54/22378?source=related_link\">",
"      Microbiology and pathogenesis of tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/54/23401?source=related_link\">",
"      Toll-like receptors: Roles in disease and therapy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f42_17_43290="Advanced case 6";
var content_f42_17_43290=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F72997&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F72997&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1274px;\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Advanced case 6",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 319px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 594px\">",
"   <div class=\"ttl\">",
"    Normal ECG",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 594px; height: 337px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal electrocardiogram showing normal sinus rhythm at a rate of 75 beats/min, a PR interval of 0.14 sec, a QRS interval of 0.10 sec, and a QRS axis of approximately 75&deg;.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_17_43290=[""].join("\n");
var outline_f42_17_43290=null;
var title_f42_17_43291="ACC AHA IABP in MI";
var content_f42_17_43291=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F71542&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F71542&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    ACC/AHA guideline summary: Intraaortic balloon pump (IABP) in acute myocardial infarction (MI)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class I - There is evidence and/or general agreement that an IABP should be used in patients with acute MI in the following settings",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Hypotension (systolic pressure less than 90 mm Hg or &ge;30 mmHg below the baseline mean arterial pressure) that does not respond to other interventions unless further support is limited by patient's wishes or contraindications or unsuitability for further invasive care.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Low-output state",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Cardiogenic shock not quickly reversed with pharmacologic therapy as a stabilizing measure for angiography and prompt revascularization.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Recurrent ischemic-type chest discomfort and hemodynamic instability, poor left ventricular function, or a large area of myocardium at risk. Such patients should be referred for urgent cardiac catheterization and, if appropriate, revascularization.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class IIa - The weight of evidence or opinion is in favor of benefit from an IABP in patients with acute MI in the following setting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Refractory polymorphic ventricular tachycardia in an attempt to diminish myocardial ischemia.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class IIb - The evidence or opinion is less well established for an IABP in patients with acute MI in the following setting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Refractory pulmonary congestion.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2004; 110:588.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_17_43291=[""].join("\n");
var outline_f42_17_43291=null;
var title_f42_17_43292="Features of systemic sclerosis";
var content_f42_17_43292=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F67889&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F67889&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical features of the major systemic Sclerosis subsets",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Diffuse cutaneous",
"       </td>",
"       <td class=\"subtitle1\">",
"        Early (&lt;3 years after onset)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Late (&gt;3 years after onset)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Constitutional",
"       </td>",
"       <td>",
"        Fatigue and weight loss",
"       </td>",
"       <td>",
"        Minimal, weight gain typical",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vascular",
"       </td>",
"       <td>",
"        Raynaud's often relatively mild",
"       </td>",
"       <td>",
"        Raynaud's more severe, more telangiectasia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cutaneous",
"       </td>",
"       <td>",
"        Rapid progression involving arms, trunk, face",
"       </td>",
"       <td>",
"        Stable or regression",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Musculoskeletal",
"       </td>",
"       <td>",
"        Prominent arthralgia, stiffness, myalgia, muscle weakness, tendon friction rubs",
"       </td>",
"       <td>",
"        Flexion contractures and deformities, joint/muscle symptoms less prominent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gastrointestinal",
"       </td>",
"       <td>",
"        Dysphagia, heartburn",
"       </td>",
"       <td>",
"        More pronounced symptoms, midgut and anorectal complications more common",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cardiopulmonary",
"       </td>",
"       <td>",
"        Maximum risk for myocarditis, pericardial effusion, intersitital pulmonary fibrosis",
"       </td>",
"       <td>",
"        Reduced risk of new involvement but progression of existing established visceral fibrosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renal",
"       </td>",
"       <td>",
"        Maximum risk period for scleroderma after 5 years",
"       </td>",
"       <td>",
"        Renal crisis less frequent, uncommon after 5 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Limited cutaneous",
"       </td>",
"       <td class=\"subtitle1\">",
"        Early (&lt;10 years after onset)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Late (&gt;10 years after onset)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Constitutional",
"       </td>",
"       <td>",
"        None",
"       </td>",
"       <td>",
"        Only secondary to visceral complications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vascular",
"       </td>",
"       <td>",
"        Raynaud's typically severe and longstanding telangiectasia",
"       </td>",
"       <td>",
"        Raynaud's persists, often causing digital ulceration or gangrene",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cutaneous",
"       </td>",
"       <td>",
"        Mild sclerosis with little progression on trunk, face",
"       </td>",
"       <td>",
"        Stable, calcinosis more prominent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Musculoskeletal",
"       </td>",
"       <td>",
"        Occasional joint stiffness",
"       </td>",
"       <td>",
"        Mild flexion contractures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gastrointestinal",
"       </td>",
"       <td>",
"        Dysphagia, heartburn",
"       </td>",
"       <td>",
"        More pronounced symptoms, midgut and anorectal complications more common",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cardiopulmonary",
"       </td>",
"       <td>",
"        Usually no involvement",
"       </td>",
"       <td>",
"        Lung fibrosis may develop, but often progresses slowly, Anti-SCL-70 predicts increased risk of severe fibrosis. Maximum risk for developing isolated pulmonary hypertension and secondary right ventricular failure.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renal",
"       </td>",
"       <td>",
"        No involvement",
"       </td>",
"       <td>",
"        Rarely involved, anti-RNA polymerase predicts increased risk of renal involvement.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_17_43292=[""].join("\n");
var outline_f42_17_43292=null;
var title_f42_17_43293="Pravastatin and inflammation";
var content_f42_17_43293=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F69156&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F69156&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 496px\">",
"   <div class=\"ttl\">",
"    Predictive value of inflammation post-MI attenuated by pravastatin",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 476px; height: 282px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In the CARE trial, patients experiencing a recurrent coronary event within two years of a myocardial infarction (MI) had higher serum concentrations of C-reactive protein and amyloid A compared to those without an event. Pravastatin attenuated this effect; the risk of a coronary event in patients with evidence of inflammation taking pravastatin (third column) was lower than in those with inflammation taking placebo (fourth column) and was identical to those without evidence of inflammation (first two columns).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Ridker PM, Rifai N, Pfeffer MA, et al, for the Cholesterol and Recurrent Events (CARE) Investigators, Circulation 1998; 98:839.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_17_43293=[""].join("\n");
var outline_f42_17_43293=null;
var title_f42_17_43294="ACLS algorithm cardioversion";
var content_f42_17_43294=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F74033&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F74033&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Synchronized cardioversion algorithm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 383px; height: 436px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Notes:",
"     <br>",
"      1. Effective regimens have included a sedative (eg, diazeparn, midazolam, barbiturates, etomidate, ketamine, methchexital) with or without an analgesic agent (eg, fentanyl, morphine, meperidine). Many experts recommend anesthesia if service is readily available.",
"      <br>",
"       2. Both monophasic and biphasic waveforms are acceptable if documented as clinically equivalent to reports of monophasic shock success.",
"       <br>",
"        3. Note possible need to resynchronize after each cardioversion.",
"        <br>",
"         4. If delays in synchronization occur and clinical condition is critical, go immediately to unsynchronized shocks.",
"         <br>",
"          5. Treat polymorphic ventricular tachycardia (irregular form and rate) like ventricular fibrillation.",
"          <br>",
"           6. Paroxysmal supraventricular tachycardia and atrial flutter often respond to lower energy levels (start with 50 J).",
"          </br>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2000; 102:I-164.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_17_43294=[""].join("\n");
var outline_f42_17_43294=null;
var title_f42_17_43295="Extensive primary TB x-ray";
var content_f42_17_43295=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F64190&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F64190&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Extensive primary tuberculosis in a toddler",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 333px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFNAYwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDwaOVlkb5jnJ71ZSVs58w/TNZ24GRiOmTVuAjHPagC8krHGGbH1qWKVwwO9h+NVkqaEjeKANCG5l3YDN+dallcSZyWYenNULdQOmOa0IAFUEdetAF03G8EEvx3zVKXzHbljge9atqqyIOACeTxTZIAwwAOelAGQVIH3j69aaobn5jz+Yq7cQ7FGBznmokTBAA5NAFaRCVxubn3oEbnu2PrV3yccgfXFT20KyA7gcj0oApWs09o4Mbk4OcMa7nQmivoRPEDvU/OgPKn/CuVlt1Azjj3qfRL+bS75biHkDhlPRh6UAdndaPp2qZjuYtrngSKcEGuE8R+Gp9LkYwu0kOeD3r1CzS01G3S9tWynVl7qfSsXVX82VlU5XONpoA8ldHV8bmGfepUSTAO5sGus1XRlcmSFcN1K1l/ZSvylcEdqAM60Rt5LE4HvWlbqADxz65pqWwX7tSgshAK8D0oAnSB2UHJH41aEM2wfMV980tpLGyjcuPY1bmePyDz7CgDKMt5C+133L65q7DfII/3ruDjk5rOmlO8hgcVFNIFifnmgDbF2r4KSAj2PWtCxlJJ+Y57c1wDTAEbDg57GtGw1OWPhXJI9aAO/g3s4xKfoa3bNpIYC5kOT0ANecw+IJEfJINbdn4iDxZeMj3z1oA6m4v5Gbhztx64qEXUkrqDKevrXOXevIw3AcY5rIfXxu4J49KAO+W5cAhpML271Sub9VBLSdPQ1xcuuyFflBPpzVVbi8uyFjXGepoA7BtUijG7cTntVVpbvUGOxvLi9c1nWdgygNMd7j16CtSEZUB3x7DigCE6LbTECaaR27gNxTLzTLOyB8kfNjpW7HHbWkDXE0nljtk9fwrjta1kTSP9mBA6ZoAoajcbQdzYPoDmseW4d2/iA6VOVLuWJyxqcWoKj5uaAMo7icljx71G4cZ+Zvzq9LDtcjHtUDx4yKAKpZsfeP505CzH7zD8aVkwOBmrVrCCgY0AAn2KCSQRUr3rBchs0PbA5PYdqqsgQHigBJrthxk/gaqzXRYfeP50TYPaqc0ew5HQ0AMaRifvN+dQu7Bs72/OnMfWoScYoAimnbBGSD9aW1kfYfmPX1qtMSW5/CnW7kKfrQBVicsTn1q9bEYxWXbNmR/941p23SgC6vAqeM45qGPt71Ipx2zQBpW0o4B49K0oJNzAZHHesJDkcEVZiYhByaAOqsZAvykjnpk1dRS7AKOD3rm7Fn89G5wDXa20O5EZf4qAM+8sg8Qz1Bql9kKAZUg11d5aFbZWA+XuaoGIY+YUAYJiYcDr3qxbJhWB4atCS1+XcoyCcVD5ew9KAIJI/wB2QfSq4i45q3IjEHnjPQ96FUEbSO/FAD9Lvp9Ol3Qsdh4Zc9a31AvEE8Zyx6jPIrJs7BpWyF4HrW7Y2LW7BmBIx0oAY0BKEEZ4yTWNe2ytkY+bsa6G6uY9pRBhfesS9uFztQfjQBzNw7QTbXjxUqyROoABDD071cl8uVtsi/8AAqr+QAflPH5UARgEMCDtq0SWiwB71DlwVVxkY71rafCkq7SpH1oA5q53h8DrWfdhijZP4V191aoSQUAPTNZd1ZoVOBzj0oA5E5zVi2UlidxrQks1DH5RViwsUzyvJoAr24KuABn1zWwrmOIll7VZtLGEOvygnNXbq1RFO5OfagDlrlpZTtGdp7U6205mYZrWjjUyKojGSfSrH+q4QAE8E0AQW2nKGAlwB6Ct6xttuNkWFFZHyo4LNz65rXttQaNNu7I7UAWxDjJ4A71Tu7oRKxtY/wB4vBY/0qylytwQswwM8EU9tLLKWjcEUAcndSTTktJIzseTmqzRDHTnvW/f6bJGC23r1xWS0R3HcMUAVI0UP0q0qAkjuOlMER3VIu4EccmgCjeIzSHA6+lV3tzjJFajINx7jvUkdvk5x8ueKAMVbTJBPPpVuO2xH7davyQjbgDmrawMtuu4cYoAylVdmR96si/b94V4x9K178CCN3U9Ovoa5aecuzM3XNADpCPxNVJ3BOB1HekeYsSOgqLigCN+W96rynFWXPvVWbkdqAKkrdTUUcuA33evenSkBWyee1UUfl8H+KgB0JxI2T/Ea1LU8Y4xWVFxKfUk1p2pG4dxQBpxkYqQH0NQxnIqVfWgCWME9qvQKWZR1zVSJe/c1ftmCSoaANyxh2gcc+9d7o8C/wBlrK4+76+lclpsStErYzzXY6fKBZ+X1GOQaANdSlzpzoVBG3jArn5YfTr6Yra0tdoIB469arXUQW4bnGO9AGasBJA6CoLuJCTtGWrU6gYHHTNJFYvcTEgbF6ZoAwRaSMwAQn6VowaYuBnk/Sumt7COOPCjgdTWTrGoRWm5LXG7uaAJYIo7WBfMIA9O4qjret/Z7R/syjOMZPasuW/Z/vP1rI1W5WWNlPOfSgDJvtduWcnfyagTUppFyZD9Ky7mJg7Yzj3psKndndjbQBuR3UpPL9PWr0MwfG7jPpWRbQuRuBDZ9K04YSE+YgMfSgCVpGSVdr7lPrWtaysI8qcVhrHJ5uCDx6VtWqMIgDQBJI27JbrVWVfkPf8ACrUsbgDK8GoJFZQ3HbFAGW0QDY/GrFsuHU8AVDkj61LbMWONgxQBohvLZT1bOeKWaZiNz8j3qKJH3BgBtxyaiuw7RNkUAAnUScACs7UL4Qg45PpVO9uJIhwDn17VkvO8gO4kmgCxdatKe6g9qhi1a6Q8Sn6Gs6UNuzgkU3Y+KAOu03xJOpCyKjH3FdnoevLLEwmjxjkYryq0BDKT1HauisrzGBuxQB6WlxZ3kZCSbXx0asm803JPy8ZznFc9Fe8ZLVf0zWZEcAtvXPIboRQA24sWQFlHFUtm1gdueeldpbwxahFvtwFYDlDVK+0vAZ41O8ckGgDBjt93zYzntTzFjIFW1Ux5B4b37UmwlcigCK1tvPmUHpnnFat9HDJtijBBUYApumR8+YQcAdBUBb/T9xOAGzzQBzPiZDGFhxyOWrkLiPaSQK7vxMPOu9/QEdq46/jEec0AY0v3jmmZ61JNjrULHmgBrnK1VuTxU7HrVSZsmgCjeMBj1NVYHCqwPrUl8xVx054NQ26llJHrQBJCSJW/3q07c4IxWZH/AK0/7xrTgHIoA0Yz8oqZOTUEXQVahHI/SgC3EB0q7Zx7plyKpxDjOa2tLQcHr6UAb9mdsahfxFbunyksN2cfyFYVsMAAjFads2OhGQPzoA6mxcRNnOcHgVHqgY3ZIxhuazrCfCbWb71XmZpI1J+8pxQBPYWhuGy2do9K6C2tEVfmwEUZqtpCfuFwvPtVu/kFvauP4iO1AHOa/qrHdFbZVenHU+9cfcb3Ylq1ruUlmJXr1OayLm4ijHzNQBBIFWIEkk1n3TjacLk4pt7qgwVjXIrCu76V/uuQPSgCS7jZmJJUfjVRQFkwZBjvVSSQs2SST9ahdiTkUAdJanbgIwYHqRWzBhgMGuNtWKjOSD610GmTl+Cc+9AG3bowYleSa3NPj80qrR59x1rn4CwcEMRzXS6bOXjJ7juKANKe0jWJdyDa3Q1lXFgpBIYj2NafmkxrnnHaopThCcA+1AHOGwBfgg5OOlWbbTVST7xxVgsC5Hb+VWrRMk55XFAEcdsoPlIBzyTVDUx5YYCJeO9WrmTY+EbArG1m6MFm8hO4ngZoA5XVpWL4P+FUCRgY9Kgu53kkyzkk81EZWwOefWgCxINx44pFU/U1UMpOckikEhBHJoA1oNy9vrWhbkM21lwO9c4kxJ4Y5+tXILmROFcigDphEJECqxUZq3BbsgBRhWRZ6i425Ctx0rXhv4WI3JtNAG1pF5cWlyjLnGccd674qlxGsiDlhkj0rgtMaOd1ZHG1T0rs9Ou0YKj9OxoAzNXsgPnQcjn61gvjvnNdve2wkXcrZHauPubaVZMFSMnAoAu2DBLFi/GTisqZiHcqc1cmcRxhI+ijmsiVyZWIY89hQBV1Bt/f5q5bVlJUEc10V229GHQjvWHejclAHOSDPAFV36gdqu3AIcj34qnLxQBA549qqSHkirTngiqTnGT6UAZ163zFR0zmo7UnyzgZ5ouz8w46/pRa8o3+9QBJD/r29M5NakHXBxWVAczPxn5q1rbGRjpQBoRCrkA4qpFVyDGPQ0AW4VyRjqa6GyjCoPbisbToyzBj0FbVp029utAGpCCOT244qwCVU46k1WVxsxk+tPhDyyKFHPSgDWtGyyj+LOcV0+n2LM5dx+7bnFUNG07YA8vL+lbGo30djbLvcAnoB1oAvLdLbR+XEPmUYz6Vi6jqcMQfL73+tczqOtzSS/Ido9u9ZpuxKh5JI60ASavdSOxZD8p9PWufupic9/etaV2Iygz6g1m3NsZjxhCaAMW7cjoazJJG3HOPSti8smj+82QPSsxkVCcDJ96AKwViwABxSsjA4yKsoGYDg1G8MhYsQcUASWUTs5GQa6DSrR92dpH0rF0+MpOp7e9dvpkYx+GaACG3dcbeTW7psBWA7wykmq6wnGR+Bq7ZeYMgEsPfvQBeWN2ztXdxVe53LGVxit2ONvs6uvAU844qtfRQyxjOA2eaAOaicFjvA645q9aOMEAY96SWzGdyNu57irdpagxlS4XnNAGVNEZJZCv8P865bxcGFmg5xnk13ZX94YwBtOc+9ch4ytpZLNsggKc0Aeczqxc+maVVIBxzSspD4Jp3HQcetAEJRjjHX3pyREt94cc0pB3H0+tPQZ7igBYofQ+9SBGDZOOakgjGcbx+dXIY1zkspA96AIrXeDkA1r2cYLbmOT6VFApLZwoB9K0xswPl5AoAswS+WRtIHritS21loMbmBUetYJdAOKiETOeXIzQB3+neIY5yIy2weh6GuhMEc1uGwGBHB9K8oiSSLO07iK6Xw1rc9tdJHJmSJyAUb+lAF3WNPe2hZ0BZCeT6Vy1xMVOFPNeo6qkYYADdA46eleZa7am0vXQ52k5B9jQBRlYFT0rLuSAuDgmr24YwCPxqldgAHHFAGJfLzuFZ0nKmta5Q8jNZci4zQBRlGV9KpydDg1elUnvjFUJj8pI7frQBmXZYMeOPWm2hPlnH96lvOoz0ptt9w9etAEtup85gD1b0rXtgCQTWZajM7YPetS2OGHpQBoQj5farkAyABVSLpWlYJucHsPSgDXtY9kSirsXyMAOhqtDjGD1qyBnaR1FAFyJsHjvXV+GbEbPtD4z/AA1ysCktXoehwsbeEr0UYHpQBd1af+x9LSUANPJ09F964G6u5r2dnlJLk9fSu88QbXtlik+fjv2ribi0eM7l5U9/SgDMmizyzfWo0TauU6+tTzyxxH5yM+lZ1xqARj5QFAF4TDbh/lYd6gubiKI5LAmsO6u5ZCfmxjtVGSViACSaANO81JGclYxz61iTTszNjA+lOLE9Tmqv8RoAcZG67jUBlkJILHH1qzGCylSvFQvE+elAD7VmMvU12ukTSCIYJxjoa5HTrWR5xtUkV2emwMicKaANZJmMajdj6Vt6ZcO4KucnHArDjhKJnBxWzo6bnHB47mgDoYZnYbSO3Sq96xZ9oXHar0SjjAJ471m3RxKQeD6mgCqxO3HA5qzbRsy4I4NRqoYgKcnvWhCQiBSOvT1oAybxWjJwCDnpWDrJL27o4ySMc11F380vyjI7msbUrctGdy4zzzQB43e/ubh0J6HGKqliT147V0/izTminEqxZjb+IDpXPeT6Hp2NADFp8Q+bpT4kGTnvVmCJN3TnNACIgCbj1zUgwB1qV1Qt0wOlI0UZY5YjHFADBKVxliPxqxDezqcbzgetQtbccMGqNgytgKcUAa0WqY4dM+4q9Df25wC20+hrn4xkZwaljiG4Mx/A0AdbBH5xBjOVA6571t6bCts4dhvft7VxljOYD+7fCjrW3aa4Y2/egSAd6APSYJRc223JMi81yHiqBg6Fl3DBGfSrGkazbzSZimCueNpPNal1bvcEPIuUx9aAPNJoijZA4qvKVKndzXW63pJhVpogTFjkelcpPEQp44oAy7jk8VmXKkNn1rVl+9k8iqV0uVOKAMmcHB45rPl6HjitKUYOcVnzdT6UAZF3nniorbKoR71NdhicjpmmW2NhyOc0AW7RQJG+tadsMk1nWgOXJH8RrTtehoAuxdK29NTbHuIrIgXJFbcJxEoAxxQBciGfw5q9AAwzniqFucZrd0W2N5cpEo4J59hQBp6Rp5nUSSKQnb3rt9NzHb7dpCr3HApukaasxKk7beEcsOlc94t8Q4VrXT8JCOCR1agC7quowRswd/Nk6bQelcrf6rLKxVRtUDHFYD3k287WYmpY5fMGJRg0AQXuZfmDHcf0rMkWVegJ9xW+sUZzk06SNUUYA6elAHNHeexzR5DONzcVtSIG5KBffFVLhoI+S+4j0oAzTbrnlz+FNMOwbwnHrUk93GrARx8+9QPezMpXIANADlVicBT+VPmgkKZA7VEksjrgMRUybwo5P50AaGjwOmwsDkngV2FhDuOAOKwtKtpFRCWPPNdHaGWNhxk+nSgDWjgG0DB6Vbstqsq4wc8YHNQRTHyQSo4q5Zzx+YjSKDk9emKAN+3QNCfpkGqVzbLKwII4PINWoptsZCjtgcdqjUP0A/OgDNubRlGVXdzninQRPIwIVlPA/Cr7bs5IpyrJuAGBQBAbUIVYnDHriquo2eWYhS39K2hASMk8jpVa5LqpPJ7UAcPrWl/aoJIiucjjNeV3sDQTNGw+ZSRzXttwSHJbhq8z8a6a0d2Z1GI35/GgDl1K5XJxzV6RYl2ssmR+orORPzqxtOOvbpQBbMsONxLHHQU15Inb5dw7nimwW7SAHbgetK8ZHFACK8RYgNj8KtwRxuQBIKpbFjySOajZzkFTigDbC4UKSp/rTkijYgtx2rCFw4HDk/WpI7+Rep4oA1ZRHykdV2hlPR+Pao4rtCMEAZ71bidZRgSUARRCaJgwByO4r0H4feIp/tyWl3+9t2+Ul+q1yNrayysMJ8nc10+lxQw7Qi7Txlu9AHd6rZxJPIYyJLWXgj0rynXLU2t5JD2B4+lekCZngVozvXGGGa4PxS++/ZgMfKBg9qAOSuBhsDp7VVkXg55q/c8sapPnGPWgDHuFwSKzJRhzW1eoMkjmsab7xxQBk3Ywx9M8VFa8ox/2qlvEJc5OOahteI2H+1QBoW4+ZsdM1p2y/KPWs63+8xHTNadsMgUAaVsK0omxj3rOtxxV+LlloA0oAAua7TwbGN0jjAfAANcbac9QMV2/hCIjcZPljOCKAO6sZQ1hLAi7VZSCQP1rzTWtPe3u380hlz8pHpXpIkEFg2wYBGB61y+pwRlWaZlUejHmgDiGjQEBF/SkELcsw4qfU7mK2Vvsy7z71zd1qVxPlSxUeg4oA2JLmC2JzKC393rVV9XUjao9uawjknmkzzigDSlunmyMk59KrELtOfyNV45G6AGpNkj/AMJxQBHJGrcjk1B5L5GB+NallYSO4LZC56+laAhQNtABwOtAGfZWxCEtwexqwsKoVDZOTWnHCvkjcpI9aktCJbhIzH93pxQBr2kY8qPCnHTpWtChDAkHFW7OECKNdgya0WhVmG1QFAoAz0ACA9B70yNzJKu3gBula7WReM4AIqKGwaOQkEZoA1bEB8Z6mtNIwOCMmo7C3O3lQGHpVqSNlOeo+lAEEka5HTmmhSsjYwOBU2DkZ5zTZ0wPl/WgBwHH05qvdRMQWHpUkIctlvu9zVidC8XykcjOaAOTvbdnZmXt1BrC17TPtdoVZe3ArtjEoY8ZPr61Xu0y2w4K4x06UAeB3mnyW0zI/UHiltrZGYCQnJrvPFWkkMZUUEjrXK28UQk+dlGDQA5o1jgUIhJBwBWdNBhmGD1roJJbWNQd4qn9usXEgdjkdDigDCmVV6H5jxVYxNjrWnusmJLM/txUDm3Zj5bkY7mgCg0THgAZphDDgD8KvBVJ4ZTUwtvl3Eg0AZWc4xnI61ZtxtILH8BV4QRrjj8DSPDGSSAQe1AF+y1eaAbcjaOxrfsdct5AqToEJ7iuNZNv8QNRFnBAGce1AHs+jyK8DfZZBIMcAVmazpn2tHYrif6da4Tw/q1xpt4kkMhGD07GvZruNb/S7LUbeNVkYAuvrmgDxe9iMUjq+Qw4INZ0o4rtvG1ksd0syAASLnj1ri5+cmgDPuBuGKxrldp46VtzcqPWsi9QjkUAYd6MNkVBbZ2N/vVZvwBggnJ9qgtvuH60AXbU53Z65Na1uOFB/Ssq2HzP6buK1rcHaKALsJwa1LcqQMHmsuIncO1XoRyKAOs8OWJvbtEI+ReSa9E0fTftMpCDbFFwWrk/A0W2xlkGd7ttH0rvPNFt4bnitCfNZTk9yaAMTxX4ktbBPstthpB1bsDXAX+ryXMpYuWz+VVtYDzXTqqsSDgk1RjgMTZcn6CgCWQmXOc81DJZO/OABV6KZcYAAqeQOQNpHpQBitYkAkNk+lRm3IOCAK3EhVXJf9ahdbcMScH2oAylj2kBevt2q7FbSSKXYgL+VI5i3Hyhgjnmqssk0jFQWYegoAuiaOFh+9yRxgc0W17br8rK7nNMttMZkDvwDVuLSizABeKALZu08sBYmKAcCtLQCjShmtz8x65pYNLZ0SLYc9z6Vu2tmkGEBwcUAb1nNE67DD8w71eQRFAUBGO1UrKBeGwRjqKuN+7DEcjrQAArtIHapbGDdKMAmqtvFI8mc8A1pWhKsezdaANqygwPnGMd6e4I4ABot2zjuMVK3rQBQlQZxtzx2qJkRTnHJ9auyrnkGq8i5IO0AUAVny2QDx7VLEMJhsmnpGcnNSlQR8h/CgDNmdCxQKBjvWHqNywm+TGAK1b+B43Z1JAPpXMTSObpwOfc0ARXKm6BWUZzwDXC6zo0kE0jRjqfzr0BMgjK7iATVS7smvCflJX6UAeXojsSgJB96qTxiBiG+ZjXod94ckjjMkac1x2pWE5kbeMEHigDFdehB4PXFNAOw4OKtm2lVsBc5qGSGRSQUIJoAiIHHNOSV0PDHHvQqFTjac/So5fkJ55oAsrdt35p5u0PTaCO9ZchbjJ4pg46UAbIRZOVfcaURsCM8CshZGRgRmtSxuyjqZlDr/dNAG7otik0oadMIOR716rYyONJjERyqcYBrzvSb61uGVciNzwAeBXa6PujVlDcY9aAMLxrL5kcK98k1wUy43dq9A8TQPeb5EQboxwPWuAvHb5hjaRwRQBm3GFGO9ZV2NwNaM/WqFwOD7UAYt9gR845qjbbdjfWr1+MpwB+NUrbARunWgC9a8lu3PFbFsOBWNaMCz+x71s2xOBnH4UAXouoq9bjkYqjARmr8LAYzQB3nhK422TxKcNnjHXmu802Atblps7cdK4PwpCLbZPMfvdBXo1soFoZGYBNuaAPO/EWnhLh3hX5SckCucmjAyWOB6V1fiDWbeJmSH5nHGa8/wBSmluJnYEjPYdKAJZbmFDhSWPtTG1OUKFU4FZmWHXg+1NJOfWgDXS4ym9pMt6ZqEu00mRwD2qih246k1LH5kjAIpzQBp28KbuTljV6BE81QwHvio9MsG+9K3Wt2z06EHL53HnJoAUGORVVVx7Vs2FtA0QLfeHtTba2hiKmPDP246VftoX82NcEAtyQKAOn0LS0+xBiuXbvjpWkuixA7iBu65IqSzWRYhsbAA6YqZ5Dgb5Cn0oAh/s4KPlGexFRtYbuCMDvxWnFl0znJxTtjEjIoAoJp4RG24qOOEq/I5rXMePWq6RkSEP0oAkgGBx0qVulPigxjA4NSSxde1AFQk44GBTCM8UsyuOAOKjJkPAGSOcUAKRjvT41JXJGOKbHG5ILce1XoFVgy460AY11EW3biTnjpXMzaY6zSNjbziu4uozggc1hTEBnBzQBiW9uqN8w29qvR2oKsdwyaSTaPmIz7VFHfMkjrgbPpQA+5h2owXnPSuL8Q6WJ8si8nr25rumuiI/lRGX1xXO+ILp4YySV59BQB5bqMElpOBtOBVS4mUgMc5x0roddDzpvR8MeRxXGTySK5Vm6djQBbErNJjoD2pZ4kfJGNwqiszDngmlS4JbgGgBjwgnvTRbsQSCMe9XkMbYbIyRmnxqGOO9AFBYHXoPxqQBh1Bq48ZB3Ak+tRPJtJAHP6UANWZk56Ed66fwv4nms7uNLhi9uTgg9q5QjecHvViKBsgp19KAPadVgj+zwXtuQYZcA15p4us1tdSYqPkkG8Yr0TTNy+DrSKfO/qQa47xyFYWrHqAVoA4SfOQO1ULroe3FaE/0rOuehoAxb4/J6/Ss+3BKH69qu6h07/UVRtwShO7vQBctDiVx2JratGyBWBavi4bJ71uWfSgDUgAzWxo1v9qv7eLBIJrEgyZOOmK6XwiQurwk+9AHpmgael5qJhI/dQJlqo+LvEBCTWtqcW8fyHb3ra8NXCwwyk5Dyg7iK4u/0qd2mhZWALZB9RQBy9xcec3ynP1qsYZJDkDj3rfi8MXhlBjTHu1dRpPg9ZMfbHOfRRxQB5x/Z7tnqT7Cp4dBu5SPLhO31xXt9j4VsYQNkStgdTWmumW8XO1FH0oA8QtPC1w7AyoR9eK3bTw55aDJVVFejzW9thsKGb1rJv4kWNlCkD1HagDnG0uKGDfkFvSoXkEZAOB6EVPfwTCPKMxB5P0rIydylw4I9aALDXKxvvyeK09I1ZnvYlWNsDnrVJzAYgWjxnuelaGiLH527y8e4oA7Wz1dsYaPjvVtNTZmAMakE9cVjAM0fykDI9KVX8nucnsKAOhjvmHyqEBqzHPIcBiMnvisrSY1VC8xy3WtKMFj8pA7igC6kxPGc8VEhG7nPJzUBRssSxNNjDIxIJI9KANu32FQcmnS4JNQWh+QHke9TsDg9aAIyqHqKjYKDwOKeQfXimNycDoBQAmMNzjFKAOg603pQDhjjpQBDdklMfrXM3znzyB09q6i6G5CR1rl7lSZjx1oAgdhsx/FWey4YvyVz09K0ZrY4JHU9x2qNbIlCvOe/vQBFYyo3ytznjFM1WzSdcIFGBnmm/wBmNHKGWRt2e/ap54ptuSVIIoA4XXLBk5wAfQDg1xGq2i7ywXD161rVqZ7VASu8fgRXEalpUr5AwaAOCMbqxPpTU3bvm4FaN/aTQSlJFOe1UnUqeQaAF5A4qPz2Q8momcqeCQaYTu5J5oAs/bZGGCfl96kiuQR861QBxzThyOtAGvCEk5Vhn0rodE013kWaRMoOg9a463RshjkDtXTaNrk1myq/zoOx9KAPV7ArPpixSjgHH0rgfHaSR3UcfVFHDe9d14Wv7XVbKQQuBLjOwmsLXbM30FxDIP3q5K+oxQB5ZcA4zWbdYAP0rUu1KFlPUHBFZd2QVP0oAwNSIC49ao2x+Q5z1q1qjYAXHWqdtzGcetAEluSJ2IOBmt+zbiucifEpJ/vVv2TZAPtQBsQkgjFbOjTeReQydcHmsOEk4rovDtp9qvVB+6nzGgD1fw/CWUSSn5SPlU1tT2Au8eXxKo4P9KyvDhN2qoB/q+DnniujnvrfT0wTluwHegCja2gj/wBYAGHBzVsS28ZIXaSO1Zl3cy3z/JlPTH9arQpIjkSg5P60AdCl++3gDb6UbjMpI5GM5NVbaMEDJ5q5HCytx07j1oAiMBPQ4J5qG5t1CEkhj0wa1VUFTxzTXiBXAUk+uKAOYltVZGDLjuKzLrTU80YGSRnOK7M6fIx5GFpJ9JXGSCTQB5zcWhjQgcj0q9pUEqRmRSRjpx1rr20aIkfJk+4rT0/TooYwpUfgKAMO1jmkX5lJ/SrosC0ifd4POa3Xt0UDy1H0pLS3/eFipGDQAsdkqxjJ4x0qRIFA4UmtAKNoAAwKXG3nHNAFIRZGO1MMQV8A9a0gPl7YNMMY3epoAbaoVP8ASp5RheDgU+NBx61YmjGxTx9DQBms6+uTURlXspqeS2JJIIGaha3fqSKAIZJgvNLbkuckdelI8IYjcaki+QjHagBZEOxqwpoENwTuA9a6V9pjbOema5u7YC4LDoKAAwj+H60zysMGBzntURulQ4U9e+elQSSHhkckk9jQBbZC3AGcnoarvA6ISwOe1VxJL5mQzfnUE95Iud7HGfWgCjq1s8q7kGD3xXKzM8MrZGRnua19SnkWRvLlODz17VzOpPK2SHJz3FAEGtxxXMZcKqkelcpcxqxJHIFWr65uVJUsdtY32oq5U8/1oAXapbBFRPCoJ28fSpBMjZyuO1LGoYnnFAFZoMng09LRgN2RVwRBeetSAEDpQBVVWHBHFKGK81ZbAHHNMKF+TjNAGv4R1SS11qBlb5GYKRXqetjbqIdcAlQT715f4Y00z6pE3IjjIY+/tXpWrSN56syjOOtAHkviiIQ6vdKo43ZH41zN70Peut8WuH1e4KjjgVyl6OD60Ac3qf3sg5yMVWtfuN/vVa1M5ftVa3+431oAZH/rHx61vadyo9BWDF/rXHua3dPPC9RxQBtQdq7nwhCF06ecn5icCuGt8kj6V6J4PVX0xEbpvyaAO4E6aD4ZiuBtNxP096wLS+e5k8yViXb1q/4rb7VotoY8EQNggehrG0y2kkZcDauc5oA6/TuVOc81tQ2zTLgrlfWs/Q4AgXeGbPrXXWkSlQV6UAZ1rp7ocnp0rVgsgRgnn2q9BCDwDkVbWAgEjpQBlraBGPGKlFtyMCtAgAjdjio5GAGRxQBVaL19ahkjUdufep3csSAeKrSg+pBPegCFnjQfKNxpsc5TBCAVLJCSnuaSK2LMAc0ARTXUnygLzmnLLKkJIYZPei6g8qRVBBJqYR/u8d/50AJDPLIoy5x0xU6P83XoaiRcDkDArOub827ZK5x2FAG9I4XHPGPWmCdd33vzrnV1cu4VhjjNI2ohuACT70AdbBcqB2qUz7iORiucsb0ScHj61dE5wMH8qANMnd6fhULjrUUM+eC3WpWwVyW5oArN98/pSUSEBjyDTd2WHSgCZQSpHaub1IETEdK6gDjNc7rKFbnJHBFAGLIGK4HHpUcSuuMnir5iXygSOfakjiIVWK5x2oAWKLK5ZGzjmqF9FwcjH8q6Lcu1SDwe3pUN3GrxMcZxQB5vrFu6yZyfYZrGug6RYYcHv713WrxRkAun4+lc3qMEbwY6DPFAHF6lGXjPc+1cpeIVlyBXb3dqQGBYrjt61y1/FiXkc0AZ8eeDnjvU29eCDimhdoPvTGXBJ7UAWBKVGc8U03bdFAx71VLE96Q+1AF6O5U43fjV22xI6qhGTWJnnirtkxjIcE7v5UAej+H7cWqrjnPJNdjfolxYo5GMDg15noGvGKVUuTuj6bu4r0bzBd6Qr2p3IOuD0FAHj2uB/t0/mDDbjXPXmdpxXfeNbMCOK6QYDfK1cHej5DmgDl9TJMmBnioLb7jfWptS/wBYfXpUFt9xv96gBkZ/fN9TW3YHIT0rCU/6Q3OMk1s6cT8ueBQB0Nv1XFdv4PmIhki7hsgVxNt29MV2/gRSL7zmXMQwPxoA9H0/T1e0/wBIGd3amwac8E4QKNn8P0rdtFLgBRgGtE2saR7pMDHQmgCpp9sRgntW7a4gP3hj0NYK6iu7Yq4xxViGZpPzoA6iOdP4KmWckHnisSzZ1IyOPStUEBc9jQA6QlunSoSxBAbOKd1wM9+vpTWkjXqcnNADsblHal8tcgjFRvI7fcTAHcjrVUR3Jk2s/B6YoAuSRqAAOp96lghLLlenaqS27gKWY5zV62ZlXljmgCA2sss+4DjPerosdgG88+1ELOH+Xp15q1JLiI7iAfrQBRe2jjQkn35rldVcSTNheAcYFbWp3G+Ip5qqD0wetc/dFMENISR/dFAFeJFZgSCGqK5BWQFMEZ59qdDOC5CA8HGa0RHFMV3Jkjr70AM03OzjpnrWmEJXIP1NNhhVUwvFX4osQ5fjPY0AZiysrYBPtWhGSyjrTZUBHGOOhFTW5OzAIoAjMbHsafBCS3NSFSXyasIMfSgCXZhB71h6yoDKRW/uxHWHrj/d2j60AZJ2hOgyKZ5kYA6/hUMkqlTk/N7VA7gQbc5PfFAF2K7iO4fMB64pBe24DBnJFZcx2jBOAaoXDhCVU8jpQBd1SazaA7ZTnr0rkdQeIn93ICc1o3eSpQcqR1rl5mG5lPY0ALd7X+UjJPQ1ymsIFlJYjOe1W7+d45MIxGOawry5ZmJY7jQAx2A69KjGGOCOKI2VhjoaBgGgCKWEgkiosEcnpWkiiQZ605rePbnPPQigDOjUMasowC4qx5af3R9aili2jr9KAE80Jzmu5+FmstFqxsZ2LQXIIAPODXnrBs5bvW74Ml8nX7STOArZoA7TxVahdN1CAfMY2LKfavKbwZQ85Fexa8wkt7onq6NXj18MAj0FAHJajnzG5PFQ233W+tWNRwJfm61Xtf8AVt/vUAQHPnN9TW1p/RaxTjzWz6mtuwBwPwoA6O16fhXpfhO0K6dagA7pm3HFebWYyBXuHhC1VbrTg5Ajij3sCOvFAHSxXcOkWyx3TgzEZRe5qEXkt2dznK+npXCanqE2oaxPcO54chQOgANdfoMonhUHiUDkUAXzas581OvcVftEYfe6/wAqs2sG7aMZ461p2+nc5PGetACWsWFyM4q3kgBcZz2q5aW6oMFfxqX7Luk+vQ0AZ8cTuwLdasJaYYnbWlHbAe9WCiIvpQBm/ZugA4pTbhfvD8a0HkUL07VQuHctkZIoAhutq4OcCqDXShiq8n6VJdoWBySABVBIxvyefSgC1Hcvk5PGeRVTUZZHQqpwT6VaC7MEj60jxhuDx+FAHLmNjIPM+8KkYbhyOO5Fa81qHYkLyOtRyWjHOQce1AGTFCu4gHAPOcVaiZI2wMn+tWILFi5BHB6e1WBZbWHPFAEtm5A3Adu/arBYt9RUFtGTI2DVlkKjA5oAhK889antj7VATtXoeKmglJbHSgCwV6jHHWpVH3cZpBnFPG5ec8nigAf9K5/XycAZ4rpGiJHHpWFrtu7IMA8c8UAcqzDjr1x0pwXABPQ1KluzSHj86tNaOQuM5+lAGPezKFGRlvX0rJvZmYcKSvqfWusksMg70zTBpcRUh04NAHHszNbhkBDAciuZv7eQOcRMCec16xDo8ar0wKyr7Sg7PxyOlAHkGpWsjqWZegyK5h4XZy1epeItLkiHyBiDXMy6aApypz3oA40o6ngUjF89DiuoksExgjA+lSRWVuWwRgmgDm7WYpj+taKyxyYHGBWhd6KrcxYI9qyZ9OmhJ25OKAJZUA+ZentVRm3HntVc3EkbYOfpUomWRemDQA7APFaWiQMtyJF4Kng+tZ4ALAjoemK6PRo18tVzhv50Ab2pXJGmys2PuEc15hfdHNej+Ioz/YoZRyePwrzi9BKkDqaAOR1I/M2ar2n+rP1qzqYxJVa0/wBWfrQBE+PNbj+I1s6fuEY55/lWM+fNYnsTW3pwwqccGgDpNP5ZOeOK9s0q7ZHgVCCNo/LFeKWHGPbmvVdFfesDDPzKOBQBC8LR388ZGMOcGux8OWTiRZeV9vWoF0cm7juHX745z611um2wVRtFAG5YW6BVKjJ9a2YYvl5GO1Z+ngjC4OavvMiHGST6CgCyEUcgU8lVAOeR2rLl1A7scj3qH7aTxyTQBt+bngYqNnXqX61itcOcYP61Lbqz8tkUAaYO4YILDPah1K4woxUUIKDK5I/nUxdpOKAKc8BlJzUa2oj5I9q0FhkZxjgVaFuCuX5AoAyBB5h4U5PWn/YSx+bOB7VtRQKNrLwKsz2w2hgODQBzyWCL1H40slmFTp171pyqirgt17VDJIqqAFJ+tAGQ1tt6DNQXEWCP5VqlmY54+lJsU9unPSgDOtLcBizfgKlEG/g1cjibdnGRU4hUAt0NAHPz22CTzUlrAA4PNac0QYVFHDtfigCRIlA5GRTliDHgdD+dSrHxntUiLjgDtQAojATpzWbqMKkZbII/WtZeB3qre9OlAHOG3RWyUGadhR26dquS47DNQhNwOAc0AVm2EjKnNSCOIjkkHpk1KYgFJIpqxE4Hb1NACSwoEGxhmqM1rkZxg1cmiYfMD9aqSSmNc78n0oAwtXs0lQ4Vc9ya4y+0guScAH+ddlfagzBg67RnsKypZkkbCbT6k0Aee6jYSxSEHgdhWeIihBcnArt9QgR3Luw2jvXJ6mnzNtOR2oAht54ySpJ9uelR3h+XDDO7vWblkkwc8mtO3Vp12svI6UAYl5p25S1Y1xavCM4NdzHBvBU/hWff6cSOvNAHK2kjBx6Cuq0q5Wc7cfP6Vh3li9ufu98nFQLK0OHViGHQigD0OV/tNgY+fk6ivO9Zga3uJEII7j6V2/g+6/tGKWIjMwU5HrWD4xtmURzYwT8pAFAHmWrD58Y/Gqlr/qz9av6wArHJ71RtfuN/vUARSZMp+prf05fkTntWC/Mrf7xrodNGAo7YoA37JOR6GvWvh5B9pjUvnMf3fpXl2lwmd44xyXYCvZPBMP2aVDj5R8uKAO/W1DwEEAkcg1Ja7U++eBR56QJuY8noKypZnNyR2PI9qAOiW7IBCZA9utSrKXX0NZNrliM5NaUfTmgCRotwySTiolXknnj9KtxsoXkUwDJ4HBoAWIA4OKtQtg4A61Hbwndn+Gr8KYJwoHNAE0SMQvy4qzFEB9etEQ2qD1FS+YBg4xigB8aDd1qSQoqYY81We5VDmNTmo0cuSWJNAFkS9NoBI6E02WaRzgsSKYBg9adjgdx6UARyAYyB81QSpkZHerJXH0qN16DtQBCkeBwMUkgAbJ6Yqyh9fyoaPPJ+tAEETYbGce1SZ6ZpmzJ7c1YER2EgYxQBAy5bnFNEYz/WpZExjjqaYI/mORxQAoUU44AoCGlCEEntQAuMiqV2h71qxREr90iq93AzIcDpzQBhNHjilVcc4NWTEA3I+lTrb/LjigDOMeSRSYwa0mhWqdzCACBQBkX86gbRkiuY1e78uIvn7vatjUHERcHPfmvPvFEsvkP82AWwOaAJW1tLtXUgBx71lNdMHeQNtArmftZgcnJyeuKuwXiXCAMQWNAFq41EyHZL8uehrOuzuORnJHSrEqpKoGPxrPlZo5AOqjj6UAQRW/mTfd4FbmlW371ExyeKrWLguRwCa6vw/YiQmUDHFAGdNppjdiq/Sq8+ntjzXX5a7eW0DogIAPcgdabJp6NFtC5B7UAebX1mrowYZBrhtWg8i4Kj7oP5V61rGnGIHaMCvPNYtyWfK85oAi8G3rWOv2UwOV3hHHqDXR+PbTbbXQXBEchYEelcdpSFdRtlxz5g/nXa+LpC9jdg4INAHi+tD5jwMVm233G+tbOtrkGse3+4eO9ADCMzkf7RrorBSMDjgVgIu64OOu7+tdFZDFAHb+CbfztTQkZCKWr2Gy2WOjC7k4DngeteYfDhFM1y5HzKnFdx4zumSDTbFDhI4hI2OhJoA3rDUnvohK3XpgVqI29NxHPauS8MSMsJQ885Ga6qKTIUcA/SgC/aTjGB1zWnDMrdGya5zY4mAT7p5NbdhDwGxQBohtzcZxVqNd208n0qOKLCjPJzxV2IAEAHnNAE8MWAAKtIFHG38agWUKaQTZGOaALwYBfaq0rsxO3pntTA5xz07VHvxjk0APAYkDPSrcQAx6VUGSe2KtxD5QPSgCYce9LgDGMmnBGJBHTvUyQ4HJ596AITGxGAM0wwsTz93PStAYTp196inkVRkkfhQBX+z7Tz+lIykdenrTvPBBwPzpyPlSCPxNADEiDSDKnAq0iA5BApobn/AAqSMMGJNAFeeMc4XpzgVCAOauuMnrULR85FAEKrx0qVEyOlCoTt5PFWo0wB696AFjjAQjGeKrTR4ycVoJgAYpk+0o3HNAGG4UEkrzTWkH1pbpx5mM5NRAZzkigCKS5jX5TwwqhJcCRicg1LNEDKWLVRulRMkEAdTQBm6rAGOeMmuA8YWoeNVBwepFdre3yDeS2QK43XJY73BVysgJxQB5jfxMisSORxWfY3BRsE45rq9b06TyywRjt61z0di7tgr0PXFAGxaS4jI6r70tyisTtI3Co47WRY+hxipLeJ5JVUITzjpQBLp9pJLMu0c13mkx/ZYvKGfxqvoOliAKGT52HU1tx2/lsQw470ASrKpUBuMCgfK24EEHriopk6kZrNa6eCTBPyj3oAm1mAPGTwDivP9a0/II28+uK7+S78+IBRz0INYl7EsisD17YoA8zsrNo9agzztbdnFa/ip8afID1Y4rZTSwZpZlH3RjNc34tYrEqHrmgDzjWBgHjnFYUQwG+tdHqqce9c+By2euaAGwj/AEr/AIEa6CxyDzWFEALk59TW9YgdaAPQ/Acpg+0Ef3RXX+Iv3zWEhOd0W09+lcN4PJEsijqy1393EZtGtmA/eRNyfagCbQvlK9yRiustNzNgjg9cVzmh27SZIGOlddp1uFIyefWgC/Z2vOT07CtaJdgwvA7iq0WFGM1KJuAAaALiuAAKf5pye2ODVETE9afHJzyKALxl3N14qWFvTO33qnG2Qc1Yjb5fQk9KALAPJweKXjjrUagnHFTKtAEsCkjrxV6IBRg5qrCcfUVYEnvQBdjIKjgc8YpJJABtI59qqCVmA549KdnjJoAleQkZJ/WoHJJ6gj0qTIPUVEy4bmgAPbP5U4OAcUzA60nfmgCykgByeMVOJe+4/SqSk1LGNxHFAFhpAT15pNwPOfak2gdaAvp09KAHo2D0qZGyOBUcadd1SKMdDxQA/JqK6Yqp6elWFTI61BfxloTt7UAYF0QX4PPeq7tgYU1YnXru5qndHbAz9cUAZOsailnEWZsGuK1jxT8v7rHuc1J4humuFlUk7T0+leYXd00MskbYODxmgDqU8RJcSNHKQAT2NW5bdZ7Rmi+bI4Yc4Nef8t8ynBre8NalcW7mNsvFnkGgC7azPHI9vcqWU9Ca3LHRYJVz5QG71FWUgt75UlCgH+Lird3eRWEQAYAKPzoAq/8ACORqmMZHtTZILXTIiXRcgZHFMt/Ef2hggG0fSsHxTfSMVAIMeCKALdp4k8278tUyR0Irr7ORZ4i56mvK9BVvthIHBHBr07TlMduueD/OgB1yMEjj8KxtRRWUk9q3rjBXdxzxWTeR5Bx1oAx1kZGGOnrTZJFc7cDdmldPnII7dc1W8lvPUrwByaANW3tv9EIAAB61554+tzHOCBhU49a9FtZ0VNrAc9a5HxfbrPBcEAklSR+FAHj+qLlPaucfiR/rXS6l9xh0Fc5IAZH570APtoy902PU10NjDyqgfjVHTLVjdSNjnOBXW6Pp5eVeDn6daANfwvbsl9AcdTivVtM05p4TEVyG61zXh7Q5BIrsnT9K9e0PTNsQYr97HSgDF03SvIwuMAcDitaO3CDpW21ptHSoHg6gCgDOJCggUBWbqPer/wBl7nipUtCecdqAKKJgccVNEhPUcVeS1welTR23NAFNIznpVmKM7elWkg55FSeVyBg0AQovGBnNSHpjHSpQnYUuw46UAMQnaM9alTPINCRHpU6RHHSgBEXipMe1PjQnntU3lj0oArcjtSHk8c1aZAMkjrUflZPHFAFfB6UuMdas7AO1IUBoAhUZOKsRkbeBSBcdKUA7uBgUAONGfzpMHOKMEHmgCRSO9SI3AqEA5GKkVT1NAFpCKRzngVGhwRzTjg8g4NAGZf22ZNy9xyKzbq232zKBlsdK1NQu47bJc1jJqiTOwjI60AcNruiGWN2QkMc8V5J4h0e6tJWZ0JH6V9KXFukybtucjmuc1bQraeN1kUfiKAPnuw3biGGAK3tOtJQxMa5Hau7ufClmk2/Z+VWoNGt41G0YP0oAx9HR4mwAcHrms7xyJVVCmQp4rtlsdkeVGSar6xpiXdoyyDJFAHmOmzHb8w2+9N1XdIFjbnPf3ro7nQ2QAJgL1rM1O22gKvX1oAraWyxOozyvtXeafOJ7dc5JA9elcRZ2krNuGQK6rR2MURU4zQBuRruiYd6zrpSpOa0rOTdjp6U28gDAjAJ9aAOVmX943ahQFjLY5PtVq/iKNntVB3AUk+lAGRqt00LOycYovZEu9ItpgeXR1P1ArM1eTJYDvSJL5ekRI3YO/wCdAHleqcBx2zXNy8yufeuj1Q5DfWubbl3+tAHqnhPw1cX95N5cRO09cdK9W8N+B2jdWlTn6dK9k8OeDtLsPMEEQG45OFxXRQaRbRfdWgDz3TfDvlqMJx0ziuys7Hy4AAvQelbS2kK9EqbaMYxQBzcsG9jgY7VH9k5HFdC0Cc8VEYV3UAYgtR35pfs9a/krTfKXFAGYtuPSpFhFX/KHNKIgBQBRWMD3pfL9qvCIVIIloAzlh9BxUgg9q0BEKkEY4oAoLBjtUyw4q4IxS7QKAKwi46cCnCP24qxRQBBs56U0xY5AFWcUhUGgCk0fPem+XV0qM00oKAKuz0p20nJzzU5QU1kFAEDYHWlUA8A5+oqZY1NPSMCgCMJweeaCCKsgYoIBoArHpxmqt5I0a8ZBPFaDIByKp3CZbBOee9AHM6xHJNF3Y5rJhtJVkDYIrtzaRuBnvQbCIDI/lQBn2iFoQH4OKp6hbtgjsa6K3tkGKknto3GCO1AHBS2pzwMg+1Q/YCTleOewrrJbFFc4Y4zUsdjHjOf0oA5JrN4kJYcnmofspaNuv0rrru1TP0OKimtI1h49KAPP7u1C5V8c1izaZHK/IJJ712GoWqtM2WP5VTW0UOBu/SgDAXSQqZxSCyCIQB3rs47JPLOTn8KjnsY8gZ7elAHMWalXwQQegrQZCxwwBrQFkisCD39Kc0C7uT3oA568s9ykVz91ZMm4KOvevQWtEJINUbjT4m69fXFAHk19p7tMqBfvHn2rO1iJ4rWcYwFjIFeoyabEZHY9V9q5XxVp8Ys256sB0oA8H1OM7WrnJBskYe+a9A16wRJGw36Vx19Z7blgHOB7UAf/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This is extensive primary tuberculosis in a toddler. There is right-sided hilar adenopathy, narrowing of the right mainstem bronchus, and collapse-consolidation of the right lower lobe.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jeffrey R Starke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f42_17_43295=[""].join("\n");
var outline_f42_17_43295=null;
